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Abstract of the thesis
1. A strain resistant to melarsen oxide was produced from a laboratory
adapted line of Trypanosoma brucei using the short passage method.
It was necessary to passage the original line of trypanosomes 18 times
with 16 exposures to the drug to reach a resistance factor of 13.
With the help of a drug sensitivity test, using the oxygen electrode
and Warburg manometry, it was found that the new strain is a heterogene
population of trypanosomes with respect to the sensitivity to melarsen
oxide. The resistant character is stable after serial passage in rats.
2. Different alternatives were suggested and investigated in order to
rationalise the development of resistance in biochemical terms.
The alternatives were:
- Modification of metabolism to bypass the action of the drug.
- Modification of enzyme targets with regard to different kinetic
parameters, increased specific activities and different
sensitivities to the drug.
- Modification of the drug transport.
3. The metabolic studies showed that although the glycolytic sequence
is the basis of metabolic route in both parasites, the resistant strain
shows lower pyruvate/glucose and pyruvate/oxygen ratios from glucose
catabolism when compared with the parent line. Furthermore some CO^
is produced by the resistant strain with an RQ value of 0.1 (approx.).
These characteristics are observed in the absence of the drug.
The patterns of inhibition of the oxygen consumption with whole cells
from the parent line and the resistant strain were different. The I
value for the parent line was 6.25 x 10 ^M melarsen oxide and only 25
to 30% inhibition is observed for the same parameter at the highest
concentration of drug used (250 x 10 ^M) in the resistant organism.
The patterns of inhibition in water lysates however are apparently
the same in the parent line and the resistant strain? this feature is
ix.
interpreted in terms of a permeability barrier for the drug in the
drug fast trypanosomes. The general carbon balance with whole cells
from the parent line was severely affected under the influence of the
drug as a sharp reduction was observed in the pyruvate/glucose and
pyruvate/oxygen ratios from glucose catabolism. This corroborates
data already reported, suggesting that pyruvate kinase (E.C. 2.7.1.40)
is the focal point of action of organic arsenicals. When the same
parameters were investigated in whole cells from the resistant strain
a minor inhibition of the metabolism was found, with the difference
that the metabolic ratios remained constant in the presence of the drug;
furthermore the CO^ production described in the absence of the drug
was abolished. Therefore it is suggested that although some common
site of inhibition is still affected in the drug fast organisms, there
is also the possibility of a minor pathway for the further metabolism
of pyruvate when the drug is present.
4. The enzymological studies suggest that pyruvate kinase already
reported as the main target of arsenicals in trypanosomes has the same
kinetic characteristics in the parent line and the resistant strain.
The S5Q values with respect to phosphoenolpyruvate were 1.60 - 0.30 x 10
Hill coefficient = 2.16 - 0.30. The K value with respect to ADP was
m
3.17 - 0.22 x lO ~^M. The V values in terms of mg of protein were
max
also the same in the parent and resistant line. Phosphoglycerate
kinase (E.C. 2.7.2.3) another target of organic arsenicals did not
show any modification as a result of the development of resistance.
The enzyme showed apparent hyperbolic responses with respect to ATP
and phosphoglycerate; upon linear transformation of the data, ATP
showed biphasic linear responses with K value = 0.89 - 0.20 x 10
mi
and K value = 0.30 - 0.9. Phosphoglycerate showed a simple linear
m2
+ -3
response with K value = 5.80 - 0.42 10 M. The V values in terms of
m max
X.
mg of protein were also the same. Pyruvate kinase and phosphoglycerate
kinase in resistant strain showed similar patterns of inhibition with
respect to melarsen oxide when compared with the parent line (I^q
-5
value for pyruvate kinase = 7.60 10 M melarsen oxide; I value for
-3
phosphoglycerate kinase = 0.53 x 10 M melarsen oxide.)
5. When drug transport studies were performed it was found that melarsen
oxide gets into the parasite via a carrier mediated mechanism with the
following kinetic parameters, calculated using a non-linear correlation:
~*6 —1 —1
K value =14.42.10 Ms V =5.19 nmoles min mg protein , Hill
t max
coefficient = 2.27. It was found that the resistant strain lost the
carrier mediated transport mechanism and only a diffusion component,
assumed to be present in the parent line, remains responsible for a
low rate of uptake. The transport of melarsen oxide in the parent line
is concentrative, inhibited by the analogue melamine (K_^ 7.0.10 ^M) ,
temperature dependant, inhibited by iodoacetate and possibly involves
-SH groups as indicated by the lack of uptake of the pentavalent sodium
melarsen.
Uptake studies using different arsenicals suggest that there is a
single site of uptake for the drugs studied and that resistance in the
new strain is the result of a modification of that part involved in the
binding of the melaminyl residue of melarsen oxide at the uptake site.
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1. INTRODUCTION
1.1 General introduction
1.1.1 Natural history of sleeping sickness and drug resistance
Human trypanosomiasis (sleeping sickness) is recognised today as a
major health, economic and social problem in Africa. The trypanosomes
of man and the counterparts in domestic animals, with the consequent
problems caused by them, are a major barrier to economic and agricultural
development in large areas of the tropical sub-continent. In practice
it has been found that chemotherapy plays a major role in the control of
human and animal trypanosomiasis. The causative organisms and the
disease, which have been studied since the beginning of the century,
are of sufficient importance that today they are considered main features
of the Special Programme for Research and Training in Tropical Diseases,
sponsored by the World Health Organisation (WHO, 1976) .
Trypanosomes of the brucei group are the causative organisms of
sleeping sickness. Members of this group are of wide distribution,
especially in Africa, and throughout the world (Ormerod, 1979).
Trypanosoma brucei rhodesiense (hereafter referred to as T. rhodesiense)
and T. brucei gambiense (T. gambiense) are responsible for the acute and
chronic forms of the human disease respectively. Probably both
subspecies of trypanosome which infect man in Africa evolved from
Trypanosome brucei brucei (T. brucei) or at least from a common
ancestral species (Baker, 1963). Normally, an infectious disease such
as sleeping sickness, changes its natural history as parasite and host
establish a genetic balance based on the invasiveness of the parasite
and the resistance of the host, when an insect transmitting agents are
also involved (Ormerod, 1970).
Different approaches to restrain the disease have been taken either
by controlling the insect vector or the parasite. In the first category
both tse-tse eradication with insecticides (Davis, 1971) and insect
population control with sterile males (Dame, 1970) have been tried.
2.
The former is the most common and practical method in the field (Burnett,
1970). Vector eradication by insecticides, if 100% successful, could
interrupt the transmission cycle. The ^ vulnerable aspect of vector
control by insecticides, however, is the risk of reinfestation.
Biological control by the release of sterile male tse-tse flies is
being investigated, the principal constraints being the development of
suitable systems to produce colonies of flies and the reduction of the
population of insects to manageable densities prior to the release of
sterile males (WHO, 1976). For many years it has been accepted that
the best way to control sleeping sickness is to form permanent
agricultural settlements so that the tse-tse fly is excluded from
inhabited areas and is not constantly around the houses (Wilcocks, 1962).
Another important approach to the control of sleeping sickness is
that of selective chemotherapy and removal of the trypanosomes from man
or infected animals. Chemotherapeutic control of African trypanosomes
relies on only a few active structures, four drug classes now being
available: suramin, melarsoprol and nitrofurazone for curative
purposes and pentamidine for prophylaxis. All these drugs have serious
side effects.
Drug resistance to most chemotherapeutic agents is a widespread
phenomenon. It has been suggested that it is as old as chemotherapy
itself (Schnitzer and Grunberg, 1957). In 1907, when Ehrlich reported
the trypanocidal action of rosaniline he also included Franke and
Roehl's observation that the trypanosomes could be rendered resistant
to the dyestuff. Resistance to melaminyl arsenicals, of which melarsoprol
is a representative, is a matter of serious concern. It has been
reported recently that resistance to melarsoprol is occurring with
increasing frequency (WHO/FAO, 1979). Apart from the work of Damper and
Patton (1976a,b) on the mechanism of resistance to pentamidine,
3.
little or inconclusive evidence is available regarding resistance to other
drugs like organic arsenicals and specifically the melaminyl arsenicals.
It is for this reason that the main objective of this thesis was to gain
some insight into the mechanism of development of resistance to these
active substances in T. brucei.
1. 1.2 Taxonomical position of T. brucei
The systematic position of trypanosomes among protozoa, with special
reference to the African organisms, has been discussed rigorously by
Hoare, (1970). The genus Trypanosoma has been divided into two sections:
salivaria and stercoraria, in which the different subgenus are arranged
(Hoare, 1964). This subdivision is based on the development of the
parasite in the mammalian host, the subgenus Trypanozoom to which the
Brucei group belongs, being classified in the first section. Trypanosomes
of the Brucei group may be regarded as a complex species, in which there
are different groups of organisms with different modes of transmission,
different degrees of virulence and epidemiology; these characteristics
however, are not sufficient to justify a classification higher than
the subspecific level (Ormerod, 1967).
The proposals for the nomenclature of salivarian trypanosomes and
for the maintenance of a reference collection, as suggested by the
WHO (1978), were used throughout this work. An attempt has been made
to present the pedigree of newly developed resistant lines, using this
nomenclature.
1- Life cycle and morphology
A complete account of the development of resistance in these
parasites should consider the possibility of modification of some
aspects of their physiology throughout the life cycle. The possibility
is greater for the stages of the life cycle in the mammalian host,
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when the trypanosomes are in direct contact with the drug. No information
is available on the possible participation of the insect stages and the
role of the insect vector on the development of resistance. In any case
transmission by the insect vector does not seem to impair the stability
of drug resistance in trypanosomes (Murgatroyd and Yorke, 1937, Gray
and Roberts, 1968).
Infections with T. brucei, show a marked variability, in size and
shape of the trypomastigotes circulating in the blood (pleomorphism).
The three main different forms are the long slender (L.S.), the short
stumpy (S.S.) and the intermediate (I.S.S.) form (Hoare, 1970, 1972).
The development of different forms is not confined to the stages in the
mammalian host but also occurs in the insect vector, where the S.S.
trypomastigotes or preadapted forms for the invertebrate undergo
further morphological and biochemical change (see Figure 1.1). An account
of the biochemical significance of these morphological changes is seen in
Table 1.1, adapted from Gutteridge and Rogerson (1979). Finally a
monomorphic, laboratory adapted line of T. brucei was used in the
experimental section of this thesis. It should be noted that the
arsenicals are equally effective against monomorphic and pleomorphic
lines (Flynn and Bowman, 1973).
1.1.4 Development of the life cycle in vitro
One of the greatest obstacles to studying the physiological changes
associated with drug resistance in trypanosomes is the inability to
cultivate these organisms in vitro (Bishop, 1959). The present status
of the in vitro cultivation of animal infective African trypanosomes
(where the phenomenom of drug resistance occurs regularly) was reviewed
recently by Hirumi et al„, (1979) . The continuous propagation of
haematozoic trypomastigotes of T. brucei and T. rhodeniense, retaining
their infectivity for the mammalian host is now possible (Hirumi et al.,
5.
1977a,b, Hill et al., 1978). Although, there are some chemical and
physical parameters that remain to be fully characterised, in vitro
cultivation of these parasites is a potentially important tool for the
study of the development of drug resistance under fully standardised
conditions. However the original statement of Bishop, still obtains
in spite of recent developments in this area of the biology of the
parasites.
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1.2 The action of organic arsenicals and drug resistant in
1.2.1 Terminology of arsenical drugs
The nomenclature of Doak and Freedman (1960) has been adopted in
this work. The names and structures used are shown in Table 1.2.
The structures do not necessarily represent the form in solution.
Some information is available on the dominant forms of organic arsenicals
in solution but by no means is there complete agreement on pka values and the
extent of hydration. A complete account will be found in Webb (1966).
1.2.2 Development of the melaminyl arsenicals
The development of the chemotherapy and chemoprophylaxis of
trypanosomiasis in man has encountered many technical problems; the
particular case of aliphatic phenyl arsonic acids and their reduced
counterparts can be used to exemplify this point, the development of
resistance being a major drawback to their utilisation. Differences in
sensitivity between different lines of T. rhodesiense and T. gambiense
also made these drugs ineffective in some cases. Finally the toxicity
of these structures made them unsuitable for widespread use. A need
for new compounds active against African trypanosomes was evident by the
middle of this century and a unique class of phenyl arsonates and
arsenoxides, in which melamine (2,4,6-triamino-s-triazine) is coupled
to the para-position of the metal containing substituent was developed
by Friedheim, (1940). The new pentavalent arsenical,named "melarsen"
was found to be very effective against late-stage human trypanosomiasis.
The trivalent analogue melarsen oxide (Friedheim, 1944) was very potent
against the flagellates in vivo and in vitro (Rollo and Williamson, 1949)„
Unfortunately, according to the latter authors, the toxicity of melarsen
oxide precludes its general use.
The activity of melarsen against tryparsamide resistant T. gambiense
is of considerable practical importance as it was found that the
7.
compound was not only active in the laboratory (Williamson and Lourie,
1948) but also in the field (Van Hoof, 1947). Also medication with
tryparsamide and other pentavalent arsenicals may be responsible for the
development of ocular lesions under experimental conditions (Hurst,
1959). Melaminyl arsenicals are however apparently unable to produce
optic lesions. The organic substituents therefore appear to have some
specific influence on the uptake of these drugs by the central nervous
system (CNS) (Williamson, 1962; 1970).
The development of B.A.L. (dimercaprol or 2,3 dimercaptopropanol)
by Peters et al., (1945) as a detoxifying agent for arsenicals by the
formation of a stable ring compound with the trivalent arsenic, led to
the development of different organic arsenoxides. The first was the
less toxic compound melarsoprol (Mel B) and the second an even less toxic
and more water soluble derivative, melarsonyl potassium (Mel W)
(Friedman and De Jongh, 1959). The main advantage in the use of
melaminyl arsenicals was their ability to cross the blood-brain barrier
and to show activity against the late stages of infection with CNS
involvement (Williamson, 1962). This characteristic seems also to
depend on the drugs ionisation state and lipid solubility (Friedheim
and Vogel, 1947).
In spite of the problems associated with drug resistance and
toxicity, Mel B is widely established as the drug of choice in the
treatment of the later stages of sleeping sickness. Nitrofurazone is
employed in melarsoprol resistant cases (WHO/FAO, 1979).
It has been suggested (Flynn, 1971) that these disulphide
derivatives Mel B and Mel W are hydrolysed to the arsenoxide form,
before they can be active therapeutically. Because of the evolution
of these compounds from melarsen oxide and the necessary reversion
to the original structure for activity, melarsen oxide has been used
in the experimental part of this work, as a model for the melaminyl
arsenicals _
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1.2.3 The action of arsenicals on metabolism
Organic compounds of arsenic have been used as toxic agents for
several hundred years. The toxicity of these compounds made them
particularly popular as suicidal and homicidal poisons of widespread
use during the 16th and 17th century. As a result of their potent
action much effort has been directed towards elucidating the mechanisms
of action of these compounds.
It has been known for a relatively long time that inorganic
arsenite has a lethal effect on trypanosomes but its toxicity precluded
general use. Thomas and Breinl, (1905) realised the value of sodium
arsanilate in the control of murine trypanosomiasis and at the same
time, the curative effect of this compound on human sleeping sickness was
reported. From the beginning there has been disagreement about the
action of arsenicals in vivo and in vitro. For example, the above
observation did not correlate with that of Ehrlich (1909) who reported
that sodium arsanilate was inactive in vitro. Thanks to the variety
of results obtained and to the antagonistic conclusions put forward a
complete generation of organic arsenicals was developed for the treatment,
not only of trypanosomiasis, but also of syphilis and of amoebiasis.
These new compounds are now well known as enzymatic and metabolic
poisons in mammalian tissues (Webb, 1966).
Ehrlich, (1909) suggested that pentavalent arsenicals must be
reduced to the trivalent form in vivo to be active and he did not
consider the mechanism of action to involve the release of inorganic
arsenite. A very important phenomenon reported since the appearance of
organic arsenicals was that certain microorganisms become increasingly
resistant to these drugs during continuous exposure (see Webb, 1966).
Some of the most important concepts in chemotherapy were suggested
as a result of the work with organic arsenicals. Ehrlich recognised the
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importance of the quantitative measurement of the relationship between
the dose of a compound and the therapeutic effect produced by it.
Another concept developed was the existence of an arseno-receptor in the
cell, required for the drug, to exert any biological action. It was
later found that these specific receptors within the cell were thiol
(-SH) groups (Voegtlin et al., 1923 and Barber, 1929) . The original
concept of arsenicals as "protoplasmatic poisons", suggesting that
arsenicals exert their activity by non-specific coagulation of proteins
(Ehrlich, 1909) was therefore untenable. The idea of metabolic
inhibition was gaining ground and a clearer picture emerged, although
without definitive conclusions.
Krebs, (1933a,b) showed that arsenite caused a marked accumulation
of pyruvate and other ketoacids during the metabolism of amino acids by
kidney preparations. It was evident that the oxidation of ketoacids
was specifically blocked by arsenicals and, this observation was the
first evidence of the primary metabolic target in the mammalian model.
More evidence with different tissues has substantiated this hypothesis.
The work of Peters et al., (1946) and Peters, (1955) demonstrated
without question that pyruvate oxidase and the oxidation of pyruvate
are extremely susceptible to trivalent arsenicals and this also
suggested the participation of thiol groups in the mechanism of the
reaction.
However the mechanism of action of organic arsenicals on the
metabolism of trypanosomes remained a mystery for many years as it was
shown that monomorphic bloodstream trypanosomes lack the a-ketoacid
oxidase systems (Ryley, 1956, Grant and Fulton, 1957, Flynn and Bowman,
1973). Hence there must be an alternative site of action for arsenicals.
It is now known that there is a definitive preference for pyruvate
kinase, which has been pin-pointed as a major focal point for the
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trypanocidal activity of organic arsenicals, melarsen oxide being
one of the most important (Flynn, 1971). It has also been shown in
this thesis that the enzyme phosphoglycerate kinase of T. brucei is
inhibited by different arsenicals. The main site of action pyruvate
kinase is constant for the pleomorphic and monomorphic forms of the
parasite (Flynn and Bowman, 1974). A more detailed account on the
action of organic arsenicals, including the melaminyl arsenicals,
is given in subsection 2.1.6.
With regard to the therapeutic effect of these compounds, the
earliest arsenicals used were usually pentavalent arsonic acids.
The same compounds were found to be inactive in vitro so reduction is
considered necessary, as the arsenoxides are the recognised enzyme and
metabolic inhibitors (Webb, 1966). It has also been suggested that the
organic part of the molecule does not participate directly in the
reaction with the target but serves to modify the properties of the
drug molecule, especially with regard to the penetration of cell
membranes. More evidence on the state of oxidation of arsenicals showed
that atoxyl and other related arsonic acids are not readily reduced to
arsenoxides in the body. However, local reduction by the parasite
remains a possibility (Crawford and Levy, 1947; Frost, 1967).
This situation remains unclear as Lourie et al., (1935) reported
reduction of tryparsamide to a highly active compound when incubated
with erythrocytes. To avoid any complications as a result of the
state of oxidation of the drug, the trivalent arsenical melarsen oxide
is used in this work, this compound being active both in vivo and in vitro.
1.2.4 Carbohydrate metabolism in members of the Trypanozoon subgenus
It may be seen that the action of organic arsenicals is closely
related to the metabolism of carbohydrates in trypanosomes, it has also
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been suggested that a modification of the metabolic pathways involved
may be acquired in the development of resistance to these drugs.
A brief review is therefore appended of the general metabolic pathway
of carbohydrates in members of the Trypanozoon subgenus, because of
the involvement of the mechanism of action of arsenicals.
Respiration in bloodstream trypanosomes occurs via a cyanide and
CO insensitive pathway, found in all members of the Trypanozoon subgenus
(von Brand, 1951; Fulton and Spooner,1959). The members of this group
have an absolute dependence on an exogenous supply of carbohydrate.
Glucose, fructose, mannose and glycerol will support mobility and
respiration of the L.S.form(Ryley, 1962; Bowman and Flynn, 1976).
These organisms have no endogenous stores of carbohydrate or any other
endogenous source of energy (Ryley, 1956).
The metabolism of carbohydrates is incomplete. Aerobic glycolysis
occurs via the Embden-Meyerhof pathway with the difference that it
proceeds at a faster rate than in the host tissues. Also, pyruvate is
released into the host bloodstream (Ryley, 1956; Grant and Fulton, 1957).
Pyruvate cannot be further metabolised as bloodstream forms of L.S.
T. brucei do not have a-oxoacid oxidases or a functional citric acid
cycle (Flynn and Bowman, 1973). It has been found recently, that the
rate limiting step of glycolysis in these parasites is the transport of
glucose into the organism (Gruenber et al., 1978).
The NADH generated during glycolysis by the action of glyceraldehyde-
3-phosphate dehydrogenase is reoxidised by means of two coupled enzymes;
NAD+-dependent L-glycerol-3-phosphate (GP) dehydrogenase and a particulate
GP oxidase originally reported by Grant et al., (1961). Catalytic
amounts of dihydroxyacetone phosphate (DHAP) are then reduced by NADH
to form glycerophosphate, which is the substrate of the GP oxidase.
GP is reoxidised to DHAP with the reduction of molecular oxygen.







The scheme was constructed from results published by Oduro (1977);
Opperdoes et al. (1977) and Opperdoes and Borst (1977)
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The overall reaction catalysed by these enzyme systems is the transfer
of electrons from NADH to molecular oxygen forming water, with a net
glycolytic yield of 2 moles of ATP per mole of glucose. Pyruvate is
the only end product under aerobic conditions (see Figure 1.2). As reported
above pyruvate is not further metabolised because of the absence of a
functional Krebs cycle and also the lack of lactate dehydrogenase
(Dixon, 1966) . Two enzymes are present for the fixation of CC>2 in L.S.
forms of T. brucei (Klein et al., 1975); malic enzyme and ADP-dependent,
PEP carboxykinase have been characterised, pyruvate carboxylase being
absent. The metabolic significance of these enzymes is still open to
discussion.
Under anaerobic conditions, Grant and Fulton (1957) and recently
Hammond (1979), have shown that one mole each of pyruvate and glycerol
accumulate per mole of glucose used. DHAP is postulated as the final
electron acceptor (Bowman and Flynn, 1976) . Originally it was thought
that glycerol could be formed by the action of phosphatases on GP as
reported by Harvey, (1949) and Gerzeli, (1955). However, there is much
evidence to indicate that ATP is synthesised from GP anaerobically
(Fulton and Spooner, 1959; Opperdoes et al., 1976; Clarkson and Brohn,
1976; Fairlamb et al., 1977). Recently it has been found that
glycerolkinase uses GP and ADP to form ATP and glycerol with a net
synthesis of ATP (Hammond, 1979).
The line of T. brucei used in this work corresponds to the
characteristics described above.
1.2.5 Distribution of glycolytic enzymes and compartmentation in T. brucei
It has been recently shown that in T. brucei many of the glycolytic
enzymes are located inside a microbody-like organelle (Oduro, 1977;
Opperdoes and Borst, 1977). This localisation is different to the
situation in other eukaryotes. The localisation of these enzymes in a
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particulate form indicates that the organelle can catalyse the following
reactions:
glucose + 2 DHAP + 2 > 2 (GP + 3PGA)
glycerol+ 2 DHAP + P. > 2 (GP) + 3PGA
l
It can be seen that the reactions performed by the glycosome are self
sufficient for the production and use of ATP, the reduction of NAD+ and
the reoxidation of NADH (see Figure 1.2) .PGA leaves the particle and once
in the cytoplasm is further metabolised to pyruvate with a net synthesis
of ATP. At the same time GP leaves the particle, under aerobic
conditions, to be oxidised in the mitochondrion by GP oxidase, these
reactions may be summarised as follows:
3PGA + ADP * Pyruvate + ATP + H^O
GP + hC>2 * DHAP + H2<D
The intracellular localisation of the GP oxidase complex was until
recently thought to be in a microbody-like structure (Mtlller, 1975) .
However, new evidence supports the idea of a mitochondrial location
for the enzyme (Opperdoes et al., 1977). It has also been found that the
localisation of glycolytic enzymes in Crithidia fasciculata and in
different stages of the life cycle of T. cruzi, is similar to that of
T. brucei. It has in fact been suggested that the glycosome is a
general feature of the members of the Kinetoplastida (Taylor et al.,
1980).
Trypanosomas are, as reported earlier, dependent on glycolysis for
ATP synthesis. It has also been suggested that the glycosome has evolved
to optimise conditions for glycolysis by creating a compartment where
optimal concentrations of enzymes,substrates and cofactors are maintained
(Opperdoes and Borst, 1977; Oduro, 1977). Also, it has been reported
(Visser and Opperdoes, 1980), that the enzymes within this particle
exhibit latency, suggesting the presence of a limiting membrane.
Table1.3:hectionofarsenicalsenzym sim mb rtg nuTrypa ozocn. Enzyme Adenosinetriphosphtase Glycerolkinase L-a-glycerolphosphate oxidase 91 Hexokinase 90 a-ketoglutarate decarboxylase 99 Phosphofructokinase Phosphoglyceraldehyde dehydrogenaseSource T.eguiperdum T.brucei T.brucei 89 T.equiperdum 89 T.rhodesiense(SS) 89 T.rhodesiense T.equiperdum PhosphoglyceratekinasT.bruc i PyruvatedecarboxylaseT.rhodesiens(SS) Pyruvatekinase Trioseph sphate dehydrogenaseT.brucei T.hippicum Phosphoprotein,phospho¬ lipidsmetabolismT.equ perdu a,5*'calculatefromtheriginalArsenical oxophenarsine melarsenoxid oxophenarsine melarsenoxid oxophenarsine tryparsamide melarsenoxid phenylarsenoxide oxophenarsine Tryparsamide oxophenarsine melarsenoxid phenylarsenoxide reducedatoxyl melarsenoxid phenylarsenoxide melarsenoxid phenylarsenoxide reducedatoxyl oxophenarsine oxophenarsine data.
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However it was found that the pool of glycolytic intermediates inside
the glycosome equilibrates with the cytoplasmic pool. The possible
involvement of the glycosome in the development of resistance was
partially evaluated in this work.
1.2.6 Mechanism of action of melaminyl arsenicals
As mentioned previously the primary site of action of organic
arsenicals in mammalian cells is considered to be the a-ketoacid oxidases
(Peters et al., 1946). Undoubtedly the toxicity to the mammalian host
of these drugs is due to inactivation of metabolically active thiol
groups, probably involved in oxidative reactions (Voegtlin et al., 1923;
Johnstone, 1963).
From the known nature of the metabolism of monomorphic trypanosomes,
the organic arsenicals would not be expected to exert any profound
trypanocidal-effeet. L.S. forms of T. brucei and T. rhodesiense do not
oxidise pyruvate or a-oxoglutarate and cell lysates of these organisms
do not have demonstrable pyruvate oxidase activity (Flynn and Bowman,
1973). In spite of this, there is a very rapid effect of melaminyl
and other trivalent aromatic arsenicals on the flagellates, suggesting
a site of action on the energy producing systems (Williamson, 1975).
The site of action was found to be constant in monomorphic and pleomorphic
lines of trypanosomes and also independent of a-oxoacid oxidases in vivo
(Flynn and Bowman, 1973). Analyses of the mode of action of melarsen
oxide, showed the terminal glycolytic enzyme (pyruvate kinase) of
T. brucei to be the main focal target inhibited by the drug (Flynn and
Bowman, 1968; 1969). A summary of the action of organic arsenicals,
including melaminyl drugs, on semi-pure enzymes from members of the
genus Trypanozoon is presented in Table 1.3.
The general mechanism of action of these toxic agents consists of
at least two stages; a preliminary fixation, which may be reversible
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and a subsequent lethal action at the target site (Clark, 1937). This
idea correlates with the double functional feature of toxic agents
proposed by Ehrlich in which the "haptophore" is involved in binding to
a cell receptor and the "toxophore" exerts the lethal action. Melaminyl
and other aromatic arsenicals are considered to have these characteristics,
the organic residue being the haptophore and the arsenic moiety being the
toxophore.
The selectivity of melaminyl drugs for the flagellates can not be
explained in terms of thiol inactivation, as the equivalent target
enzymes in the mammalian host are also inhibited (Flynn, 1971). Instead
it is thought that this is controlled by the non-metallic portion of
the molecule. Some effort has been put into the investigation of the
effects of substituents on the organic residue to aromatic arsenicals
(King and Strangeways, 1942) . Lately it has been suggested (Newton, 1974)
that changes in the substituent groups of organic arsenicals may alter
the affinity of the compounds for their binding sites on enzymes or their
ability to penetrate permeability barriers. The paramount importance of
the organic residue is clearly recognised, not only in the uptake itself,
but also in the degree of selectivity of the compound for the parasite.
In the case of the melaminyl arsenicals the melamine ring serves to
increase the preferential uptake of the drug by the parasite.
It is concluded that the rational approach to the development of
resistance to melaminyl arsenicals should take into account this dual
character ascribed to the drug. Therefore an analysis of the target
enzymes and the mechanisms of uptake of melaminyl drugs was undertaken.
The investigation was not confined to the study of isolated enzymes but
also covered the study of the general metabolic properties of different




The different methods available for the estimation of organic
arsenicals can be broadly divided into bioassay techniques and physico-
chemical estimation of arsenic after digestion of the organic matrix.
Bioassay techniques have been used quite frequently in studies on drug
resistance in trypanosomes (Yorke et al., 1931; Eagle and Magnusonr
1944). The procedure consists essentially in exposing a given number of
parasites to a dilute drug solution, removal of the cells by centrifugation
and determination of whether the drug concentration remaining in solution
suffices to affect unexposed parasites. This routine has been adapted
*
for the estimation of melaminyl arsenicals (Hawking, 1962), and primary
information on drug resistance was developed with this technique.
However this technique is unsuitable for estimation of the kinetics of
the uptake of melaminyl arsenicals, which can only be studied with the
help of a more accurate, sensitive and reproducible method for estimation
of the drugs. It has been suggested recently (WHO, 1977), that for
the development of the rationale behind drug resistance and also the
general mechanism of drug action, radioactive drugs are needed.
Unfortunately no labelled arsenicals were available at the time of this
work.
By looking at the structure of a member of the melaminyl group, it
can be seen that different potentially important methods can be used
for estimation. Some routines have been tried; such as a modification
of Marsh's test but this method relies on qualitative estimation
(Hawking, 1963). Diazotization of the amino groups and coupling to a
chromogen has been tried without successful results due to the
instability of the melaminyl ring in acid conditions (Flynn, personal
communication). Recently a new method of estimation of trypanocidal
arsenical drugs, isotachophoresis, (Flynn, 1979) has been developed.
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This technique was only developed after a chemical estimation method
had been in use by the present author for a considerable time. The
chemical method was therefore retained in order to have comparable
results throughout the experimental work.
For the purpose of this work major attention has been paid to the
estimation of arsenic in the drugs using physicochemical methods.
Broadly there are three stages to consider:
1. Organic digestion of biological samples.
2. Recovery of arsenic from the digestion mixture.
3. Estimation of arsenic.
1. The treatment of the organic sample prior to analysis depends largely
on the analytical method used for measurement of the arsenic (Lewis,
1977). For the assay of total arsenic content, wet digestion of the
biological samples was chosen as a viable method. This method of
ashing is accomplished through treatment of the material with strong
mineral acids, peroxides or perchlorates. A small modification of the
routine suggested in the U.S. Pharmacopeia, (1975) was used in the
present work. Details of the method are found in Materials and Methods.
2. For the recovery of arsenic from the digestion mixture, different
methods are available. One of the most utilised involves the conversion
of the arsenic to a highly volatile hydride As^H^ followed by
quantitative evolution into a trapping solution (Lewis, 1977).
3. Again several techniques have been described to measure the arsenic,
most determinative methodology being based on detection of atomic species
or coloured complexes prepared from arsine. The technique of choice for
the present work involves the production of a highly coloured complex of
arsenic (III) with silver diethyl dithiocarbamate (AgDDc) (Dal Cortivo
et al.f 1960). This colorimetric method is reliable and the costs are
low. The only major disadvantage is that the digestion of the organic
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sample, generation and trapping of the arsine in AgDDC with several
samples, is a time consuming routine.
1.2.8 Resistance; Historical account and definition of the problem
Franke and Roehe (1905) discovered the phenomenon of drug resistance
when working in Ehrlich's laboratory. Infected rodents treated with sub-
effective doses of trypanocides developed a recurrent parasitemia after
a short period of time; after the relapse, a second treatment with the
drug proved to be ineffective. The new resistant character was stable
in the population of trypanosomes. It was then realised that organisms
under treatment with chemotherapeutic agents become resistant to the
drug to which originally they were sensitive. Observations of this kind
have been reported since the beginning of this century and nowadays it
is a common aspect of the chemotherapy of African trypanosomiasis
(WHO/FAO, 1979). Arsenical resistance was first developed in vitro by
Browning (1907), who also found that there was a variability in the time
required to generate resistance according to the arsenical used.
The development of resistance in vitro is now an accepted routine to
obtain drug fast trypanosomes to certain drugs (Schnitzer and Grunberg,
1957).
Yorke and Murgatroyd (1930) suggested that the term arsenical
resistance was improperly used since general tolerance to all arsenicals
is not developed. Instead resistance is developed only to a certain
class of arsenicals. Also Williamson and Rollo (1959) developed a
resistant line of trypanosomes to melarsen, which was cross-resistant
to other unrelated non-metallic drugs, indicating that the resistance
was not directly related to the metal moiety. In view of these
findings, and the ones presented in this work, it is suggested that the
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term "arsenical-resistance" should be rejected and replaced by a more
comprehensive definition which includes the organic residue, as well as
the metal part of the drug.
As suggested above it was found that the development of resistance
to a particular drug was accompanied by resistance to closely related
structures. More details on this particular topic are discussed in the
section 2.2.3 of this introduction. It is important to notice at this
stage that resistance to melaminyl arsenicals is an established concept
in the chemotherapy of African trypanosomiasis. It was found by Rollo
and Williamson (1951) that resistance to melarsen was possible and the
development of resistance to this structure produced cross resistance
to tryparsamide and pentamidine. The list of species which have been
rendered resistant to arsenicals includes T. equiperdum, T. equinum,
T. brucei, T. gambiense and T. lewisi. Studies on resistance to organo-
arsenicals have been carried out with different lines of the parasites
and with many organic arsenicals.
Many reviews have been published on protozoan drug resistance
including the phenomenon related to trypanosomiasis (Schnitzer, 1932;
Schnitzer and Grunberg, 1957; Bishop, 1959; 1962; Hawking, 1966;
Williamson, 1962; 1970). None of these reviews is able to give a
substantial indication of developments in the field with regard to
the mechanism by which resistance arises.
In the meantime it is useful to adopt definitions of drug
resistance in order to have a frame of reference in later discussions
"Resistance can be defined as a temporary or permanent loss of
the initial sensitivity of the microorganisms to the effect of
an active substance. It manifests itself after exposure to agents
in vivo or in vitro"(Schnitzer and Grunberg, 1957).
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"it can be defined as a temporary or permanent capacity of the
cells and its progeny to remain viable or multiply under
environmental conditions that would destroy or inhibit other
cells." (Bryson and Szybalski, 1955).
"the sudden or gradual, permanent or transient loss of the
originally present susceptibility to a chemical compound."
(Lamy, 1967).
Two main suggestions are found in these definitions. Firstly the
stability of the change in the populations of trypanosomes is taken
into account, after exposure in vivo and in vitro. Secondly the resistant
character can be obtained by different mechanisms which implies
different origins of drug resistance.
The experimental evidence gathered so far has shown some basic
patterns by which resistance can be recognised. For example a drug
fast organism no longer responds to the largest possible doses in vivo,
or to high multiples of the minimal active concentration in vitro.
Coupled to that, it has been found that trypanosomes can retain these
characteristics for long periods of time even through cyclical transmission
by insect vectors (Schnitzer, 1955; Gray and Roberts, 1968).
Finally it is important to note that the rational approach to the
study of the mechanism of action of trypanocides and hence, the
development of drug resistance, should consider the molecular basis
of the relationship between these structures and their receptors.
1.2.9 Origin and genetics of drug resistance
Origin
Two basic questions can be put forward regarding the ultimate
nature of the change occurring when microorganisms become resistant
to active agents. First, how is the resistant character passed from
21.
one generation to another. Second, what are the mechanism by which the
parasites acquire resistance to certain drugs, this second question is
dealt with in section 2.2.5.
Opposing views have always existed on the relative importance of
selection of mutants as opposed to phenotypic adaptation, to explain
the origin of drug resistance. In some instances it is likely that
both processes may be involved (Bishop, 1959; Schnitzer and Grunber,
1957; Peters, 1970).
A classification of the possible origins of drug resistance was
offered by Bryson and Szybalsky (1955); a summary of the classification
is presented as it resumes most of the discussion on this particular
aspect:




2. - Genetic exchange
2.1 - by gametes
2.2 - by transduetion/transformation
B. Resistance dependent upon non-genetic change of phenotype
1. - Introduction of a new physiological function
2. - Elimination of cytoplasmic structures
3. - Accumulation of drug inactivating factors
4. - Selection of an alternative physiological function.
Co Resistance dependent upon composite changes.
Obviously the classification presented is completely operational
and it can be seen that some subdivisions are not mutually exclusive.
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In order to understand the two problems suggested at the beginning
of this section, particularly regarding the heredity of any possible
change in drug sensitivity, the cytogenetics of trypanosomes must be
clarified. Little concrete information is available on this aspect of
the life cycle of these parasites, as evidenced by a recent report on
the life cycle of T. brucei (Ormerod, 1979).
The genetic aspect of drug resistance related to the biology of
trypanosomes have been discussed many times (Schnitzer and Grunberg,
1957; Bishop, 1959; Walker, 1964) but no definitive conclusion has
emerged.
Regarding the transfer of genetic material, there are opposed
views; on one side, those suggesting the transference of the resistant
character (Inoki and Matsushiro, 1960; Inoki et al., 1961) and on the
other side, those who did not find any exchange of genetic material
(Amrein, 1965; Hawking and Walker, 1966). In spite of this difficulty,
development of drug resistance in terms of diploid expression and
genetic exchange has been suggested by Walker (1964).
To conclude, it is suggested that resistance in a population of
trypanosomes is acquired by a succession of genetic events that are
favourably selected when the drug is present (Hawking and Walker, 1966).
1.2.10 Cross resistance studies
Resistance to trypanocidal compounds is not necessarily confined
to the structure to which the resistant line has been developed; cross
resistance can occur between compounds differing in chemical structure
(Bishop, 1962). The cross resistance patterns in arsenical resistant
lines of trypanosomes have resulted in a very complicated picture.
Furthermore, arsenic resistance as such does not exist as organisms
highly resistant to one group of arsenicals can retain their sensitivity
to other arsenicals (Williamson and Lourie, 1948). This complex behaviour
could be explained using King and Strangeways (1942) data. They postulated
that there were different mechanism of uptake for different organic arsenicals.





































































Most of the information on cross resistance is reviewed by Williamson
(1970) . A summary of the relevant data is presented in Table 1.4. This
classification is based on the ionic characteristics of the different
drugs. A recent classification by Zakrzewski (1973) used different
categories to group the different cases of drug resistance selective
cross resistance and non-reciprocal cross resistance. In general,
knowledge of the earlier stages of trypanocidal action has been largely
inferred from drug resistance studies (Williamson, 1962) .
However, little information is available on the mechanisms and
kinetics of drug uptake or on the mechanisms by which mutual interference
occurs. Both these facets of the problem should be taken into account
when dealing with the subject of resistance.
1.2.11 Experimental development of drug resistance
The principal methods used for the production of drug resistant
parasites have been reviewed by Schnitzer and Grunberg (1957). Drug
resistance in trypanosomes, once it has fully developed, is a relatively
stable character. Drug resistance persists with some variation depending
on the drug and the line of trypanosome used (Bishop, 1959). A summary,
of the classification of the methods for producing drug resistant
organisms, is as follows (Schnitzer and Grunberg, 1957):
A. Development of resistance in vitro
B. Development of resistance in vivo
1. By repeated exposure
1.1 - in one animal
1.2 - in serial passages
a) relapse method
b) short passage method
c) continuous exposure
1.3 - development of resistance under reduced
host response
2. By single exposure.
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It can be seen that there is a variety of techniques which can be
employed for the development of resistant protozoa. The final choice
of a particular technique or techniques will depend not only on the
availability of the drug, but also, on the sensitivity of the trypanosomes
to the chemotherapeutic agent and the availability and type of animals
in which the resistant line is going to be developed. Another important
aspect, when developing drug fast organisms, is the time for the
appearance Qf stable resistance which has been found to be rather variable
(Hawking, 1963) .
From the classification presented, two main routines have been
evolved for the development of resistance in protozoa; in vitro and
in vivo techniques. It is clear that the in vivo techniques have
received considerably more attention than the in vitro techniques.
The main reason for this is the difficulty of keeping living protozoa,
particularly African trypanosomes, in axenic conditions. It must be
mentioned that in spite of this difficulty the method has been used to
produce a tryparsamide resistant line of T. gambiense (von Brand et al.,
1953).
The present status of the in vitro cultivation of animal infective
African trypanosomes has been reviewed recently by Hirumi et al. (1979).
As reported earlier in the Introduction, the technique evolved for the
cultivation of T. brucei requires the presence of a fibroblast feeder
layer. The potential of this technique in the study of the development
of resistance in vitro remains to be evaluated.
As discussed above, and in spite of the difficulties of keeping
T. brucei in vitro, exposure to melarsen oxide for short periods of
time, in a simple buffer system, was assessed as a means of developing
resistance.
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After an appraisal of the methods, the technique of choice was
the short passage method, first used by Margulis (1910) and Morgenroth
and Freund (1924). This system of developing drug fast trypanosomes
is the most frequently used, particularly in experiments carried out in
small rodents; The principle consists of the interruption of the influence
which the drug treatment exerts on the parasites by removing them from
the environment of the treated host to a new host before a significant
reduction in the parasitemia has taken place (Schnitzer and Grunberg,
1957). This method has been used recently by Damper and Patton (1976a)
to produce pentamidine resistant lines of T. brucei and T. rhodesiense.
One of the most valuable characteristics of resistant lines prepared by
the short passage method is the fact that they retain their immunological
properties. Finally a line of T. rhodesiense resistant to the pentavalent
arsenical, Melarsen, was developed by Rollo and Williamson (1951) using
a similar method to the short passage method.
1.2.12 Mechanisms involved in the development of drug resistance
With regard to the mechanisms of development of resistance, different
categories have been postulated (Schnitzer and Grunberg, 1957; Pollock,
1960). It is clear that these classifications are operational; on the
other hand one mechanism can not be considered to be independent of the
others. Some times the experimental evidence is inadequate to show
clear differences between the categories. A general classification by
the above authors is as follows:
a. Changes in metabolic functions so as to eliminate the steps
susceptible to the drug.
b. Inactivation of the drug by a drug fast organism.
c. Target altered in such a way that its sensitivity to inhibition
is decreased or overcome.
d. Alteration in permeability with a subsequent decrease in
the penetration of the drug.
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a. Changes in metabolic functions so as to eliminate or by-pass the
steps susceptible to drug action.
Ihe basic metabolic functions of African trypanosomes have been
characterised (Bowman and Flynn, 1976). This information can be used
to assess any possible differences found in resistant lines of
trypanosomes when compared to their parent lines. Knowledge of the
metabolic characteristics of resistant trypanosomes has still to be
developed. One of the first reports on this subject (Reiner et al.,
1932) showed no difference in the respiratory rate of parent and arsphenamine
resistant line of T. equiperdum. Some more preliminary evidence
can be found in the work of Yon Brand et al. (1953). These data
suggested rather inconclusively that these may be a minor difference
in the carbohydrate metabolism of T. gambiense resistant to tryparsamide.
In spite of the small differences found, the latter author concluded, as
did Harvey (1949), that there was no substantial change in the metabolism
of carbohydrates by trypanosomes resistant to arsenicals. This view
is not shared by Williamson (1953a,b) who suggested that a strain of
T. rhodesiense fully resistant to melarsen, differed markedly from the
parent line with respect to the utilisation of some substrates.
However, these results are contradictory, because they suggested the
presence of lactate dehydrogenase in the parent organisms. It is now
a well accepted observation that the African trypanosomes do not have
this particular enzyme in their Repertoire (Dixon, 1966).
In general no definitive evidence exists on the metabolism of
carbohydrates in trypanosomes resistant to drugs of the melaminyl series.
Therefore, a more comprehensive approach should be taken in the design
of experiments concerning possible metabolic differences that may arise
as a result of the development of resistance to these drugs.
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b. Inactivation of the drug by a drug fast organism.
As stated previously organo-arsenicals owe their toxicity to a
great affinity for thiol (SH) groups (Voegtlin et al., 1923). This
observation suggested that resistant trypanosomes may have large stores
of SH groups to detoxify organo-arsenicals (Voegtlin et al., 1924),
implying that the accumulation of organo-arsenicals by resistant
trypanosomes would be as great if not greater than that by normal
parasites. This hypothesis has been tested by various investigators
but not detectable difference was found in the thiol content of normal
and resistant trypanosomes (Hawking, 1938; Harvey, 1948; this work).
An increase in the ability to enzymically detoxify a drug by
conjugation, oxidation or cleavage may also account for melaminyl
resistance in trypanosomes. A classical example to illustrate this
point, although not in the area of pathogenic protozoa, is the development
of the drug destroying enzyme, penicillinase, in penicillin-resistant
forms of bacillus and staphylococci (Benveniste and Davies, 1973).
c. Target altered in such a way that its sensitivity to inhibition is
decreased or overcome.
It is reasonable to visualise that certain configurational changes
in the drug-susceptible enzymes as well as changes in their activities
in trypanosomes undergoing acquisition of resistance, could explain the
problem, in macromolecular terms (Sevag, 1955). Abnormal metabolism
of the cell, abnormal population dynamics, etc. may be related to
altered states of target enzymes in the resistant parasites.
Sevag (1946) suggested that enzymological changes in trypanosomes
undergoing the acquisition of resistance to thiazine dyes, involve a
configurational change of the enzyme targets with subsequent loss in
the affinity for the dye. It has been mentioned in a previous chapter
that the kinases of trypanosomes are particularly sensitive to the
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action of melaminyl arsenicals and other arsenicals in general. It has
also been suggested (Flynn, 1971) that the presence of hydrophobic amino
acid residues around or near the active site of pyruvate kinase are
important for the binding of aromatic organic arsenicals, including
melarsen oxide. Thus a minor modification in the primary structure of
the sensitive protein around the binding site of the lethal agent,
making the binding less favourable, could explain decreased affinity
and hence resistance at this particular level. An example in this
context is the strain of Plasmodium berghei resistant to pyrimethamine
which has developed a modified dihydrofolate reductase with higher
specific activity and with less affinity for the lethal agent, when
compared with the parent enzyme (Pinder, 1971).
Finally if an organism can achieve a substantially increased
synthesis of a target enzyme, it stands a chance of overcoming the
inhibition by an active substance. Nothing is known about the differential
activity of target enzymes to organo-arsenicals in parent and resistant
lines of T. brucei.
T. brucei depends on glycolysis for the generation of ATP. As
discussed earlier the kinases, particularly pyruvate kinase, are the
most sensitive targets of organo-arsenicals including the melaminyl
series. In this work pyruvate kinase and phosphoglycerate kinase were
studied in relation to their kinetics and sensitivities to melarsen
oxide in both drug sensitive and resistant line.
d. Alteration in permeability with subsequent decrease in penetration
of the drug
The evidence pertaining to this category is sometimes difficult to
appraise, due in part to the different methods used to estimate the
drug (especially arsenicals). It is clear that more accurate techniques
for the estimation of these drugs are required to make the results of
experiments on permeability more interpretable.
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The experiments of Yorke et al. (1931) first showed that an arsinilic
acid fast line of T. rhodesiense did not absorb as much drug from
solutions as did the parent line. Hawking (1937) corroborated these
findings in experiments with trivalent arsenicals and tartar emetic.
His data indicated that resistant trypanosomes did not absorb the compounds
to which they were resistant, but took up other arsenical compounds to
which the strain was still sensitive. Similar conclusions were reached
by Eagle and Magnusson (1944) using a spontaneously developed line of
T. equiperdum. This type of evidence is not exclusive to organo-
arsenicals, the same kind of observations having been made by Hawking
(1934) and Fulton and Grant (1955) when working with acriflavine and
stilbamidine, respectively. Other workers (Williamson and Rollo, 1959;
Williamson, 1959, a,b) from their experiments on selective interference,
cross resistance and the effect of metabolic inhibitors suggested that
a stereospecific change associated with the initial drug uptake may
occur in resistant trypanosomes. However, a change in permeability
as a result of the acquisition of drug resistance does not seem to be
a general rule as found by Ormerod (1952) , who reported similar levels
of drug uptake with the parent line, and a spontaneously developed
line of T. equiperdum resistant to antrycide, stilbamidine and
2-hydroxystilbamidine. It has also been found that although pentamidine
and stilbamidine resistance is associated with loss of the kinetoplast
in T. brucei, this condition itself did not alter drug transport when
developed above. However it was found that pentamidine has lower rates
of transport in trypanosomes resistant to this drug (Damper and Patton,
1976,b). Similar results showing practically no transport of melarsen
oxide into a resistant line of T. brucei are shown in this work.
On the basis of the evidence presented above it is clear that
although something is known about the general mechanism of resistance,
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explained in terms of differential permeability, a more detailed study
of the mechanisms of transport of organo-arsenicals is required,
taking into account the kinetics of transport. Such a study has not




It has been reported earlier in this thesis that the kinases are
particularly sensitive to the action of arsenicals and indeed the
mechanism of inhibition by melarsen oxide has been characterised for
pyruvate kinase (Flynn, 1971). The action of other organic arsenicals
on hexokinase and phosphofructokinase has also been reported (Chen,
1948; Jaffe et al., 1971). Phosphoglycerate kinase (ATP:3-phospho-D-
glycerate-l-phosphotransferase; E.C. 2.7.2.3) was among the glycolytic
kinases, the least characterised in trypanosomes. Therefore, a closer
look was taken at this enzyme, regarding the general kinetic properties,
the mechanism of action and the potential inhibition by arsenical drugs.
The introductory review of the properties of mammalian phospho¬
glycerate kinase is presented to enable comparison between the host and
the trypanosome enzyme.
Phosphoglycerate kinase, hereafter PGK catalyses the transfer of
high energy phosphate from the acid anhydride bond of 1.3 dipnospho-





















The biological occurrence of PGK has been studied recently by Fifis
and Scopes (1978). Using affinity elution chromatography, they isolated
the enzyme from a variety of sources and the structural and kinetics
parameters showed that the enzyme was a highly conservative protein.
PGK is a key enzyme in the glycolytic pathway of aerobes and anaerobes
and in carbon fixation in plants. PGK from various sources has shown
variation in the motility patterns, in gel electrophoresis (Scopes,
1968; Bendall, 1961; Engers and Madsen, 1968). Recently Wolfgang
et al. (1979) showed the presence of multiple forms of PGK in skeletal
muscle and erythrocytes using C.M. sepharose.
1.3.2 Isolation and physicochemical properties
The enzyme,from various sources, has been isolated in crystalline
form (Biicher, 1947; Kriestsch and BUcher, 1970; Scopes, 1971;
Blake et al., 1972). It has also been shown that it is a monomeric
protein with two globular domains and with a single polypeptide chain,
as suggested by x-ray diffraction analysis (Blake et al., 1972;
Wendell et al., 1972). This structure is not specific for PGK but is
similar in other kinases e.g. hexokinase and adenylate kinase (Anderson
et al., 1979).
The specific activity of the pure enzyme from different sources is
3
around 10 units/mg protein for the back reaction (Scopes, 1969;
Krietsch and Bdcher, 1970). It has a molecular weight of between 45,000=
50,000 depending on the technique used (Scopes, 1973). The amino acid
composition of purified PGK from different sources is again highly
conservative; lysine, aspartic acid, glycine, alanine, valine and
leucine are the most abundant residues while histidine, tyrosine and
tryptophan are the least abundant (Larsson-RaznikiewiCz, 1970;
Krietsch and Bucher, 1970; Yoshida and Watanabe, 1972) . PGK cannot be
dissociated into smaller subunits. It is formed, as reported above,
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of a single amino acid chain with N-acetyl serine as the NH^ terminal
residue and isoleucine as the COOH terminal residue (Banks et al., 1979).
For the large scale purification of PGK, Cibachrom blue, a structural
analogue of ATP has been used. Reproducible purification has been
obtained from Sacharomyces Cerevisiae (Kulbe and Schuer, 1979).
As reported Fifis and Scopes (1978),using affinity chromatography,
isolated the enzyme from twenty different sources.
1.3.3 Thiol content in phosphoglycerate kinase
Variable results have been observed with respect to the thiol
content of PGK from different sources (Kriestsch and Bticher, 1972).
Experiments with parachloromercuribenzoate (pCMB) and 55' dithiobis
(2 nitrobenzoic acid) (DTNB) detected seven and one -SH groups in the
purified enzyme from rabbit muscle and yeast respectively. It was also
shown by these authors that MgADP and 3 phosphoglycerate delayed the
action of the thiol reagents on the rabbit enzyme, suggesting the
involvement of -SH groups around the binding site of the enzyme.
No inhibition was found in the yeast enzyme.
Similar results, with respect to the inhibition of activity with
thiol reagents, were found using PGK from human erythrocytes (Choy
and 0!Sullivan, 1975). Nine out of the eleven -SH groups reported for
the erythrocyte enzyme reacted with DTNB. Again thiol involvement
around the active site was suggested by the delay in the inhibition by
DTNB produced by MgADP „
The thiol character of trypanosomal enzymes is- poorly understood,
probably because of the difficulty in obtaining large quantities of
a relatively pure enzyme for experiments on -SH group estimation and
inactivation in the presence of substrates and thiol reagents. However,
trypanosomal pyruvate kinase has been defined as a thiol enzyme not only
because of its sensitivity to pCMB but also to different organic arsenicals
(Flynn, 1971)„
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Finally as reported earlier in this Introduction, the kinases are
particularly sensitive to the action of arsenicals in trypanosomes.
Of these enzymes PGK is the least characterised. Some studies on
the kinetics, mechanism of action and inhibition by organic arsenicals
were therefore carried out on trypanosome PGK.
1.3.4 Kinetics and mechanism of action
The kinetic parameters of PGK have been evaluated (Bilicher, 1947;
Rao and Osper, 1961; Krietsch and Btlcher, 1970) . It was claimed from
the data obtained for the backward reaction, that the mechanism proceeds
according to the Michaelis-Menten model for both substrates. Typical
2 -3
Km values for the back reaction are: for MgATP Km = O.11-0.48 x 10 M
-3
and for G3P Km = 0.63-1.36 x 10 M. However, not all authors are in
agreement with this, as is discussed below.
The nucleotide specificities of the yeast and muscle enzymes have
been described (Krietsch and Bticher, 1970). In both cases the enzyme
has the highest activity with ATP. However, ITP, GTP, dGTP and dATP
supported activity when tested using the back reaction. As with other
kinases, PGK has an essential requirement for a divalent cation for
2+
activity. Mg has been found to complex with either ADP or ATP;
the complexes being the true substrates. Irregular results have however
2t
, ....
been found when working at high Mg concentrations (Larsson-Fh zmkiewicz,
1967). These data suggest that there are two binding sites for each
substrate on the enzyme. Yoshida and Watanabe (1972) reported that the
enzyme activity, as a function of the concentration of ATP, did not fit
the Michaelis-Menten relationship. Again the suggestion was that two
binding sites for the substrate were present. Several descriptions of
the mechanism of action have been put forward suggesting the possibility
of a rapid random mechanism for the binding of substrates (Larsson-
Raznikiewicz and Arvidsson, 1971; Lee and O'Sullivan, 1975).
35.
However, new evidence has suggested that the mechanism of action of
yeast PGK is complex, and the concepts of substrate activation, double
2-
binding sites for MgATP and G3P, and product inhibition are gaining
more ground (Schierbeck and Larsson-Raznikiewicz, 1979). Some disagreement
seems to exist about the number of binding sites for G3P as suggested
by Scopes (1978a*b), who advocates only one site for this substrate in
yeast PGK.
As reported, the postulated mechanism of action of PGK obeys a
rapid random reaction with no mutual interference for the binding of
either substrate. Further evidence from initial velocity, product
2-
inhibition and substrate analogue inhibition studies, with MgATP as
the phosphoryl donor, indicated that yeast PGK obeys this mechanism.
2+
Similar results have been obtained for other activating metals (Mn ,
2+ 2+
Ca , Co ) and other nucleotides (ITP, GTP) with human erythrocyte PGK
(Choy and O'Sullivan, 1975).
From the information derived from the crystal structure of the
kinases it has been suggested that the enzyme possesses a deep cleft
between the two domains of the protein. PGK is a good example of this
group (Anderson et al., 1979), there is no definitive function for
the feature. So far it has been found that the cleft is narrowed or
closed upon binding of the substrates (Banks et al., 1979). These
results have been corroborated by Pickover et al. (1979) , using x-ray
scattering of PGK in solution.
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1.4 Final appraisal and objectives of the work
From the practical point of view, experiments concerning the
mechanism of action of chemotherapeutic agents at the molecular level
may generate, as suggested by Gutteridge (1978), new ideas which will
eventually lead to the synthesis of new and more effective structures.
The same argument could be used to rationalise the need for new
research on the mechanism of development of resistance in trypanosomes,
as the cause of the appearance of drug fast organisms is directly
related to the chemotherapeutic agent and the way in which it produces
its lethal action. Obviously there is a great interest in the mechanisms
by which resistance can arise in trypanosomes, as this knowledge can
help to develop methods of preventing the acquisition of resistance or
of combating the resistance once it has arisen. A high priority has
been given to this approach by WHO (1977) as it will not only contribute
and
to chemotherapy but also to immunology/(. epidemiology of
the disease.
For human trypanosomiasis four drugs are now available; suramin,
nitrofurazone and melarsoprol (MelB) or melarsonyl potassium (MelW)used
for curative purposes and pentamidine for chemoprophylaxis. No new drugs
have been introduced for more than twenty years and all the drugs
mentioned have serious side effects. The two organic arsenicals in
use, Mel B and Mel W, are derived from the trivalent arsenical melarsen
oxide. It is assumed that these complexes are catabolised in vivo,
to the latter active structure. Therefore melarsen oxide was chosen
as a model for the group of melaminyl arsenical drugs. It is on this
structure that most of this thesis is based.
This work had the following main objectives:
1. To produce a fresh line of T. brucei resistant to melarsen oxide.
Stabilates of different populations of trypanosomes exposed to different
and consecutive doses of the drug, were prepared. The main aim was to
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develop a Reference Collection for possible comparison among the lines
obtained and possible extensions of the work.
2. To compare the basic metabolism of parent and resistant lines of
T. brucei. It has been seen earlier in the Introduction that some
information exists on the metabolism of arsenical resistant trypanosomes.
However the information is inadequate and contradictory. Much information
has been gathered on the glycolytic parameters of parent T. brucei.
Hence, these characteristics are used as tools to compare the general
metabolism of parent and resistant lines of the parasite.
3. To investigate the kinetics and the interaction of pyruvate kinase
and phosphoglycerate kinase with organic arsenicals in parent and
resistant lines of T. brucei. It has also been reported that the kinases
are particularly sensitive to the action of arsenical drugs. Pyruvate
kinase and phosphoglycerate kinase were considered key enzymes in the
glycolytic sequence of these parasites, not only because of their
potential sensitivity to the organic arsenicals but also because they
are directly involved in the production of ATP at the substrate level.
Therefore, the kinetic parameters and inhibition patterns of these
enzymes, from parent and resistant lines, were investigated. As reported
phosphoglycerate kinase is the least studied enzyme of the glycolytic
kinase group in trypanosomes, therefore particular attention was given
to the mechanism of action, mechanism of inhibition by arsenical drugs
and other physicochemical properties of this enzyme.
4. To investigate the uptake of organic arsenicals by parent and
resistant lines of T. brucei. Finally, some of the information gathered
on the uptake of arsenical drugs by resistant lines of parasites,
points towards a reduced absorption of the drugs when compared to their
parent lines. It is suggested that in this way the fast organism bypass
the action of the active agent. Based on this assumption a closer look
was taken at the mechanism of uptake of melarsen oxide and some other
related arsenicals in parent and in a resistant line of the parasite.
2. MATERIALS AND METHODS
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2. Materials and Methods
2.1 Line of T. brucei studied
The parent line of T. brucei TREU 55 (Trypanosoori Research,
Edinburgh University) used in this thesis is a monomorphic population
of trypanosomes derived from a wild population of T. brucei. The original
sample of trypanosomes was maintained by serial passage in mice to give
TREU 1 which was then subsequently passaged in rats producing TREU 55.








As mentioned above TREU 55 is completely monomorphic and it
produces a fulminating parasitaemia with the subsequent death of the
host animal 3 or 4 days after inoculation with the parasites.
2.2 Host and maintenance
Wistar albino male rats are used throughout the experimental part
of this thesis as host animals for the T. brucei infection. For the
establishment of infection, stabilates of T. brucei stored in 10% (v/v)
glycerol at -70°C were allowed to thaw and diluted to give 15 to 25
motile organisms per microscope field when observed under high magnification
(400X)? 0.3 to 0.5 ml of the trypanosome suspension was inoculated
intraperitoneally. The infection initiated in this fashion produced
peak parasitaemia 72 hours later. For the further maintenance of the
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infection, syringe passage was used every three days to infect clean
animals. The procedure was as follows: infected blood from the tail of
a parasited rat was diluted, with either citrated saline or phosphate
saline (cf. 2.3), so that 10 to 15 parasites were visible per microscopic
field under high magnification; approximately 0.3 ml of the trypanosome
)
suspension was routinely injected intraperitoneally into each rat.
Peak parasitaemia was again observed 72 hours after infection of the
animals.
Stabilates were prepared as follows: infected blood was collected
by exsanguination, after cardiac puncture of the right ventricle , into
1 ml of phosphate saline buffer with 5 IU/ml of heparin. The blood
was diluted in PSG buffer (see Section 2.3) to give a final concentration
7
of trypanosomes of approximately 5 x 10 cell per ml. The number of
organisms was determined by haemocytometry. Glycerol was then added
to a final concentration of 10% (v/v). The suspension was throughly
mixed and dispensed immediately into plastic capped tubes (1.5 ml);
after closing the tubes they were arranged in a small plastic rack and
o
taken directly to a deep freeze at -70 C. After a day the tubes were
removed from the rack and placed in a plastic container in the same
deep freeze. Stabilates prepared in this fashion kept the original
infectivity even after seven months storage.
2.3 Buffer solutions
Phosphate saline (PS buffer): 53 mM disodium hydrogen phosphate,
3 rnM sodium dihydrogen phosphate, 45 niM sodium chloride, pH 8.0
Phosphate saline glucose (PSG buffer): as PS buffer plus 1%
glucose, pH 8.0.
Phosphate saline glucose albumin (PSGA buffer): as PSG buffer
plus 0.5 mg/ml of bovine serum albumin (BSA), pH 8.0.
Tris-Sucrose: 10 mM Tris-HCl, 0.25M sucrose, pH 7.6.
Figure2.1:Thes ortpassagemethod. Wistaralbinora swereinfectedtraperi oneallyi htryp nosomesdescr beS ti2.2.Bloodf m theailofratswamonitoredd yund rph sc tra ticr copyestim tetnumbir ulating parasites.Onchighparasitaemiaw sre edthinf ca imalerre tthsubeffectivedos f melarsenoxidinphosphatsaline.Afterther pyw thdrugdbe ocon id ablereductio parasitaemiah soccurred,trypanso^mesweru edinfectn wgr upf ;hrocesrep at d wi-thincreasedd ugconcentrations(stextffu th retails).
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Tris-DTT: 100 mM Tris-HCl, 1 mM dithiothreitol, pH 7.5.
TEA; 10 mM TEA-HC1, pH 7.5.
Citrate saline; 157 mM sodium chloride, 51 mM tri-sodium
citrate, pH 7.0.
2.4 Production of a resistant line of T. brucei using the short
passage method
As discussed in the Introduction, there are different routines for
the production of drug fast trypanosomes (Schnitzer and Grunberg, 1957).
Two major routines have been used for the production of resistance
in vivo: the relapse method and the short passage method; the first
one has been discarded as it has been found that it produces serum
resistant organism (Bishop, 1959).
The short passage method, first used by Margulis (1910) consists
ly
of the parenteral administration of a drug to experimental^infected
animals with doses that approach the minimal or sub-effective drug
concentration with continuous sub-passage of the treated trypanosomes.
The main feature of the method is that the trypanosomes are removed
from the treated host before the drug has exerted a considerable effect
on the parasitaemia. As the number of passages increases, the dose to
which the trypanosomes are exposed is also increased (see Figure 2.1).
This objective was accomplished in practice by infecting groups of
4 rats, using the already reported method for infection (Section 2.2).
The animals were monitored for the development of parasitaemia by
examination of a drop of blood from the tail. When the concentration
0
of trypanosomes was approximately 10 cell/ml the animals were weighed
and inoculated with sub-effective doses of melarsen oxide. After therapy
with the drug, the parasitaemia was further monitored and before a
considerable reduction in the number of circulating parasites had occurred
(10-20% reduction) a sample of parasites was used to infect a new group
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of rats. The relapsing trypanosomes after inoculation were treated with
higher concentrations of drug by repeating the procedure described above.
It should be mentioned that stabilates were produced throughout
the development of the resistant character in order to produce a reference
collection. Furthermore the development of the resistant character
was monitored using a drug sensitivity test described in Section 2.13.
2.5 The isolation of trypanosomes from blood elements
Trypanosomes were isolated from the bloodstream of infected rats
when the parasitaemia was at its maximum, as indicated by inspection
of blood from the tail. The method used was that of Lanham (1968).
As reported by the same author the technique relies on the difference
in charge at the surface of blood cells and trypanosomes. Isolation
of the latter is carried out using an anion-exchange resin.
The procedure used was as follows: the blood from infected rats
was collected, after cardiac puncture, into 1 ml of PS buffer containing
5 IU/ml of heparin. After centrifugation at 100O g for 10 minutes at
4°C, the supernatant plasma was removed by aspiration and the white
trypanosome layer was resuspended in cold PSG buffer; the centrifugation
stage was repeated. The white trypanosome layer was pre-mixed with, an
equivalent volume of DEAE 52 previously equilibrated with PSG. The
slurry was then poured on top of a DEAE 52 column (bed volume approx.
20 ml) and the trypanosomes were isolated from the remaining blood
cells according to the method of Lanham (1968).
The method as described above produced a yield in terms of packed
cell volume of approximately 0.6 to 1.0 ml per adult rat. To assess the
motility and purity of the trypanosomes, prepared as described above,
a sample of the final suspension of cells was examined under phase
contrast microscopy. Only preparations with a 100% motile organisms,
resuspended in the appropriate buffers according to the experiment
performed, were used in this thesis.
Figure 2.2: The morphological appearance of the parent line and the
resistant line of T. brucei.
Parent line
Stained blood smears were prepared from tail blood of infected animals
with parent and resistant organisms. For details of the staining
procedure and microphotography see Section 2.6.
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2.6 The staining method and microphotography
Blood from the tail of infected animals was spread as a thin film
on glass slides and allow to dry. The preparations were fixed with
absolute methanol and allowed to stand for 30 seconds; the excess
methanol was shaken off and the slides placed in Giemsa's stain for
50 to 60 minutes (1 volume of stain + 9 volumes of distilled water,
pH 7.0). The slides were then removed from the stain and rinsed under
running tap water and dried.
Stained trypanosome preparations were examined in a Vickers M17
microscope.
Microphotographs of slides prepared from the parent and resistant
lines of T. brucei stabilate [BEU melarsen oxide 0.52] are shown in
Figure 2.2. I am grateful to Dr. J. Haywood of the Biochemistry
Department of the University of Edinburgh for taking the photographs
shown in this thesis.
2.7 Trypanosome motility test
For routine evaluation of the quality of the trypanosome preparation,
after isolation from blood elements, and for the purpose of some
specific experiments described in this thesis, the trypanosome motility
was qualitatively evaluated according to the following notation:
Description of trypanosome activity
Description: Notation:
Most trypanosomes show maximal movement of body and flagellum +++
Most trypanosomes have frequent movement of body and flagellum
but have become slow compared with above ++
Approximately half of the population have slow movement,
the rest of the organisms have infrequent movement of body
and flagellum +
Most trypanosomes are moving with Brownian motion, except for +
infrequent movement of flagellum
No apparent movement is observed and there is a considerable
number of lysed cells o
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2.8 Preparation of trypanosome homoqenates
2.8.1 For enzymological studies
A volume of packed cells prewashed in PS buffer was resuspended
in 9 volumes of 2 times distilled water. The trypanosome suspension
was then subjected to homogenisation by hand, with an ice cold teflon
pestle in a glass homogeniser (Wesley Coe Ltd., Cambridge) in an ice
bath. Approximately 20 strokes were necessary to produce a homogenate
without whole cells, as indicated by observation under phase contrast
microscopy.
solution
The trypanosome protein^ produced in this way, was then frozen in
an ethanol bath at -40°C in a round bottomed flask and the protein was
lyophilised. The dried material was stored in vacuo at O to 4°C.
2.8.2 For metabolic studies
0.5 ml packed cell volume (1000 g max, 10 minutes) of prewashed
trypanosomes was resuspended in 30 ml of Minimal fortified medium,
as described by Flynn and Bowman (1973) (details below); the process
of homogenisation was done as above ensuring that the homogenate did not
contain intact cells when examined under phase microscopy. The material
prepared in this way was used immediately for metabolic studies
(see Section 2.11).
The composition of the Minimal fortified medium was as follows:
KC1, 200 pmoles; EDTA, 3 pinoles; nicotinamide, 25 pmoles; MgSO^,
20 pmoles; BSA, 10 mg; phosphate buffer pH 7.4; 67 pmoles; ATP,
5 pinoles; NAD, 5 pmoles; total volume 3 ml (Flynn and Bowman, 1974) .
2.9 The preparation of protein for enzymological studies
50 mg of freeze dried material (10 mg/ml) was resuspended in an
appropriate buffer for the enzymological studies of PK and PGK (see
Section 3.4.3). The suspension was hand homogenised using a Dounce
homogeniser equipped with a tight fitting pestle; 20 strokes in an
ice bath were necessary to produce a homogeneous suspension, as indicated
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by examination under phase contrast microscopy. The homogenate was
dispensed in plastic tubes and centrifuged for 1 hour at 100,000 g in
a preparative centrifuge (Sorvall model L2-65). The rotor used was
model 50 t^ at fixed angle.
At the end of the centrifugation stage, the supernatant was
poured on to a Sephadex G25 column of 20 ml bed volume, preequilibrated
with the appropriate buffer. The protein peak was collected with the
void volume and made 10% (v/v) with glycerol. The material prepared
as above was used immediately for enzymological studies. A diagram
of the procedure is found in Figure 3.16.
2.10 Enzyme assays
2.10.1 Pyruvate kinase
For the estimation of PK the method of Bflcher and Pfleiderer (1962)
was used and modified as suggested by Flynn (1971). The method depends
on the coupling of pyruvate formation to lactate dehydrogenase producing
lactate with the subsequent oxidation of NADH. One of the major
advantages of this assay system is that the pyruvate is removed from
the medium; therefore, the possibility of product inhibition is
discarded with this system.
The assay principle to measure the activity of PK as suggested
by Bttcher and Pfleiderer (1962) is:
PK
i) PEP + ADP "* pyruvate + ATP
ii) pyruvate + NADH + H+ lactate + NAD+.
The components of the reaction mixture for the assay of trypanosome
PK as suggested by Flynn (1971) are:
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Reaction mixture at pH 7.4: Final concentration
or activity:
33.30 x 10_3MTEA
MgS04 6.67 x 10 3M
KCl
NADH 1.33 x 10 3M
LDH 5 I.U.
ADP 0.41 x 10 3M
PEP
-3
1.67 x 10 M
plus enzyme sample and water to 3 ml.
2.10.2 Phosphoglycerate kinase
The assay of PGK activity is often carried out using the back
reaction of the enzyme leading from 3-phosphoglycerate to 1.3 diphospho-
glycerate. The assay system used for the estimation of the activity
of the trypanosome enzyme is based on the method originally described
by Krietsch and Bilcher (1970) . The assay principle to measure the
activity of PGK, as suggested by these authors is:
PGK
i) G3P + ATP "■ 1.3 diphosphoglycerate + ADP
ii) 1.3 diphosphoglycerate + NADH + H+ ^ 3 phosphoglyceraldehyde
There is a known variation with regard to the cations and
nucleotide requirements of PGK from different sources. Therefore
it was necessary to study the particular requirements of the trypanosome
enzyme; the experiments performed in this respect are shown in
Section 3.41. Saturating concentration of all reactants in the assay
system are used in order to ensure a representative activity of the
enzyme. The concentrations were:
+
+ NAD + P.
1
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NADH 0.16 X n -310 M
GAP-DH 8 .1 I.U.
ATP 3.0 X HO
1 U)
S
G3P 10.0 X 10 3M
+ enzyme sample and water up to 3 ml.
Both enzymic assays involve the oxidation of NADH + H+; therefore,
the reaction can be followed spectrophotometrically at 340 nm. To this
effect all the reactants in both enzyme assays were pipetted into silica
cuvettes (1 cm light path) and preequilibrated in the spectrophotometer
for not less than 5 minutes. The spectrophotometer used throughout the
experiments was a Unicam model SP800 fitted with scale expansion and
coupled to a Unicam slave recorder model AR25. The temperature of the
o
cell compartment was 25 C maintained by means of a circulating water
bath with pump.
The reactions in both assay systems were started by addition of the
trypanosome enzyme, unless otherwise stated (e.g. inhibition studies).
The initial velocities were estimated by tangential measurement to the
trace on the slave recorder.
2.11 Standard manometric conditions
Purified trypanosomes, obtained by the method discussed in
Section 2.5, were resuspended in PSGA buffer (4 mM glucose) after
being washed twice in the same buffer. The final protein concentration
was adjusted to approximately 0.8 mg/ml suspension.
The 0^ consumption was measured in a conventional Warburg
instrument at 25°C with air as the gas phase; each flask contained
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2.7 ml of trypanosome suspension with 0.1 ml of 40% (w/v) KOH:, absorbed
on fluted filter paper, in the centre well of the flask, and 0.3 ml
of 6M perchloric acid in the side arm. The flasks with the components
described above or as otherwise stated were allowed to equilibrate for
10 minutes in the water bath of the instrument before starting the
experiments. Since changes in the barometric pressure and minor
fluctuations in the temperature are potential sources of error in the
manometric readings, thermobarometers were submitted to the same
experimental conditions as the other manometers and used to correct
for the possible error mentioned above as described in Umbreit et al.
(1957). The gas exchange was terminated by addition of perchloric
acid from the side arm.
For the determination of the respiratory quotient (RQ) the
simultaneous determination of consumption and carbon dioxide
production is required. The Direct Method of Warburg was used
for the determination of CO^ in the presence of oxygen consumption
(Umbreit et al., 1957). This method uses two identically prepared
reaction flasks, the only difference being that one contains alkali
in the centre well and hence the evolution can be determined;
the other flask is prepared without alkali and therefore records
the balance between consumption and CO^ production. By taking
in to account the readings in the respective manometers and their
respective flask-manometer constants for oxygen and COit is possible
to calculate the gas exchange and subsequently the RQ value (Umbreit
et al., 1957).
The possibility of differential metabolism in the trypanosomes as
a result of the different treatment of the preparation (with and without
KOH) has been evaluated (Flynn, 1971) and no evidence has been presented
to suggest that a particular metabolic change occurs attributable to
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the presence of a CO^ sink in one of the flasks. As mentioned in the
metabolic section (see Section 3.2), there was a minor binding of
atmospheric CO^ due to the phosphate based buffer used (even when
freshly prepared); correction was made for this binding by treating
two thermobarometers, with equivalent volume of buffer, in the same way
as the experimental manometers (with and without CO^) and correcting
for any CC^ found in the buffer after acidification with perchloric
acid.
Xs
Immediately after acidification and deproteinisation of the flasks
contents, determination of metabolites was carried out. The procedure
used was as follows: the flasks were emptied into chilled conical
centrifuge tubes and the denatured protein removed by centrifugation.
Aliquots of the supernatant are neutralised with 3M KHCO^. Samples from
the supernatant, after centrifugal removal of perchlorates as a
potassium salt, were used for metabolite estimation (see next section).
For the determination of 0^ evolution in water lysates the procedure
was exactly the same as for whole cells, except for the resuspension
of the homogenate in a Minimal fortified medium to allow for gas
exchange (Flynn and Bowman, 1973). Details of the preparation of the
water lysate and the Minimal fortified medium are found in Section 2.8.2.
2.12 The estimation of metabolites
After deproteinisation of the flask contents at the end of the
incubation period, metabolite consumption and production was measured
enzymically using the method of "end point estimation" (Bergmeyer, 1978) .
Other metabolites closely related to the metabolism of carbohydrates
in trypanosome are glucose, pyruvate and glycerol? they were measured
using the method suggested by Fairlamb and Bowman (1980) in a single
procedure. The method is as follows: deproteinised samples (0.06 ml)
-3
were assayed in a reaction mixture containing 50 x 10 M Tris HC1,
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pH 7.5 with 50 x 10 M KC1, 10 x 10 M MgS04, 0.2 x 10 M EDTA, 0.15 x
-3 -3 -3
10 M NADH, 40 x 10 M ATP and 50 x 10 phosphoenol pyruvate; with
distilled water to a total volume of 3 ml. The pyruvate concentration
was measured after addition of lactate dehydrogenase (5.0 IU/ml)
as a decrease in the absorbance at 340 nm. Pyruvate kinase was added
(4.0 IU/ml) and after a new steady absorbance was obtained glycerol
kinase was added (1.7 IU/ml) to measure glycerol concentration, followed
by hexokinase (1.4 IU/ml) to measure glucose concentration. The
absolute concentrations of these metabolites were determined using
standards that have been treated as the unknown samples.
For the studies on carbon balance from glucose, samples were
treated as in Section 2.11, except that a zero time sample was used
to define the substrate changes over any period of incubation chosen.
2.13 Drug sensitivity tests with the oxygen electrode
Trypanosomes, isolated as described in Section 2.5 were used for
a routine drug sensitivity test; the cells were resuspended in PSG
buffer to a final concentration of approximately 0.8 mg of trypanosome
protein/ml, and incubated with different concentrations of melarsen
—6 —8
oxide (range 0.1 x 10 M-9.0 x lO M) in a Clark type oxygen electrode
(Yellow Spring Instruments Co.) polarised at -0.8V. The electrode
was adapted to fit a perpex reaction chamber of 3 ml capacity,
containing a magnetic stirrer. The system was connected to a Servoscribe
potentiometric recorder. The incubation chamber was thermostatically
regulated with a water jacket connected to a water bath with pump set
at 37°C. For the calibration of the oxygen electrode the value of
—6
2.17 x 10 O2 in air saturated water was used for calculations (Kielley,
1963); for the setting of the base line in the absence of oxygen,
sodium dithionite was added to the water in the chamber and allowed to
equilibrate.
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The linear initial rates of oxygen consumption (nmoles O^-niin \mg
protein "S by trypanosome suspensions, at different concentrations of
melarsen oxide, are compared with untreated trypanosome suspensions
and presented as percentages. Duplicate values were usually obtained
at each concentration of drug determined in palindromic series.
The system was used during the production of the resistant line;
a typical set of inhibition patterns is shown in Figure 3.2.
2.14 The preparation of glycosomes and estimation of multienzyme activity
Trypanosomas isolated from blood elements as described in Section
2.5 were homogenised with the prewashed abrasive, silicon carbide
(Norton Company, grit no. 37C 400). 1.5 ml of packed cell volume was
treated with approximately 7.5 g of the abrasive and ground in a chilled
mortar until no intact organisms were observed when examined by phase
contrast microscopy. The homogenate and the abrasive were resuspended
in enough Tris-sucrose buffer to allow transference of the mixture to
50 ml plastic tubes and centrifuged for 5 minutes at 100 g (max) in a
MSE Mistral 4L centrifuge using a 8 x 50 ml swing out rotor. After
centrifugation the supernatant was carefully decanted, the pellet
resuspended and the process repeated. The combined supernatants, free
of silicon carbide, were kept on ice and used as soon as possible for
the purification of glycosomes.
For the purification of glycosomes the method of Oduro (1977) was
used. The suspensions from the grinding with silicon carbide was
centrifuged for 20 minutes at 1000 g (max) in a MSE Mistral 4L centrifuge
at 4°C in a 8 x 50 ml swing out rotor. The supernatant was collected
and the pellet resuspended in Tris-sucrose buffer. Centrifugation and
washing were repeated twice, and the supernatants saved for further
purification.
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The combined supernatants were centrifuged for 20 minutes at 14,500 g
o
(max) in a MSE 18 centrifuge at 4 c in a 8 x 50 ml fixed angle rotor.
The supernatant was discarded and the pellets resuspended in Tri.s-
sucrose buffer; the centrifugation and washing step were repeated
twice. The final pellet was resuspended in Tris-sucrose buffer and used
for the estimation of glycosome multienzyme activity.
The multienzyme activity of the glycosome was estimated using the
method of Oduro (1977). The assay system relies on the catalytic
activity of the glycosome, from glucose to triose phosphates and then
to G3P. The reaction catalysed by glyceraldehyde phosphate dehydrogenase
is blocked by iodoacetic acid; multienzyme activity is followed by the
oxidation of NADH with the reduction of DHAP to glycerol-3-phosphate,
by glycerolphosphate dehydrogenase.
The components of the assay medium were as described by Oduro et al.
-3 -3
(1980): TEA-KOH, pH 7.6, 97 x 10 M; ATP, 0.94 x 10 M; MgCl2
-3 -3 -3
13.9 x 10 M;z-.NADH, 0.18 x 10 M; iodoacetate, 1 x 10 M; sucrose,
-3
0.25 M; glucose, 400 x 10 M and enzyme, in a final volume of 3.0 ml.
The reaction was initiated by the addition of glucose, after incubation
for 5 minutes at 25°C. The reaction was followed spectrophotometrically
using a Unicam SP80Q with a slave recorder Unicam AR25.
2.15 Silicon layer filtration technique
Filtration through silicone layers has been used to study the
translocation of different substrates in mitochondria (Halstrap and
McGivan, 1979). The technique involves incubation with the substrate
to be transported, followed by rapid termination of the incubation by
filtering the particulate material through a silicone layer of a specific
density. The technique has been used recently for studies on the
transport of pentamidine in T. brucei (Damper and Patton, 1976a,b).
A modification of the silicone layer technique as proposed by the latter
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authors was used in this thesis in the studies on the transport of
melarsen oxide and other arsenical drugs.
Conical microcentrifuge tubes (1.5 ml) were filled with three
different layers: a bottom layer of 0.1 ml of perchloric acid, 6M;
an intermediate layer of 0.1 ml of silicone oil, prepared beforehand
by mixing 1 volume of silicone oil AR20 and two volumes of silicone
oil APlOO (Wacker Co.), and a top layer of 0.5 ml trypanosome suspension
in the exposing solution carefully loaded by the side of the micro¬
centrifuge plastic tube. This system with perchloric acid and silicone
oil is referred to as the silicone sandwich.
2.16 The incubation of trypanosomes for uptake Studies
Trypanosomas isolated from blood elements, as described in Section
2.5, were resuspended in PSGA buffer to a final concentration of 5.0 mg
Q
of trypanosome protein per ml of buffer (about 10 cell/ml). For the
incubation of the cells, an 0^ electrode perspex chamber (3 ml) connected
to a magnetic stirrer was used. The chamber was thermostatically
regulated with a waterjacket and connected to a variable temperature
waterbath with pump, which allowed the incubation of the cells at
different temperatures.
The suspension of trypanosomes (1.35 ml) was placed into the chamber
and allowed to equilibrate at the desired temperature; the drug was
then added in solution (0.15 ml) and the suspension incubated. Triplicate
aliquots (0.5 ml) were dispensed using an automatic pipette on top of
silicone sandwiches and centrifuged after sixty seconds incubation,
in a Beckman microcentrifuge at the maximum speed (equivalent 10,000 g).
Upon contact of the trypanosomes with the perchloric acid layer the
protein denatures and two phases appear; an acid soluble and insoluble
layer. Details of the experimental conditions were chosen from the
results presented in Section 3.6. The different layers obtained were
then ready for estimation of the drug used.
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In the case of time course uptake experiments, four microcentrifuges
were used. Every 15 seconds after the addition of the drug, aliquots
(0.5 ml) were dispensed using an automatic pipette onto the silicone
sandwiches and centrifuged for 60 seconds. The experiments were repeated
three times in order to obtain reliable results.
2.17 Determination of extracellular volume
One minor disadvantage of the silicone layer filtration technique
is the extracellular fluid which passes through the silicone layer into
the perchloric acid layer when the trypanosomes are centrifuged (Damper
and Patton, 1976a). The total volume involved was calculated by labelling
14
the exposure solution with C inulin to a final concentration of
2 x 105 cpm/ml. The radioactive tracer (3 x 10^ cpm/10 |J.l) was added
to 1.5 ml of trypanosome suspension (with 0.15 ml of blank solution)
and after incubation and centrifugation, as described in the last section,
samples of the perchloric acid soluble layer (0.1 ml) were estimated
for radioactivity. No radioactivity was found in the acid insoluble
layer.
14
As the original source of C inulin had been stored without use
for more than a year a previous purification of the material was carried
out by desalting on a column of Sephadex G25 (approximate bed volume
10 ml). The high molecular weight material collected with the void
volume was used for the experiments in this thesis.
2.18 Radioactive counting
14
The experiments on the estimation of C inulin were the only
protocols in this thesis using a radioactive compound. Aliquots from
the perchloric acid layer were mixed with 10 ml of scintillation fluid:
0.02% (w/v), 1,4-bis-(5-phenyloxazol-2yl)benzene, 0.4% (w/v) 2,5-
diphenyloxazole in 33% (v/v) Triton XlOO and 67% (v/v) toluene.
The radioactive counting was performed in a Packard model 3330 Tricarb
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scintillation counter. As the perchloric acid produced quenching,correction
14
was made by counting C inulin standards with and without the acid.
2.19 The estimation of arsenical drugs
The drugs were estimated by chemical assay of the arsenic moiety ;
the routine used in this thesis is the one presented in the U.S.
Pharmacopeia (1975). The method is divided into two main parts:
organic digestion and arsine generation with subsequent trapping in
AgDDC solution (BDH Chemicals Ltd.).
Samples containing drugs were placed in 125 ml conical flasks,
5 ml of (conc.) was added and the organic matrix oxidised by
placing the systems on a hot plate. To ensure oxidation, (30% v/v)
was added dropwise until a colourless solution was obtained. The flasks
and their contents were allowed to cool and 10 ml of distilled water
were added and reheated until fumes of sulphur trioxide are evolved.
The flasks were removed from the hot plate and again allowed to cool,
35 ml of distilled water were added rinsing the sides of the flasks.
For the generation of arsine, 10 ml of H2S°4 (20% v/v) were added
to the flasks with 2 ml of freshly prepared potassium iodide solution
(15% (w/v) in water) and 0.5 ml of stannous chloride (40% w/v in HCl
conc.). The contents were mixed and allowed to stand for 30 minutes.
At this stage the flasks and their contents are called generator systems.
While the incubation is being completed, 2 ml aliquots of silver
diethyldithiocarbamate (AgDDC) in pyridine (0.5% w/v) were dispensed
into small diameter test tubes. At the end of the incubation period,
which were
zinc (3 g) was added to the generator systems /, connected by means of
a glass delivery! tube, with plugs of glass wool impregnated with lead
acetate, to the test tubes with the AgDDC solution; the gases evolved
were allowed to bubble through the solution for at least 45 minutes.
trivalent arsenicals
At the end of this period, these generator systems with /. produced
55.
arsine. which reacted with the AgDDC (AgS.CS .N (C^H,.) ) to form a soluble
red complex (Vogel, 1978).
Standard concentrations of drugs and appropriate blanks were
submitted to exactly the same conditions as the experimental flasks
and after preparation of the standard curves, by reading the absorbance
at 525 nm, the concentration of the unknowns were estimated by
interpolation in the calibration curves according to the extent of the
colour development. Typical calibration curves for melarsen oxide and
sodium melarsen are shown in Figure 3.33.
2.20 The estimation of proteins
Protein estimation was done either by the method of Lowry et al.
(1951) or Bradford (1976). Bovine serum albumin (BSA) was used as the
standard protein with both methods; the calibration curves were linear
from 0-150 pg BSA with the first method and frcm 0-100 pg BSA with the
second method. TEA buffer interferes with the method of Lowry et al.
(1951) but not with the other method; therefore the method of Bradford
(1976) was used accordingly to avoid interference with the protein
estimation.
2.21 The estimation of protein thiol groups
The method of Ellman (1959) was used for the determination of -SH
groups in the trypanosome protein; these groups exhibit variable
reactivity towards the Ellman reagent 5*5 1-dithiobis (2-nitrobenzoic acid)
(DTNB) owing to steric factors and hence determination of total -SH
groups requires the unfolding of the protein (Habeeb, 1972). The routine
suggested by the latter author was used for the estimation of total -SH
groups in denatured trypanosome protein and available thiol in native
protein.
For the estimation of total thiol an aliquot of 0.1 ml of DTNB
solution (40 mg DTNB in 10 ml of 0.1M sodium phosphate buffer, pH 8.0)
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was added to 3 ml of trypanosome protein solution (in 2% sodium dodecyl
sulphate (SDS), 0.08M sodium phosphate buffer, pH 8.0 and 0.5 mg/ml EDTA).
The colour is developed for 15 minutes and absorbance read at 410 nm
against protein solution in SDS to give apparent absorbance. For
calculation of -SH group content, the net absorbance is employed with a
molar extinction value of 13,600M ^cm The protein concentration was
estimated by the method of Lowry et al. (1951) in the original solution
of protein.
For the determination of available thiol the reaction is performed
as described above but in the absence of SDS; the absorbance is again
read at 412 nm and the -SH content calculated in the same manner.
2.22 The preparation of organic arsenicals
Melarsen oxide and phenyl arsenoxide are insoluble in water, hence
these drugs were routinely solubilised in a small volume (0.1-0.2 ml) of
alkaline
40% (w/v) KOH, the ^ solution was diluted to the required volume
and titrated with 5N HC1. As suggested by Flynn (1971) the solution
was titrated immediately to. . neutrality, otherwise a cloudy solution
appears on back titration to neutral pH values. Possibly this is due
to instability of the melaminyl ring at basic pH conditions.
2.23 Chemicals
All chemicals were of the highest purity available ("Analar"
grade or its equivalent), obtained from BDH Chemicals Ltd. or Sigma
Chemicals Co. Ltd.
Enzyme cofactors and substrates were obtained from Boehringer and
Sohne Gmtl, Mannheim; glucose was obtained from BDH Chemicals Ltd. and
bovine serum albumin from Armour Pharmaceutical Co. Ltd., Eastbourne.
14
Radioactive C inulin was obtained from the Radiochemical Centre,
Amersham.
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Silicon carbide was a gift from Norton Abrasives Ltd., Welwyn,
Garden City, Herts. The silicone oils were a gift from Dr. Steve Shears
of the Biochemistry Department of the University of Edinburgh, obtained
originally from Wacker Co. The trivalent and pentavalent arsenicals
used in this work were a gift from May and Baker Ltd., Dagenham.
Dithiothreitol was obtained from Koch Light Laboratories, Bucks.
Sephadex G25 was obtained from Pharmacia Fine Chemicals, Uppsala,
Sweden.
2.24 Statistical methods
The mean and the standard deviations of the mean were calculated
using a texas SR-51-II calculator employing the following formulae:
mean, X = —
n
standard deviation. SD =
L(x-x)2
n - 1
standard error of the mean -
™i
L(x-x)2
(n - 1) n
Unweighted linear regression analysis of linear data were carried
out on a texas SR-51-II calculator.
The probit transformation used to analyse the results from drug
sensitivity test experiments in this work has been used to study toxicolog
and biological assay data where quantal response is involved (Mather,
1964) „ Indeed the method was used to study the development of resistance
to tryparsamide by Hawking and Walker (1966). In the present work the
linear rates of oxygen consumption obtained from the drug sensitivity
test are used for the probit transformation (see Section 3.13). The value
expressed as the percentage of inhibition of the untreated trypanosomes
are converted into probit number using the tables already prepared for
this purpose (Fisher and Yates, 1963). A plot of the logarithm of the
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concentration of drug against the probit number gives a straight line,
which represents in our case an approach to the description of the normal
distribution of drug sensitivity of a determined population of organisms.
As discussed by Hawking and Walker (1966), the straight line should
represent a homogeneous population of individualswith a "normal"
distribution of sensitivity to a particular agent. However if non-
linearity is obtained it could be inferred that a heterogeneous population
exists with respect to the sensitivity to the active agent, as at this
point the plateau seems to represent the number of organisms which
survive a particular range of drug concentrations. Although further
conclusions could be obtained from this type of mathematical analysis,
only linear traces were observed at less than 40% inhibition. Therefore
the plots are used as a semiquantitative description of the possible
development of a heterogeneous population with respect to the sensitivity
to melarsen oxide.
2.25 The treatment of kinetic data
The kinetic data was analysed using an unweighted linear regression
of the Hanes plot (s/v vs S). In some cases it was also necessary to
use the Lineweaver-Burk plot (1/v vs 1/s) for comparative purposes,
as it was found that most of the analysis of the mechanisms of action
of PGK from other sources was carried out with this plot.
In other cases where the reaction with respect to a substrate was
apparently different from first order, after linear transformation, the
V
Hill plot was used (log—— vs log S) ; the estimate of the V wasV IHclX
max
obtained from the Hanes plot. The Hill plot was mainly used to describe
the phenomenon of negative cooperativity (Levitzki and Koshland, 1969)
at low concentration of substrates with trypanosome PGK.
Where possible, two non-linear regression computer programmes were
used: one to estimate the Michaelis-Menten parameters (Atkins and
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Gardner, 1977) and the other to estimate the parameters of the Hill
equation (Atkins, 1973). The Edinburgh University EMAS computer was
used for this purpose. My thanks are due to Dr. G. Atkins of the
Biochemistry Department of the University of Edinburgh, for the
preparation of the programmes and guidance when using the computer.
To study the reaction velocities under the influence of temperature,
the Arrhenius equation was used (Ink = InA - (Ea/Rt)). The plot of
log k (rate of reaction) against the reciprocal of the absolute
temperature gives a straight line of slope -Ea/R x 2.3 from which the
energy of activation (Ea) can be calculated.
The thermodynamic parameters corresponding to the transition
. + +
state; enthalpy of activation (AH+), entropy of activation (AS+) and
Gibbs free energy (/\G+) at 300 k were estimated using the following
equations:
A H+ = Ea-RT
A S+ = Rln (ANh/RT)-R
AG+ = A H+ - TAS+
where R = gas constant; T = absolute temperature; N = Avogrado's
number; h = Planks constant and A = constant calculated from the
Arrhenius plot.
For the treatment of data from inhibition experiments the methods
of Dixon (1953) and Hunter and Downs (1945) were used. The method of
Dixon (1953) allows the estimation of K. if the rate of the reaction
l
is determined with a series of inhibitor concentrations keeping the
substrate concentrations constant. A plot of the reciprocal of the
initial velocity at different concentrations of inhibitor and at
different fixed concentrations of substrate gives straight lines which
are used to determine the constant of inhibition (K^), according to
the type of inhibition found (Dixon and Webb, 1964).
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In some instances the protocol allowed the use of the method of
Hunter and Downs (1945), in which the following equation is used:
V1 K1
1
V-V K1 + K
1 m
where v = initial velocity; V = initial velocity with inhibitor (i) at
v!
specific substrates concentrations (S). The plot of S vs
^ ^ gives
a straight line of intersection K^.
Details of the derivation of the two methods used to study inhibitory
constants are found in Dixon and Webb (1964).
RESULTS
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3.1 The production of the resistant line
3.1.1 The development and pedigree of the resistant line
Different methods were evaluated for the production of a resistant
line of T. brucei. The first of the routines tried was the short
in vitro exposure of trypanosomes, isolated by the method of Lanham
(1968), to phosphate glucose buffer (PSG) containing different
concentrations of melarsen oxide. The range of concentrations varied
—6 -3
from 10 to lO M melarsen oxide. After checking by phase contrast
microscopy to ensure survival, the trypanosomes were injected into rats
and the potential development of parasitaemia was followed. This
approach was tried on three occasions, and each time no trypanosomes
were recovered even after a period of 15 days. The method was abandoned,
and a second routine was used. Trypanosomes were injected into healthy
rats, and once a high parasitaemia was reached (approximately 50 to 100
cells per microscope field at high magnification), the infected rats
were inoculated intraperitoneally with melarsen oxide to produce a
temporary clearance of the parasites from the bloodstream. A starting
dose of 0.08 mg/kg was used (Rollo et al., 1949); however this dose
produced total clearance for at least 15 days so it was reduced in order
to obtain faster relapses. The results obtained with this method were
irreproducible and also there was always the uncertainty of whether the
trypanosomes were going to relapse after a certain critical dose.
The method was abandoned due to these disadvantages.
The other two principal methods for the production of drug fast
lines in vivo are the relapse method and the short passage method
(Schnitzer and Grttnberg, 1957). The first was rejected as it produces
serum resistant organisms at the same time as resistance develops
(Bishop, 1959), and because it has been suggested that it takes longer
to develop resistance to arsenicals (Yorke et al., 1932). The alternative
routine, the short passage method (as described in Materials and Methods)





































































A reference collection was obtained of stabilates during the productior
of a melarsen oxide resistant line of T. brucei, originally sensitive
to the chemotherapeutic agent. Detail of the nomenclature used in the
pedigree appears in the text. The short passage method was used for tt
production of the resistant line; for details see Materials and Methoc
(Section 2.4).
62.
was the final method of choice. The starting dose used was 0.08 mg/kg
and this dose was found again to be very effective in clearing the
trypanosomes. A reduction to 0.04 mg/kg was found to be a more viable
starting dose. It was necessary to passage the original line 18 times
with 16 exposures, up to a final exposure at 0.52 mg/kg to produce a
resistant line of T. brucei as judged from the routine drug sensitivity
ro.52~
[0.04
wastest used in this work. A gross resistance factor of 13
eventually obtained from the doses used. The formal pedigree of the
final resistant line produced is shown in Figure 3.1. The nomenclature
used in the pedigree for the resistant character was that suggested by
the WHO (1978). For the notation of "exposure" a black heavy arrow is
used, perpendicular to the arrows showing non-cyclical passage.
The amount of drug used in mg/kg of animal is shown, and the number of
days after injection at which the treatment was carried out. The
stabilates prepared throughout the production of the resistant line
have the following notation; the letters BEU (Biochemistry Edinburgh
University), name of drug to which the stabilate has been exposed and
then the drug dosage (mg/kg). It can be seen from the pedigree, that
lines could be developed from the different stabilates produced.
3.1.2 The routine drug sensitivity test during the production of the
resistant line
As reported earlier in this thesis L.S. forms of African trypanosomes
have an absolute dependance on exogenous carbohydrate and aerobic
glycolysis, linked to the reduction of molecular oxygen for the production
of ATP (Ryley, 1956). Therefore it should be possible to show a
correlation between the rate of oxygen consumption and the action of
arsenicals, in our case melaminyl arsenicals. Moreover this correlation
could be used to differentiate sensitive from non-sensitive cells.
As described in Materials and Methods a routine drug sensitivity test
Figure 3.2: The inhibition of oxygen uptake in the different trypanosoi
populations obtained throughout the production of the
resistant line of T. brucei.
_7
[Melarsen Oxide] 10 M
3 ml of trypanosome suspension (about 0.8 mg trypanosome protein/ml)
were incubated in a preequilibrated oxygen electrode with different
concentrations of melarsen oxide at 37 C. The linear traces were
calculated immediately after the addition of the drug and the results
expressed as the percentage inhibition of oxygen uptake in untreated
trypanosomes as a function of the drug concentration. Measurement was
carried out in duplicated palindromic series. For details of the drug
sensitivity test see Materials and Methods (Section 2.13). parent
line? Q-0 population exposed to 0.06; 0.12; 0-0 0.16;
0.18; 0.32; 0.52 mg melarsen oxide/kg.
was carried out using an oxygen electrode in the presence of melarsen
oxide. One slight disadvantage of the system was the non-linearity of
the trace of oxygen consumption at high concentrations of the drug,
when working with the parent line.
The results of these tests are shown in Figure 3.2. There is a
clear difference in sensitivities between the parent line, with 40%
-7
inhibition at 9 x 10 M melarsen oxide and the line resistant to
0.52 mg/kg melarsen oxide with 10% inhibition of the rate of oxygen
uptake at the same drug concentration. The differences between the
parent line and the populations exposed to 0.06; 0.12; 0.16; 0.18
and 0.32 mg/kg melarsen oxide are not as significant as that between
the parent line and the population exposed to 0.52 mg/kg melarsen oxide.
As mentioned earlier and observed also in the Figure 3.2 no record is
presented of inhibition above 40% for the parent line; the reason
being the non-linearity of the traces of oxygen uptake. This non-
linearity, at high drug concentrations, can possibly be explained in
terms of multisite inhibition produced by the active agent.
3.1.3 Inhibition of the oxygen uptake; contrasted in vitro
The analysis of the development of resistance to phenyl arsenicals
(trivalent tryparsamide) has been carried out in the past using the
photosensitivity technique of Walker (1966). This method "took advantage
of the cross resistance between acriflavine and aromatic arsenicals,
first reported by Jansco (1931). In the present work an attempt was
made to study the development of resistance to melarsen oxide using the
oxygen consumption as experimental parameter . When trypanosomes were
observed using phase contrast microscopy at different intervals after
the addition of the drug (under the conditions of the drug sensitivity
test used), it was found that there was a decrease in the motility
which appeared subjectively to be related to the decrease in the oxygen
Figure 3.3: The inhibition of the oxygen uptake in parent and resistant
lines contrasted in vitro.
7.0 6.5 6.0 5.5
-log Cmelarsen oxide]
The pattern of inhibition of the parent population, and the
population exposed to melarsen oxide (0.52 mg/kg) , obtained
using the drug sensitivity test as in Figure 3.2 were analysed with
the probit transformation as described in Materials and Methods
(Section 2.24). The results are presented as the probit number
as a function of the logarithm of the drug concentration.
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consumption. Hence it was assumed that the total oxygen uptake was
related to the number of motile organism in suspension, when treated
with increasing concentrations of drug and when compared to untreated
sensitive trypanosomes.
Data obtained in a similar way as for the routine drug sensitivity
test,are transformed for this analysis. The results are presented as
the percentage of inhibition of the oxygen uptake, converted into a
negative
probit number and plotted against the^logarithm of the concentration of
melarsen oxide as in Hawking and Walker (1966). Plots of this type
should produce straight lines as the probit transformation is a
linearisation of drug response experiments (see Material and Methods
for detail). The drug responses of parent line and the line exposed to
0.52 mg/kg melarsen oxide, are presented in this manner in Figure 3.3.
The response of the parent line is linear up to the highest concentratiom
of melarsen oxide used. However there is an apparently biphasic response
of the resistant line. A higher slope is found at low concentrations
of the drug and a plateau at higher concentrations of melarsen oxide.
The probit value at which the plateau was present was approximately 3.75.
As suggested by Hawking and Walker (1966) heterogeneous populations of
trypanosomes with markedly different sensitivities to active agents
showed complex probit plots which departed from the typical linear
pattern shown in this case by the parent line of T. brucei.
3.1.4 The development of the resistant character; 0 uptake inhibition
in the different stabilates produced
The results of the inhibition of uptake in different populations
of trypanosomes throughout the production of an apparently resistant
line of T. brucei were presented in the last section. Stabilates of
these, populations were prepared for further analysis using the Warburg
manometer. In all cases, trypanosomes from the first relapse after
Figure 3.4: The inhibition of the oxygen uptake in organisms from
the different stabilates produced during the development
of the resistant line of T. brucei.
2.7 ml of trypanosome suspension (about 0.8 mg trypanosome protein/ml)
were incubated in a Warburg manometer, at 25°C, incubation time 30 min,
with air as the gas phase. The rest of the standard manometric
conditions are described under Materials and Methods (Section 2.11).
The results are from duplicate flasks and are presented as the
percentage inhibition compared to untreated trypanosomes as a function
of the drug concentration. parent line; ♦ stabilate CbEU
melarsen oxide 0.06] ; [BEU melarsen oxide 0.12]; 0-0 [BEU
melarsen oxide 0.18]; 0-0 [BEU melarsen oxide 0.32]; [BEU melars<
oxide 0.52].
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injection were used for the experiments. This measure was taken to avoid
any possible reversion of the resistant character to the original parent
line. Oxygen uptake measured by electrode proved to be a valuable tool
for routine use because of its rapid response even at low concentrations
of cells. However, constant volume manometry is a more accurate and
sensitive technique for the measurement of gas evolution (uptake/
production) in biological systems (Umbreit et al., 1957). Moreover,
this technique was routinely used for metabolic investigation and it was
considered important to compare the results obtained with those from the
oxygen electrode in order to corroborate them and also to have a coherent
body of data obtained with a single technique.
The results of the inhibition of oxygen uptake by melarsen oxide
in some of the different stabilates prepared are shown in Figure 3.4.
The patterns of inhibition were obtained using the standard manometric
techniques described in Material and Methods.
Again it is found that the inhibition patterns of the lines exposed
to relatively low concentrations of melarsen oxide ( stabilates[BEU
melarsen oxide 0.06; 0.12; 0.18]) are similar to the inhibition of the
parent line, with the I for inhibition of oxygen uptake lying between
4 and 5 x 10 M melarsen oxide. With regard to the meaning of the I
values when using Warburg mamometry and the differences found with
respect to the I values obtained in the routine drug sensitivity test,
a comment is made in the Discussion,in the section on the development
of the resistant character. A small but apparently significant
difference is found for the stabilate [BEU melarsen oxide 0.32]
with an I of 7 x 10 ^M melarsen oxide and a maximal inhibition of 80%
50
at high concentrations of the drug. The pattern changed completely for
the relapse from the stabilate [beu melarsen oxide 0.52], with a
maximal inhibition of 20%. The appearance of the resistant character
Figure 3.5: The inhibition of the oxygen uptake in different populatio


























A suspension of trypanosomesCabout 0.8 rng protein/ml) were incubated
using the standard manometric conditions. These conditions and the
method of trypanosome isolation are as described in Materials and
Methods (Section 2.5). The organisms used are isolated after:
1st passage? 0-0 4th passage? □ 13th passage and compared
with the parent line
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is therefore apparently discontinuous during the production of the
resistant line as judged by the inhibition patterns of the different
stabilates.
From now on the relapses obtained from stabilates of the population
exposed to 0.52 mg/kg melarsen oxide are called the Resistant Line and
most of the comparative work has been done using the latter and the
original parent line. For the purposes of this work, the stabilates
[BEU melarsen oxide 0.06; 0.12; 0.16] are considered to have
"low resistance", stabilates [BEU melarsen oxide 0.18; 0.32]
"intermediate resistance" and the stabilate [ BEU melarsen oxide 0.52]
"high resistance". No attempt was made to increase further the level
of resistance.
3.1.5 The stability of the resistant character in vitro
Drug resistance, once fully developed, is normally a relatively
stable character even in the absence of drug pressure (Murgatroyd and
Yorke, 1937). However, stability may vary from one line to another
(Bishop, 1959). One example of the stability of resistance to organic
arsenicals is reported by Hawking (1963) who described a line of
T. rhodesiense resistant to atoxyl which remained resistant for-30 years",
after serial passage.
The next stage in this work was to check the stability of the
resistant line during serial passage, in the absence of drug pressure.
The sensitivity to melarsen oxide was estimated using the standard
manometric system after the 4th and the 13th passages. The results are
shown in Figure 3.5. It may be seen that the resistant line developed
after the maximal dose of melarsen oxide used (0.52 mg/kg) was stable
up to the 13th passage in rats as judged by the inhibition patterns.
No attempt was made to study the degree of stability of the lines with
"low and intermediate" resistance. However, it has been suggested that
Table 3.1: The action of melarsen oxide on the motility of T. brucei
in vitro
Parent line
Melarsen oxide Time (minutes)
x 10~6M 10 20 30
0 +++ +++ +++
1 +++ ++ ++
5 ++ ++ +
10 ++ +o +o




x 10 M 10 20 30
0 +++ +++ +++
30 +++ +++ +++
80 +++ +++ +++ few dead
150 +++ +++ " 1 +++ few dead
LS trypomastigotes were incubated in PSGA buffer(about 0.8 mg trypanosc
protein/ml buffer) at 25°C. The motility was recorded as a function (
time by observation under phase contrast microscopy. Details of the
motility test is as described under Materials and Methods (Section 2.7!
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lines with relatively low levels of resistance to arsenicals are
relatively unstable ({Schueleret al., 1947; Hawking and Walker, 1966) .
3.1.6 The effect of melarsen oxide on motility in vitro
It has already been reported that the reduction in oxygen uptake is
accompanied by a reduction in motility of the trypanosomes, the reason
being that trivalent arsenicals are rapidly cytotoxic due to the focal
action on aerobic glycolysis. The estimation of motility, although
subjective, gives valuable qualitative information about the sensitivity
of the parasites to the active agent.
By looking at Table 3.1, it can be seen that melarsen oxide has
the expected effect on the motility of the parent line. However, after
30 minutes of incubation at the maximum concentration of drug used
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(50.10 M) a few organisms retained some movement. The situation is
completely different with the resistant line which did not respond to
the action of the drug. At high concentrations of the drug and towards
the end of the experiment a few organisms were observed apparently dead
as judged by the lack of motility. (Note that the concentration of
melarsen oxide and the concentration of trypanosomes were the same as
for the manometric experiments.)
With regard to the small percentage of organisms which either did
not die or did die in the parent and resistant line respectively,
it has been suggested (Hawking and Walker, 1966) that a population of
trypanosomes has a "normal" distribution of sensitivities to the
chemotherapeutic agents with which the population is treated. This is
apparently shown in the motility test presented as there were a few
organisms in both lines of trypanosome which did not respond as the
rest of the population to the active agent.
Figure 3.6: The action of melarsen oxide in vivo on trypanosomes
in parent and resistant lines.
Time (hr)
5 pi of blood from the tail of infected rats with terminal parasitaemia
of the parent and the resistant lines was collected into 3 ml of PSG
buffer. Treated rats were injected intravenously (using the penile
vein) with melarsen oxide (0.52 mg/kg) in saline (0.3-0.5 ml). The
number of motile organisms was calculated in triplicate using haemocyton
and presented as a function of time. •-• parent line; ■ resistant
line; O-O parent line + melarsen oxide; resistant line + melarser
oxide; D stands for death of the animal; C for cured animal.
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3.1.7 The effect of melarsen oxide on motility In vivo
All the metabolic experiments described so far, were carried out
in vitro. The next objective was to evaluate the resistant character
in vivo, in laboratory animals. Rats with terminal parasitaemia of
either parent or resistant line were treated intravenously with the
highest concentration of melarsen oxide used during the production of
the resistant line (0.52 mg/kg), and the number of motile trypanosomes
present in blood samples were estimated by haemocytometry for several
hours. The results are shown in Figure 3.6. It may be seen that both
controls of untreated rats with parent or resistant line"infections
died within 5 to 7 hours after the experiment was started. Conversely
the parent line is cleared almost completely from the bloodstream in
approximately five hours. The resistant line showed a small reduction
in the rate of growth and the death of the animals occurred the
following day.
3.1.8 Summary
For the purpose of this work on the rationale behind resistance to
arsenicals, a line of T. brucei resistant to one of these drugs was
needed (melarsen oxide). Such a resistant line was prepared using
the short passage method. The new resistant line as reported in the
formal pedigree was obtained after 18 passages (lO weeks) with 16
exposures to melarsen oxide. The maximal dose used was 0.52 mg/kg
of animal. The line had a gross resistance factor of 13 fold when compared
with the parent line.
As it was a newly developed resistant line, it was necessary to
check certain general characteristics e.g. the stability and homogeneity
of the resistant character and the behaviour of the resistant line
in vivo and in vitro under pressure of the drug.
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With the help of a routine drug sensitivity test and further studies
with constant volume manometry, it was found that the new line was
apparently developed in stages. It was also found that the line may be
a mixed population of trypanosomes with a decreased sensitivity to
melarsen oxide. The resistant character was stable after 13 serial
passages.
Finally it was found that the resistant line proved to be effective
in killing rats under drug pressure when compared to the parent line
which did not kill the host.
The following chapters of this thesis are dedicated to the study
of the resistant character developed in this new line of T. brucei.
Figure 3.7: Preliminary experiment on the comparative carbohydrate
metabolism of parent and resistant lines in vitro.
14 ml of trypanosome suspensions with about 13 mg of trypanosome proted
were incubated in 25 ml conical flasks plugged by a rubber stopper.
The buffer conditions were PSGA with 15 mM glucose and 150 mg% BSA
(Brohn and Clarkson, 1978) . Prior to initiation of the experiment,
the flasks were gased with O^/CO^ (95%/5%) through a vent in the rubber
stopper. The gas mixture was humidified by bubbling through water pric
to passage to the flasks. The systems^incubated at 25 C in a water ba1
with shaker; the experiment was terminated by removing aliquots (1 ml)
from the flasks at 10 minute intervals and centrifuging these immediate
in a Beckman microfuge for 1 min. The metabolite estimation" was perfo]
as described in Materials and Methods (Section 2.12). The results
obtained are shown as a function of time: glucose;
A-A , pyruvate; , glycerol.
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3 .2 Metabolic studies
As has been described in the Introduction,a metabolic change has
been suggested on several occasions as a possible mechanism to explain
the development of resistance to arsenicals. Although this idea is not
shared by all authors, it remains as a feasible possibility in
Trypanosomes fast to these drugs. The suggestion of a metabolic bypass
was one of the earliest explanations for the phenomenon in arsenical
fast trypanosomes, as these drugs are accepted metabolic inhibitors.
The main objective of this chapter was to investigate the possibility of
a metabolic change as a result of the development of the resistant
character. The basic glycolytic parameters were evaluated in the
parent and in the new drug fast line of T. brucei.
3.2.1 Preliminary experiments on comparative metabolism
Trypanosomes of the brucei group, which depend exclusively on
glycolysis for generation of ATP, produce pyruvate from glucose under
aerobic conditions in quantitative amounts (Ryley, 1956"; 1962; Grant
and Fulton, 1957). Recently the end products of aerobic metabolism of
LS forms in the parent line of T. brucei used were studied and compared
with the general metabolism of other representatives of this group.
No significant differences were found (Hammond, 1979).
The results presented below are measurements of glucose consumption,
pyruvate production and glycerol production. These were obtained in
order to compare parent and resistant line. A suspension of trypanosomes
in PSGA buffer, (for detail see Material and Methods), from both lines
T. brucei were incubated in small conical flasks, in such a way that
a high surface area-volume ratio was obtained. The system was incubated
under agitation at controlled temperature with O^/CO^ as the gas phase.
At the required time, flasks were deproteinised and the estimation of
the metabolites described above was carried out. For the method of
estimation of metabolism see Material and Methods. Figure 3.7 shows the
Table 3.2: Preliminary data on the carbohydrate metabolism and carbon























X 100 98.51 82.36
The slopes of the rates of metabolite production/consumption presented
in Figure 3.7 were calculated as described in Section 2.24. From the
results obtained the different metabolic ratios and carbon recoveries
were estimated; mean - standard deviations of a typical experiment
are shown for the metabolite*changes.
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data for metabolite changes under the conditions described. Isolated
trypanosomes, in a simple buffer system at 25°C took up glucose and
produced pyruvate in a linear fashion for up to 60 minutes.
The slopes of the regression lines from these data (i.e. ratios of
utilisation/production) are compared in Table 3.2. The rates of glucose
uptake in both lines were the same, although the rate of pyruvate
production in the resistant line was apparently lower, when compared
with the parent line.
The production of trace amounts of glycerol was also observed.
This is considered to be of minor importance in the experiment as it did
not increase with time. The aerobicity of the system during incubation
is therefore ensured, as trypanosomes under anaerobic conditions produce
equimolar amounts of pyruvate and glycerol (Ryley, 1962; Hammond, 1979).
The molar ratios and the carbon recovery for the parent line showed
that pyruvate accounted quantitatively for the glucose used. On the
other hand the molar ratios and the carbon recovery suggest a smaller
yield of pyruvate from glucose in the resistant line. It should be
pointed out that the level of glycerol was again negligible, and
therefore the lower yield was not due to anaerobic metabolism by the
parasites. With regard to the presence of glycerol, the possibility of
transient anaerobic conditions during the handling of the trypanosomal
suspensions is suggested as the possible reason for the presence of
this metabolite.
Finally as a result of the small but detectable difference found
in the carbon balances of the two lines, as shown by the difference in
the pyruvate/glucose ratios, a more comprehensive approach was taken
in order to study in more detail the carbohydrate metabolism of parent
and resistant lines of T. brucei.
Table 3.3: The general carbohydrate metabolisms in T. brucei parent







(Rates of metabolite production or consumption in nmol min ^ mg protei
2.7 ml of trypanosome suspensions(about 0.8 mg trypanosome protein/ml)
-3
in PS buffer with glucose (4.0 x 10 M) and BSA (0.5 mg/ml) were
incubated using the standard manometric conditions described in
Section 2.11, at 25°C. The linear rates of gas evolution were measure
over a period of 30 minutes. After deproteinisation the metabolites
involves were determined as in Section 2.12. The figures are presente
as the mean - the standard error of the mean; in parenthesis the
number of analysis.
Parent line
O^ consumption 65.63-0.72 (3)
glucose consumption 69.61-1.56 (4)
pyruvate production 136.89-2.06 (4)
glycerol production 5.97-0.87 (2)
CO^ production Nil (3)
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3.2.2 General carbon balance in parent and resistant lines
As discussed earlier in this chapter, the metabolism of lines of
trypanosomes resistant to arsenicals has resulted in a rather inconclusive
picture. On one side some workers advocate no apparent change in general
metabolism (Reiner et al., 1936; Fulton and Stevens, 1945; Harvey,
1949). On the other hand, minor modifications in the general catabolic
routes of resistant parasites, have been shown (von Brand et al., 1953;
Williamson, 1953a). As suggested in the last section a more comprehensive
approach should be taken in order to assign some significance to the
differences found in the general carbon balance of parent and resistant
parasites. Hence the Warburg Manometric system was used for further
investigation.
The results of these experiments are shown in Table 3.3. Note that
oxygen consumption has been included in the data. The figures obtained
for pyruvate production and glucose utilisation were similar to those
obtained in the preliminary experiment. No significant differences were
observed when comparing glucose or oxygen utilisation rates of parent
and resistant line.
With regard to pyruvate production, an apparently lower rate was
again observed in the resistant line, but the standard deviations
observed precluded the assigning of significance to those results at
this stage. The significance of these results is discussed in detail
in the next two sections when the molar ratios and carbon recoveries
are evaluated.
Monomorphic, laboratory adapted lines of T. brucei should not
produce C0^r as a final product of their metabolism (Flynn and Bowman,
1973) . However the possibility of C02 evolution was evaluated in both
lines for comparative purposes. The Direct Method of Warburg was used
for the estimation of CC>2; details of the method are found under
Table 3.4: The molar ratios and carbon recoveries from glucose in the











Mean total recovery %
Molar ratios
Parent line Resistant line
0.98-0.04 (3) 0.94-0.03 (3)




0.09-0.01 (2) 0.05-0.01 (2)
Carbon recoveries °/o










The data presented in Table 3.3 expressed as molar ratios and carbon
recoveries from glucose in the different experiments performed.
+
Results presented as the mean - standard error of the mean; number
of determinations in parenthesis.
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Material and Methods. It was observed that the PSGA buffer used during
these experiments, even when freshly prepared binds some atmospheric
CC^/ possibly following the equation:
Na2HP04 + C02 + H20 «=>NaH2P04 + NaHCC>3
This error was controlled by subjecting the thermobarometers to
exactly the same conditions as the experimental barometers and correcting
for the presence of CC>2 in the buffer after acidification of the contents
of the experimental flasks. The results of these experiments are shown
in Table 3.3. A typical response for the parent line was found, without
measurable evolution of C02> However, the resistant line showed a
measurable production of this metabolite, with a respiratory quotient
(RQ) of approximately 0.10. Therefore,although the difference in the
rates of pyruvate production were small in parent and resistant lines,
the formation of a second product from the metabolism of glucose by
the resistant line seems to be certain.
3.2.3 Molar ratios and carbon recoveries from parent and resistant lines
To illustrate the distribution and recoveries of end products in
both parent and resistant line, the molar ratios and recovery of each
metabolite were calculated, the objective being to stress any possible
differences between the two lines of trypanosomes.
From the data shown in Table 3.4a,b, it may be suggested that the
aerobic metabolism of the parent line of T. brucei is similar to the
other bloodstream forms of the subgenus Trypanozoon (Flynn and Bowman,
1973; Brohn and Clarkson, 1978). There was a quantitative formation of
almost two moles of pyruvate per mole of glucose consumed, with an
overall yield of around 98%. The overall scheme of metabolism is
therefore consistent with the one presented in Figure 1.2. However,
when looking at the results in Table 3.4a, some differences may exist
Table 3.5: The levels of significance of the different molar ratios -
for parent and resistant lines obtained using the "t stude
test".














ND = no difference




The results are presented in Table 3.4a were analysed using the
"Paired student test". After calculation of the "t" value these
were transformed into probability values by entry in the Tables
specially prepared for this purpose, at the appropriate degrees
of freedom.
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with respect to the pyruvate/glucose and pyruvate/oxygen ratios in the
resistant line of trypanosome. No differences were observed however in
the O^/glucose ratios.
It is clear, as shown in Table 3.3 that a relatively large standard
deviation was found for the metabolic parameters, which may be produced
by the variation in the figures obtained for the different metabolites
from one metabolic experiment to another. Nevertheless, similar results
were consistently obtained showing lower pyruvate yields from the
resistant line. Therefore, in order to determine whether there was a
difference in the carbon balance of parent and resistant line, the
"student" t test was used, making a paired comparison of the data
obtained in the different experiments. The results are shown in
Table 3.5. The data shows that the differences found with regards to
pyruvate/oxygen and pyruvate/glucose ratios are apparently significant
at the calculated levels of confidence. Therefore, the resistant line
may have a small modification in its general metabolism, which involves
the production of lower levels of pyruvate when compared with the
parent line. Different alternatives for the fate of this pyruvate are
put forward in more detail under Discussion. However, the possibility
of further metabolism of pyruvate with production of CO^ is favoured.
Figure 3.8: The effect of the incubation time on the metabolism of
carbohydrate in parent and resistant lines in the
presence of melarsen oxide, using the Warburg manometer.
Time (min)
2.7 ml of trypanosome suspension (about 0.8 mg trypanosome protein/ml)
was incubated in_g Warburg manometer at 25 C, with air as a gas
phase and 6 x 10 M melarsen oxide; the rest of the standard manometri
conditions are as described under Materials and Methods (Section 2.11).
Incubations were terminated every 10 minutes by addition of perchloric
acid (0.3 ml, 6M).from the side-arms of the flasks. Deproteinisation
and estimation of metabolites are as described under Materials and
Methods; duplicated results are presented as a function of time for
the different metabolites estimated. parent line; resistant
line.
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3.3 The action of melarsen oxide on the metabolism of parent and
resistant lines
A difference in the carbohydrate metabolism of the resistant line of
T. brucei has been confirmed with the metabolic experiments performed in
the last sections. Nevertheless, this apparently minor metabolic change
may not explain the resistance factor observed (13 times). At the same
time this metabolic difference does not explain the different patterns
of inhibition of uptake observed for parent and resistant line
(see Figure 3.4). Therefore a series of experiments were performed
under drug pressure to determine whether these metabolic changes may
alone explain the development of the resistant character.
3.3.1 The effect of incubation time on the metabolism of parent and
resistant lines in the presence of melarsen oxide
_ r
In the absence of melarsen oxide the metabolite production and
consumption were linear under the experimental conditions used.
The question arose as to whether metabolism follows the same pattern
in the presence of the drug.
The standard manometric conditions were used in this experiment. —
The method for deproteinisation and estimation of metabolites are
_
described in Material and Methods. The concentration of drug used for
both parent and resistant line was chosen from the initial oxygen
inhibition experiments and it was 5 x 10 ^M melarsen oxide (see
Figure 3.4). The results of metabolite utilisation and formation as a
function of time are shown in Figure 3.8. It was found that the glucose
and oxygen consumption and pyruvate production were linear in the
resistant line. However in the parent line the same parameter showed a
plateau after 15-20 minutes. The standard time of 30 minutes was used
in the next set of experiments, to allow maximisation of any difference
in metabolite ratios between the two strains.
Figure 3.9: The effect of melarsen oxide on the oxygen uptake by whole
cells in parent and resistant lines.
[Melarsen oxide] c: 10 M
2.7 ml of trypanosome suspension (about 0.8 mg trypanosomes protein/ml)
was used for this experiment. The standard manometric conditions were
used at 25 C with air as the gas phase, incubation time 30 minutes.
Routines used for deproteinisation and estimation of metabolites
are as described under Materials and Methods (Sections 2.11 and 2.12).
Results from duplicated flasks are presented as a function of the
drug concentration: parent line; resistant line.
Figure 3.10: The effect of melarsen oxide on the oxygen uptake by
water lysates in parent and resistant lines.
—6
[Melarsen oxide] \ 10 M
2.7 ml of water lysates in minimal fortified medium (Flynn and Bowman,
1974) were used for this experiment} details of the medium are as
described under Materials and Methods (Section 2.8.2). The rest of
the experimental conditions were as in Figure 3.9. Results from
duplicate flasks are presented as a function of the drug concentration,
parent line; resistant line.
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3.3.2 The effect of melarsen oxide on the oxygen uptake in whole cells
and water lysates
As discussed in the chapter on the production of the resistant line,
LS trypanosomes rely completely on aerobic glycolysis and this pathway
is sensitive to the action of trivalent arsenicals. A relationship
between oxygen consumption and drug concentration was therefore expected.
A correlation was found and it was used to differentiate the parent and
the resistant line, in terms of the lack of inhibition found with the
routine drug sensitivity test (see Figure 3.2).
For investigation of whole cells the standard manometric conditions
were used with a range of drug concentrations. Trypanosomes from the
first relapse after inoculation with stabilates of parent and resistant
lines were used. No differences in the resistant character were found
under the conditions of cryopreservation used for up to 7 months storage.
The results of these experiments with whole cells are shown in Figure 3.9.
Total inhibition of 0^ uptake by the parent line is observed but
incomplete inhibition is found with the resistant line. An I value
-6
for C>2 uptake of approximately 5 x 10 M melarsen oxide is observed
for the parent line while the maximum inhibition in the resistant line
is approximately 25% at 83 times the concentration of drug to produce
50% inhibition in the parent line. The patterns of inhibition of oxygen
uptake by water lysates using the minimal fortified medium of Flynn and
Bowman (1974) (described in Material and Methods) and the standard
manometric conditions, are presented in Figure 3.10. It may be seen
that the inhibition patterns did not show a significant difference
between parent and resistant line. Therefore it is suggested that some
common point of inhibition may be sensitive in both parent and resistant
line.
Figure3.11:Theeffectofm larsenoxidnthpyruvateproductionandgluc secons mptionin parentandresistantlin . Alltheexperimentalconditionsarsdescrib dinFigur3.9.parentlin ;■-■resist tline
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With respect to the marked difference of inhibition in the whole
cells and the similarity of the pattern with water lysates, it is suggested
that a problem of accessibility of the drug for its final receptor is
involved. It was observed that the extracellular concentration of
melarsen oxide needed to produce 50% inhibition of uptake by whole
cells of the parent line is considerably less than the concentration
required to produce even 20% inhibition in water lysates. This
observation may be explained in terms of the mechanism of uptake of the
drug in these parasites (see Section 3.6). Melarsen oxide is taken up
very actively and is concentrated by the trypanosomes. Probably, in
this way the concentration of the free active agent is increased within
the glycolytic compartment, ensuring a complete inhibition of the targets
even at low extracellular concentrations of the drug. However other
possible alternatives should be discarded in order to substantiate the
one mentioned above.
3.3.3 The effect of melarsen oxide on the glucose consumption and
pyruvate production
Another two parameters directly related to the general metabolism of
trypanosomes are the consumption of carbohydrate and the production of
pyruvate. Figure 3.11a shows the results of a series of experiments,
when the inhibition of glucose utilisation is studied as a function of
the concentration of melarsen oxide. The percentage inhibition represents
the figures compared with non-treated cells for both lines of the parasite.
It may be seen that there are again different patterns for parent and
resistant line. The I value for the parent line was approximately
""6
6.0-6.5 x 10 M melarsen oxide and the maximal inhibition obtained for
the resistant line was 40% at the highest concentration of the drug used
(250 x 10 ^M). As for the possible mechanism of inhibition, several
alternatives have been suggested; first a site of inhibition between
78.
glucose-6-phosphate and triose phosphates (Flynn, 1971), secondly
inhibition of hexokinase (Chen, 1948) and thirdly, the possible inhibition
of the transport of carbohydrates into the cells. These alternatives
are discussed briefly at the end of this section.
Figure 3.11b shows the pattern of inhibition of pyruvate formation
for the parent and resistant lines. Again a major difference is found
between the two lines. The I value for the inhibition of the parent
line is approximately 3.5-4.0 x 10 melarsen oxide and only 40%
inhibition for the resistant line is found at the highest concentration
—6
of the drug (250 x 10 M).
3.3.4 Inhibition Of oxygen and glucose consumption and pyruvate
production in parent and resistant lines
The pattern of inhibition for the three metabolites investigated in









(2.5 x 10 M) 15% 20% 30%
It would appear that the results presented corroborate the view that
pyruvate kinase is the major focal point of inhibition by melarsen oxide
(Flynn and Bowman, 1974), as suggested by the clear effect of the drug on
pyruvate production. Therefore the control situation, which is the
behaviour of the sensitive trypanosome under the effect of the drug allows
the possibility of treating the data obtained for the resistant line
in a similar way.
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When comparing the patterns of inhibition for the resistant line,
it was not possible to obtain 50% inhibition even at high concentration
—6
of melarsen oxide (250 x 10 M). Therefore the I^ values are used for





I__ (10 M) 100 70 25
2d
Maximal inhibition
obtained 25% 40% 40%
As shown in these data pyruvate production is still a sensitive
point as judged by the lower 1^ value obtained. It is suggested
therefore that at high melarsen oxide concentrations, the different
alternatives proposed when the inhibition of glucose utilisation was
considered may produce a general case of multisite inhibition.
However it appears that the focal point of inhibition of pyruvate
production is still present in the resistant line.
The sensitivity of pyruvate formation and the other metabolic
parameters is only shown at higher extracellular concentrations of the
drug in the resistant line. Therefore the possibility of a permeability
barrier to the drug in the resistant line is suggested.
3.3.5 The effect of melarsen oxide on the molar ratios of parent and
resistant lines
It was found at the beginning of this chapter that the resistant
line of T. brucei has a minor difference in its metabolism which was
evidenced as a lower production of pyruvate when compared with the parent
line. In the two last sections the glucose and oxygen consumption and
pyruvate production were found not to be inhibited to the same extent
in the two lines, the resistant line being considerably less sensitive
Figure 3.12: The effect of melarsen oxide on the molar ratios with





[Melarsen oxide] 10 &M
The data collected from the metabolite experiments (Fig. 3.9 and
Fig. 3.11) performed under the effect of melarsen oxide were transforms
and the metabolites produced or consumed were expressed with respect t<
the glucose used as a function of the drug concentration. oxygen;
glucose; pyruvate/glucose; 0-0 pyruvate/oxygen.
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to inhibition. The new distribution of metabolites in the resistant
line and the differential inhibition of the metabolic parameters did
not answer about the question of a possible involvement of a metabolic
change as being responsible for the development of the resistant
character. A series of experiments were therefore performed in parent
and resistant line, with the standard manometric system, in which the
behaviour of the metabolic ratios, of parent and resistant line, were
investigated as a function of melarsen oxide concentration. Figure 3.12
shows the results obtained. It was observed that in the parent line
there was a reduction of the pyruvate/glucose and pyruvate/oxygen
ratios from 2 to 1.2 approximately at 5 x 10 ~*M melarsen oxide. These
results show the primary action of melarsen oxide on the production of
pyruvate. The data for the resistant line was different, again lower
values for the pyruvate/glucose and pyruvate/oxygen ratios being
obtained in the absence of melarsen oxide and remaining constant over
the range of drug concentration used.
The already suggested possibility of a lack of sensitivity of the
trypanosomas as a result of a permeability barrier still remains as an"
explanation of the molar ratios obtained in both parent and resistant
line. However, the possibility that the enzyme pyruvate kinase itself
is no longer affected can not be discarded at this stage. Therefore
the sensitivity of this enzyme to melarsen oxide in the resistant line
became important and it deserves to be studied more carefully in order
to corroborate the idea of a permeability barrier. The role of
phosphoglycerate kinase, also involved in the phosphorylation of ADP
at the substrate level, is potentially important as this enzyme may also
participate in the development of the new character in the resistant
line-, hence these two enzymes are the subject of a more detailed analysis
in the next chapter of this thesis.
Figure 3.13: The effect of melarsen oxide on the respiratory










[Melarsen oxide] 10 6M
All experimental conditions are as described in Figure 3.9.
For the estimation of CO^ the Direct Method of Warburg was used.
Details are as described under Materials and Methods (Section 2.11)
The results from duplicate pairs of flasks are expressed as the RQ
values as a function of the drug concentration.
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3.3.6 The effect of melarsen oxide on the respiratory quotient in
resistant line
The aerobic metabolism of glucose by LS forms in recently isolated
lines of T. brucei produces pyruvate as a major end product, and traces
of succinate and CO^ (Ryley, 1956; Flynn and Bowman, 1973). However,
upon adaptation to laboratory conditions by syringe passage, it was
found that there was a concomitant decrease of the RQ value to less
than 0.1 (Flynn and Bowman, 1973). It has been reported in this work
(see Table 3.3) that the resistant line developed, produced some CO^
when compared to the parent line. In Figure 3.13 is reported the
influence of melarsen oxide on the RQ value in the resistant line.
The standard manometric conditions, for the estimation of were
used as described in Material and Methods. It would appear that the CO^
production originally found is inhibited, as are the rest of the
metabolic parameters in the resistant organisms, when the drug is
present. However the inhibition of CO^ formation is apparently
completely abolished at approximately 80 x 10 ^M melarsen oxide.
3.3.7 The effect of melarsen oxide on the multienzyme activity of the
qlycosome
As described by Oduro (1977) and Opperdoes and Borst (1977), the
localisation of some of the glycolytic enzymes in the glycosome allows
the particle to catalyse the conversion of glucose or glycerol into
3 phosphoglycerate. At the same time Oduro (1977) described an assay
system which relies on the reduction of dehydroxyacetone phosphate to
glycerophosphate in the presence of NADH, to measure the multienzyme
activity of the system following the decrease in the absorbance at
340 nm (details of the assay medium are given in Material and Methods).
It was considered relevant at this stage to study the sensitivity
to melarsen oxide of isolated glycosomes from parent and resistant lines.
Figure 3.14: The effect of melarsen oxide on the multienzyme activity
of the glycosome.
[Melarsen oxide] M
The glycosomes were prepared and assayed from both parent and resistan
lines using the techniques described under Materials and Methods
(Section 2.14). The glycosomes were preincubated with all the compone
of the assay medium including malarsen oxide, for no less than five
minutes, and the reaction was started by addition of glucose to the
cuvettes. The linear activities were measured about 15 minutes after
addition of glucose (see text). The results are presented as percenta
inhibition compared to untreated glycosomes as a function of the drug
concentration. parent line; resistant line.
The results of duplicates of two sets of experiments are shown in
Figure 3.14. It may be seen that although the variability was quite
large, there was no inhibition of the multienzyme complex up to the
micromolar range of concentrations of the drug. The I values are
-3
approximately 3 to 5 x 10 M melarsen oxide for parent and resistant
line respectively. No significant differences can be assigned to the
values observed. It should be noted, that the reaction was started
by addition of glucose to the medium including the drug and the
glycosomes from both lines of parasites. A lag phase of activity was
observed of up to 15 minutes, before linear traces. This lag phase was
interpreted as being a result of substrate diffusion and the time
required to reach steady state concentrations of metabolites in the
glycosome. No specific activities are presented for the glycosome
preparations as it was found that there was a considerable variation
from batch to batch of glycosomes prepared from either line of trypanosome,
a feature already reported by Oduro (1977). The similar patterns
observed suggest that if there is any change in this part of the
glycolytic pathway as a consequence of the development of resistance,
it is not detectable under the conditions used. However, the possibility
of changes in the kinetic properties and sensitivities of isolated
components can not be eliminated.
3.3.8 Determination of thiol content in parent and resistant lines
When Voegtlin et al. (1923) postulated their hypothesis of thiol
groups (-SH) as the chemoreceptors for arsenicals, the view that an
excess of-SH groups will detoxify these drugs in a resistant line was
suggested (Voegtlin et al., 1924). The hypothesis has been tested at
different times and no differences have been found (Hawking, 1938;
Harvey, 1949). In spite of the information gathered, it was necessary
to check the -SH group content of the newly developed resistant line
of T. brucei.
Figure 3.15: The estimation of thiol content in trypanosome protein








Lyophilised protein from both lines of T. brucei was resuspended in +
0.08M phosphate buffer pH 8.0. Available and total thiol (in buffer -
2% SDS) were estimated by addition of an aliquot of DTNB solution
followed by incubation for 15 minutes. The colour development was
then measured at 412 nm. For details see the text and Materials and
Methods (Section 2.21).
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The reagent 5,5 dithiobis (2-nitrobenzoic acid) (DTNB) originally
described by Ellman (1959) was used to estimate the -SH group content
of parent and resistant lines. The routine of Habeeb (1972), which
estimates available and total -SH group, was used. The data shown in
Figure 3.15 suggests that there is no difference in the -SH content,
either as available -SH groups or when the protein is denatured (total
-SH groups). The detection of more -SH groups upon denaturation and
unfolding of the proteins is probably due to the release of hidden groups
with original steric impediment and hence no reactivity for DTNB.
3.3.9 Summary
It has been suggested earlier that there was a possibility of
explaining the development of resistance to arsenicals, in terms of a
metabolic change in the trypanosomes resulting in a bypass of the
arsenical sensitive site. This hypothesis is not by any means accepted
by all the authors in the field but has been considered as a viable
alternative. Therefore this suggestion was experimentally tested.
The general carbon balance was first studied in the absence of drug,
in both lines of parasite. The characteristics found for the parent line
agreed with the data already reported for other laboratory adapted LS
form of trypanosomes of the brucei group. However, the metabolism of
the resistant line was apparently modified, the differences found being
lower pyruvate/glucose and pyruvate/oxygen ratios (1.73 and 1.84
respectively). A small production of CO2 resulting in an RQ of
approximately O.l was also found with the resistant line.
The metabolism of both lines was also studied in the presence of
melarsen oxide. As reported in the development of the resistant line
the oxygen consumption was inhibited to a lesser extent in the resistant
line. This information was extended and it was found that glucose
consumption and pyruvate production are also less inhibited in the
resistant line.
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The idea of a permeability barrier for the drug, as an alternative
to explain the development of resistance, emerged in two different ways.
First, the different patterns for the oxygen uptake in whole cells of
parent and resistant line when compared with the similar pattern of
inhibition of the same metabolite in water lysates from both lines.
Secondly it was found that resistant trypanosomes are still sensitive to
melarsen oxide but at relatively higher concentrations of extracellular
drug,,
As for the importance of the lower levels of pyruvate obtained and
the CC>2 production in the resistant line, it appeared that in the case
of the molar ratios, they were conserved during the exposure of the
resistant line up to a concentration of 250 x 10 melarsen oxide.
The CO2 formation was inhibited to such an extent that CO2 was no longer
detectable under the experimental conditions used. It is suggested that
although the modification in the resistant line may be the result of
further metabolism of pyruvate possibly involving decarboxylation, the
metabolic difference itself does not participate directly in the
development of resistance. Another alternative, the possible excess of
thiol groups as detoxifying agents, was tested; no significant
differences were found between parent and resistant line.
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3.4 Enzymological studies
From the metabolic studies it was suggested that although an apparent
modification of metabolism is present in resistant line, this modification
does not account for the development of resistance to the drug.
Furthermore on the inhibition of the evolution of the different
metabolites in both lines suggested the possibility of a permeability
barrier to the drug as a result of the development of resistance.
This suggestion, however, does not rule out the alternative of modification
of the enzyme targets to melarsen oxide. Therefore a closer look was
taken at pyruvate kinase, a known target for the drug, and to phospho-
glycerate kinase, an enzyme with a similar function. The experiments
performed covered the possibility of increased production of the enzymes
as a mechanism to overcome the action of the drug and also the possibility
of enzyme modification, either producing different kinetic characteristics
or different sensitivities to the drug.
Finally, as suggested in the Introduction, phosphoglycerate kinase
is the least studied enzyme of the glycolytic kinase group in trypanosomes.
Therefore some experiments were performed to study the general properties
of the enzyme, mechanism of action and mechanism of inhibition by arsenicals.
3.4.1 Choice of materials and optimal conditions for assay
Two assay systems were used throughout the experimental part of the
enzymological studies. Pyruvate kinase (PK) was assayed by the method of
Btlcher and Pfleiderer (1952) as modified by Flynn (1971). This system was
used recently in the purification of PK from T. brucei (Flynn and Bowman,
1980). Phosphoglycerate kinase (PGK) was assayed by the method of
Krietsch and Bflcher (1970). The system, as described in Material and
Methods, relies on the back reaction catalysed by PGK coupled to the
oxidation of NADH by glyceraldehyde-3-phosphate dehydrogenase. The
reaction is followed spectrophotometrically as a decrease in the absorbance
at 340 nm.
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3.4.2 The source of enzymes used
The source of enzymes used in the experiments was lyophilised
material prepared immediately after lysis of purified trypanosomes in
distilled water. The material from either resistant or parent line
o
was pooled and stored iri vacuo at low temperature (2-4 C). The specific
activity of PGK varied slightly from batch to batch (0.7-1.0 pmol min ^mg
protein "S . It was found that under the conditions specified above,
the activities showed no considerable reduction for a period of up to
six months. Lactate dehydrogenase in the lyophilised material is
regarded as evidence of contamination from host cells. Thus any batch
with measurable traces of this enzyme was discarded.
3.4.3 The buffer system and experimental conditions for assay
a) Pyruvate kinase
The buffer characteristics and conditions used for PK have
been already described (Flynn, 1971). Detail of the assay medium are
presented in Material and Methods.
b) Phosphoglycerate kinase
The conditions originally described by Bticher (1955) used phosphate
buffer for the evaluation of the physicochemical parameters of the enzyme.
However it was found that using triethanolamine (TEA) or tris-hydroxymethy1-
aminomethane (Tris) a higher activity (by a factor 2-3) was observed
when different buffers where compared over a wide range of pH values.
As TEA produced the most consistent higher results it was chosen as the
buffer of choice in the standard assay system. Other conditions for the
assay of PGK are described in next sections of this chapter.
3.4.4 The preparation of enzymes for kinetic studies
As reported in the last section, the freeze dried material was used
as a source of enzyme in the experiments performed. The homogenates
produced after resuspension of the dried material were cloudy and heterogeneous
Figure 3„16; Semipurification scheme used for the preparation of
enzymes for the enzymological studies,
Lyophilised Protein
Homogenisation by hand using
a Dounce homogeniser (20 strokes)
Centrifugation of the homogenate
at 100,000 g x 1 hr
Pellet Supernatant
Filtration through a column
of Sephadex G25
Protein peak recovered with the
void volume and made 10% (v/v)
with respect to glycerol
Lyophilised protein from both lines of T. brucei was resuspended in
n
the appropriate buffer (see text for details) and hand homog^ised in
an ice bath. The purification scheme was followed as above. The
Sephadex column with a bed volume of 20 ml was previously equilibrate)
with the buffer as mentioned above. The protein peak was collected
with the void volume of the column and diluted with glycerol.
Figure 3=17; The effect of divalent cations on the solubilisation





, + 2+ 2+ 2+
Crude Control NH^ Na Li Mg Ca Ba
1 mg/ml of lyophilised protein from parent line was resuspended in
TEA buffer pH 7.5 (see Section 2.3) containing 0.2M of the different
salts mentioned in the figure, in the chloride form. The suspension
was homogenised by hand in an ice bath. The rest of the experimental
conditions were as described in Materials and Methods (Section 2.9).
For assay of activity of the enzyme see Section 2.10.2. Crude =
suspension without centrifugation; control= suspension centrifuged
without salt.
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and may have been contaminated with endogenous nucleotides and coenzymes.
Therefore a semipurification scheme was derived to prepare the enzymes
for kinetic studies.
For the purification of PK, the buffer conditions described by Flynn
-3
(1971) were used (Tris 0.1M, 10 M DTT, pH 7.2 with KOH/NaOH). Hence
50 mg of freeze dried material was resuspended in 5 ml of buffer and
submitted to the partial purification scheme in Figure 3.16.
The supernatant obtained after high speed centrifugation was
desalted using a column of Sephadex G25 (20 ml bed volume). The main
protein peak collected with the void volume was made 10% (v/v) with respect to
glycerol and used for kinetic analysis.
The situation however was not the same for PGK as the major enzymic
activity was found in the pellet after high speed centrifugation.
Attempts were made to solubilise the enzyme with Triton X-lOO and various
salts. The latter were found to produce more consistant results.
Therefore the effect of different cations, in the chloride forms,
was investigated on the possible solubilisation of PGK and subsequent
recoveries of the activity in the supernatant after high speed
centrifugation. Figure 3.17 shows the results obtained. It is observed
2+ 2+
that Mg and Ca ions produced the highest soluble recoveries when
compared to the crude material and the supernatant without added salts.
Some residual activity was always found in the pellets. The barium
salt produced complete loss of activity at the concentration used (0.2M).
Due to the yield obtained with the magnesium salt it was chosen as the
standard constituent of the buffer for the purification of PGK.
The rest of the purification scheme was similar to the one proposed
for the semipurification of PK including the desalting stage. The buffer
-3 -3
used was 10 x 10 M TEA, pH 7.5 containing 10 M DTT. When inhibition
studies were performed with the enzymes the sulphydryl agent was excluded
from the preparation.
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3.4.5 Preliminary experiments on the purification of phosphoglycerate
kinase
As discussed earlier in this chapter the possibility of misleading
results is always present when the kinetic and inhibitory experiments are
done with relatively impure enzymes. Although it has been reported that
the general characteristics of pyruvate kinase from "T. brucei were not
altered to a great extent with the purification procedure (Flynn, 1971),
it was considered that this may not be the general situation and therefore
a purification scheme was investigated.
The classical approach was taken in order to purify the enzyme PGK
and then perform the experiment required to establish comparisons, not
only with the impure material but with the enzyme in the mammalian model.
The following methods of purification were evaluated:
- Neutral salt precipitation
- Detergent solubilization




- Ion exchange chromatography: CM 52
DEAE 52
- Affinity chromatography: Blue Sepharose
- Hydrophobic chromatography: Octyl sepharose
Phenyl sepharose
Promosing results have been obtained with some of the techniques used.
However a final purification scheme still remains to be worked out.
3.4.6 The effect of pH on the activity of phosphoglycerate kinase
For the determination of the effect of pH, three buffer systems
were used. The range of pH investigated was from 5.0 to 8.5.First the
Figure 3„18: The effect of pH on the activity of phosphoglycerate kin
Enzyme aliquots were prepared as in Section 2.9 and assayed in the
following buffers systems: 0.1M Tris, pH from 7 .0-8.5 ;awtriethanolami
pH from 5.0-8.0; and a mixture of the following buffers, 0.03M acetat
0.02M histidine, 0.01M imidazole,0.01M Tris and 0.03M glycine, pH
from 5.0-8.5. The rest of the components, except the buffer and
condition for assay, are as described under Materials and Methods
(Sedtion 2.10.2). For the presentation of results see text.









Enzyme samples were prepared and estimated as described under Materia
and Methods (Sections 2.9 and 2.10.2). The different cations at the us<
concentrations were also present in the assay medium before addition o
the enzyme sample. The results are presented as the percentage of the
2<pnzyme actiy^ty for each cation as a function of the concentra
Mg ; Mn
2 + _ 7
Enzyme activity with Kg (10 x 10 ) = 100%".
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activity was estimated in the range from 7.0-8.5 using Tris buffer,
second from 5.0-8.0 in TEA and third in a mixture of the following buffers:
0.03M acetate, 0.02M nistidine, 0.01M imidazole, 0.01M Tris, 0.03M
glycine.
The values obtained with the three buffer systems showed some
variability. Therefore to obtain comparable results a value of 100%
was assigned to the highest value estimated with each buffer and the
rest of the activities were compared with this maximal value.
Figure 3.18 shows that the apparent optimum pH lies between 6.5-8.1.
alkaline
A sharper decrease in activity at the . A end of the scale was observed.
A pH of 7.5 was selected as the standard value for the assay of PGK.
3.4.7 The effect of divalent cations on phosphoglycerate kinase activity
PGK from other sources has a requirement for divalent cations
2+ 2+
(Mg , Mn ) for activity. It has also been suggested that the true
substrates of the reaction, either in the backward or forward direction,
2+
are ATP or ADP complexed with these ions, preferably Mg (Larsson-
Raznikiewicz, 1964; 1967; Rao and Osper, 1961). Figure 3.19 shows
2+ 2+
the response of PGK no two cations (Mg and Mn ) added as the chloride
salts. Their influence on the activity seems to be in two phases.
First a rapid activation of the enzyme, the concentration required to
— 3 —3 2+ 2+
give maximal activity being 5x10 M and 10 x 10 M of .Mn and Mg
respectively. Secondly a region of inhibition which was found more
2+ 2+
noticeable in the case of Mn than with Mg . Similar results were
found when the metal ion specificity was studied in PGK from yeast
(Larsson-Raznikiewicz, 197o£ Rao and Osper, 1961). A possible reason
2+
for the inhibition by Mn is its uncompetitive inhibition effect at
— 3 2+
concentrations higher than 1 x 10 M (Webb, 1963). The Mg salt was
chosen, at a concentration of 10 x 10 ^m, for the standard assay conditions
of PGK.




^Nucleotide % Activity 53 max
(10 * M) units mg protein
ATP loo O.89-0.22 0.90-0.1.8
+ +
CTP 11.1 1.65-0.50 0.11-0.02
UTP 15.1 3.74^0.76 0.14-0.05
ITP RA - -
GTP RA - -
RA = Residual activity only.
Activities are quoted with respect to ATP = 100%.
The kinetic parameters for each nucleotide were determined as in
Figures 3.21 and 3.22. The values were obtained from three
duplicated experiments with three different enzyme batches.
The values are presented as the mean - standard error of the mean.
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3.4.8 The effect of different nucleotides on phosphoglycerate kinase
activity
The specificity of PGK for the phosphate donor was determined by
replacing ATP with different nucleoside triphosphates.Table 3.6 shows
that besides ATP, CTP and UTP could support the activity of the enzyme
although at considerably lower activities. It was also found that
the enzyme had a lower affinity for those nucleotides. ITP and GTP
only showed residual activities at equivalent concentrations to ATP.
It is suggested that according to the levels of activity and to the
affinities found for the different nucleoside triphosphates, trypanosomal
PGK is rather specific in its requirement for a phosphate donor.
Variable results have been obtained with respect to the nucleotide
specificity of PGK from other sources (Krietsch and Bticher, 1970; Rao
and Osper, 1961). It has been suggested that the order of reactivity is
ATP>ITP>GTP>dGTP>dATP. The reactivity of ITP and GTP after ATP has been
corroborated by Lee and 0'Sullivan (1975); however, the results of this
experiment showed that these two nucleotides only supported activity at
residual levels.
As a result of the experiments performed in the last sections an
assay system was developed for the estimation of trypanosomes PGK
2+
activity. The basic components were: TEA buffer at pH 7.5 and Mg
Further detail on the concentration of substrates and other components
are found under Material and Methods.
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3»5 Comparative studies on pyruvate kinase and phosphoglycerate kinase
from parent and resistant lines
3.5.1 The kinetic parameters Of pyruvate kinase from parent and resistant
lines
As suggested in the chapter on the metabolism of parent and resistant
lines, there was a clear difference in sensitivity to melarsen oxide
between the parent and the resistant line. It has also been reported
that the focal point of action of melaminyl arsenicals is the kinases,
particularly pyruvate kinase (Flynn and Bowman, 1974), which accounts
for most of the inhibition produced by these active agents. Therefore
the sensitivity of the kinases in the resistant line, and their kinetic
parameters were investigated.
The general kinetic parameters of pyruvate kinase from the parent
line, have been recently described in detail for the semipure enzyme
(Flynn and Bowman, 1980). It was found that the enzyme is allosteric
with respect to one of the substrates, phosphoenol pyruvate (PEP);
fructose diphosphate (FDP) is a heterotropic activator. The characterisation
of the enzyme from both parent and resistant line is clearly necessary
as a preliminary approach to the description of any possible differences
arising as a result of the development of drug resistance.
Using standard assay conditions (see Material and Methods) the
system was preincubated for 3 minutes at 25<C prior to initiation of the
reaction by the addition of enzyme. The kinetic parameters obtained
for the enzyme from both lines, in the presence and absence of FDP,
are shown in Table 3.7. These data were obtained from three different
experiments with three different enzyme preparations. The initial
velocities were obtained from at least eight different substrate
concentrations, the other cosubstrate being kept at a constant concentration.
Palindromic series were used when estimating the initial velocities.
Two different computer programs were used to estimate the kinetic
parameters; for the Michaelis-Menten type kinetics (Atkins and Gardner,
1977) and for the Hill-type kinetics (Atkins, 1973).
After a close examination of the data using the paired "student" test,
it was found that there were no significant differences between the two
enzymes from different lines of trypanosomes, with regard to the Sc ,50
K and V values for PEP and K and V values for ADP. However a
m max m max
possibly significant difference was found in the "n" value (Hill
coefficient) for the enzyme in the absence of FDP (the "t" value found
was 5.06 for 2 degrees of freedom). This difference in the interaction
coefficient is difficult to evaluate as this parameter has no real
biological significance, as suggested recently by Cornish-Bowden (1979)
and Atkins (1973), and originally by Hill (1910). With regard to the
absolute difference between the two "n" values in parent and resistant
line, it' is suggested that this may be due to experimental variation in
terms of storage and age of the enzyme (Flynn, personal communication).
Another point which made this higher value of "n" of limited
interest is the argument that the sigmoidal response of pyruvate kinase
with respect to phosphoenolpyruvate is possibly of little physiological
importance in vivo, as the enzyme in T. brucei is suggested to be fully
activated by FDP (Flynn and Bowman, 1980) and the value of "n" at
these conditions did not show any difference under the experimental
conditions used.
The specific activities of the enzymes in term of the V value
max
(pmol minting protein"1") were the same for the parent and resistant line.
Therefore the possibility of a more active enzyme, capable of overcoming
inhibition by the drug, is ruled out.
Figure 3.20: The effect of melarsen oxide on the activity of pyruvate
kinase.
[Melarsen oxide] . 10 M
Enzyme samples were prepared and estimated as described under Material
and Methods (Sections 2.9 and 2.10.1). Aliquots of the enzyme were
preincubated for 5 minutes with different concentrations of melarsen
oxide and the components of t^e assay mixture. The_^eaction was start<
by addition of ADP (0.4 x 10 M) and PEP (1.67 x lO M). The results
are presented as percentages of inhibition compared to the uninhibited
enzyme as a function of the drug concentration. ®-» parent line;
resistant line.
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3.5.2 The inhibition of pyruvate kinase from parent and resistant lines
From the experiments performed in the last section it is suggested
that the kinetic parameters of pyruvate kinase are not affected as a
result of the development of resistance in T. brucei. However, this did
not rule out the possibility of different sensitivities of the enzyme
frcm the two parasites, to the active agent melarsen oxide.
One minor disadvantage of the inhibition studies at this level is
the state of purification of the enzyme and the known mechanism of action
of arsenicals as thiol poisons. The concentration of drug required to
produce a certain inhibition level will be overestimated, as impure sources
of enzyme may have a relatively large concentration of free thiol groups
(see Section 3.3.8) other than the ones situated on the enzyme.
The enzyme from both lines of parasites, have here been taken to the
same stage of semipurification.
The mechanism of inhibition by melarsen oxide has been reported
previously for this enzyme (Flynn, 1971). It was found that the drug
binds competitively with respect to PEP to produce the lethal effect.
This characteristic is used in the design of the inhibition experiment
(see below).
Figure 3.20 shows the inhibition pattern of PK from parent and
resistant lines as a function of the concentration of melarsen oxide.
When performing the inhibition studies the enzyme was incubated with
the constituents of the standard assay medium and the drug for 5 minutes;
the reaction started by addition of PEP and ADP.
The I values were apparently the same for both lines with an
50
-5
approximate value of 7.5 x 10 M melarsen oxide. It should be noticed
that each point in the figure represents the mean value of three
different experiments with three different preparations of enzymes;
the palindromic system was used throughout and FDP was not present in
the incubation medium.
Figure
3.21:TheeffectofATPconcentrationontheac ivityofs mipurifiedphosphoglycerateki as fromparentndresistantlin s.
Enzymesampl swerpr aredanestimatedd scribedund rMat rialsndMetho s(S ctions2.9nd2.10.2).Thecomponentsft e_^ssaymixtureweincubat df r5minuteswi hthdiff rentconcentrations fATP(G3constantat10xlOM).hereactionwasstartedbyadditionofal quotfe zyme.Theresultsarepresentedathnzymeactivitysf ctionofthATPconce tration.pare tl ; ,resistantline.
Figure3.22:TheeffectofATPconcent ationta ivityfphosphoglyceratek as :Han splot. ThedataofFigur3.21rerivedusingthH n splot .L ne regressionwaca ri d outasdescribedinM terialsndetho(S t on2.24).pa e tli ;■resi ta
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It is suggested from the experiments performed on the inhibition of
PK that there was no significant differences in the sensitivities of
pyruvate kinase to melarsen oxide as a result of the development of
resistance.
3.5.3 Kinetic parameters of phosphoglycerdte kinase from parent and
resistant lines
As reported in the Introduction little or no information exists on
the general physicochemical parameters of trypanosomal PGK. Nonetheless
the enzyme is a key component in the glycolytic sequence of trypanosomes
because of its localisation in the glycosome (Opperdoes and Borst, 1977;
Oduro, 1977). If the idea of self-sufficiency of this particle is
tenable this enzyme should provide the ATP for the phosphorylation of
glucose at the beginning of the sequence by hexokinase (see Figure 1.2).
At the same time, its possible sensitivity to arsenicals has not been
reported and hence its participation in the development of resistance
is unknown. As described above( pk a focal point of arsenical action,
was not changed in the resistant line. Therefore it was considered
relevant to study PGK in more detail.
a. Effect of ATP concentration
After semipurification of the enzyme from both sources as described
in an earlier section, the effect of different concentrations of ATP,
at a saturating concentration of the cosubstrate G3P, was studied.
2+
It should be pointed out that the concentration of Mg was in excess of
the maximal concentration of ATP in order to ensure that most of the
2-
nucleotide is complexed to the ion (MgATP ).
The initial velocities were measured immediately after the addition
of the enzyme and the data plotted as a function of the ATP concentration.
The results are shown in Figure 3.21. Apparently typical rectangular
hyperbolae are observed with the enzyme from both parent and resistant
lines. For the estimation of the Michaelis-Menten constants, the plot of
s/v vs s (a Hanes plot) was used. Figure 3.22 shows the converted data to give
Figure3.23;TheffectoftG3Pconcentrationnt a t vityofs mipurifiedphosphoglycerateki as fromparentandresistantlines. Alltheexperimentalconditionsardesc ibediFigure3.21 withthdiff ceatG3Ps variablesubstrat .Theresul sarpre n dstenzymectivityfun tionofthG3P concentration(ATPconstanta3x10M).parentli ;res s antli .
Figure3.24;TheeffectofATPconcentrationt activityfphosphoglycerateki as :H nesplot. [G3P]i;103M' [G3P],v Theanalysisndpresentationoftd taretsameiFigur3.22.par tli ; ■resistantline.
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linear biphasic plots. At approximately 1.5 x 10 M ATP an inflection
appeared in the plots from both parent and resistant enzyme. Biphasic
double reciprocal plots have been previously reported for PGK (Yoshida
and Watanabe, 1972; Schierbeck and Larsson-Raznikiewicz, 1979; Scopes,
1978a)when the initial velocities are studied as a function of the
nucleotide concentration. It has been suggested by these authors that
this is a characteristic of double binding sites for the'nucleotide
with different Km values. Only one active centre, however, is suggested
for the enzyme (Schierbeck and Larsson-Raznikiewicz, 1979). In the
present experiments the apparent Km values were 0.9 and 0.3 x 10 ATP,
the values being very similar in both parent and resistant line.
The kinetic parameters for the enzyme from both sources, with discussion,
is presented in Section 3.5.5.
b. Effect of G3P concentration
The influence of G3P concentration on the initial velocity was
investigated at a saturating concentration of ATP. The rest of the
experimental conditions were exactly the same as for the estimation of
the kinetic parameters of the cosubstrate ATP.
It is observed in Figure 3.23 that the initial velocities as a
function of the concentration of G3P approach again rectangular hyperbolic
for both parent and resistant line. After transformation of the data
straight lines are observed (Figure 3.24) . The information with respect
to the number of binding sites for G3P, is rather more controversial
than for ATP since Schierbeck and Larsson-Raznikiewicz (1979) , have reported
that the enzyme has two binding sites for the substrate. However,
Scopes (1978b),from binding studies using a gel filtration technique,
has suggested that there is only one binding site for G3P.
Another important feature of the enzyme is the already reported








The kinetic parameters of phosphoglycerate kinase from
parent and resistant lines.
-3 -1
K K (x 10 M) V (jumol min mg pre
—m m —- —max— * *-—-m^ m ■ —max-
0.89^0.22 0.32-0.09 0.90^0.18 (3)
0.85-0.30 0.30-0.11 0.85^0.21 (2)
5.60-0.42 1.lO-O.28 (3)
5.8CH0.40 1.15-0.32 (2)
The results presented in Figure 3.22 and 3.24 are presented as
mean - standard deviation of the mean; in parenthesis number of
experiments.
Figure 3.25: The effect of ATP and G3P concentration on the activity
of phosphoglycerate kinase: Hill plot.
log [Substrate] - lo ^
The data from Figure 3.21 and 3.23 are presented using the transformat:
v r
2_°g vs ]_Qg [_sj. Linear regression of the data was carried ou
max
as described in Materials and Methods (Section 2.24). [ATP].
[G3P].
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Larsson-Raznikiewciz, 1967) . This characteristic can be detected by
studying any change in the absolute value of the Hill coefficient
(Hill, 1910). Further analysis of the data was carried out by
transforming the data using the Hill plot, the slope of the straight
line obtained representing the n value.
The results of this analysis are presented in Figure 3.25. It was
found that when ATP was the independent variable a biphasic plot
emerged, with n = 0.28 at low concentrations of substrate and n = 1.08
at higher concentrations. The situation was not exactly the same for
G3P which showed an apparently perfect straight line with an n value of
1.06. Therefore the data suggest that there was activation when the
variable substrate was ATP. However when G3P was used there was either
not activation or under the conditions of the assay the enzyme was fully
activated as values lower than n = 1 were not observed,
c. Kinetic parameters of phosphoglycerate kinase
The values for the Michaelis-Menten constants are collected in
Table 3.8. Apparently there are no significant differences occurring
as a result of the development of resistance at the level of this
particular enzyme.
The specific activities of the enzymes as judged from the V ^ are
also the same. Using the same reasoning as for that used with PK, these
conclusions do not preclude the possibility of changes in the sensitivities
of the enzyme to melarsen oxide. The data corresponding to the
inhibition of the two enzymes, from parent and resistant trypanosomes,
is presented after a closer description of the mechanism of action of
the enzyme in the next section.
3.5.4 Mechanism of action of phosphoglycerate kinase
It has been mentioned in the Introduction on PGK that the enzyme
has a complex catalytic mechanism which is difficult to explain in simple
Figure3.26:TheeffectofG3Pntb ndingATiasemipurifiedphos hoglyceratekinas . [aTP](mM)1/[A P](mil"1)il Aliquotsofsemipurifiednzymewerpreincubatedi hthcompon ntsftas aymix ureon ining aconstantoncen rationfG3P.Themix urewasincub tedf5mi tes25Cat react nst rt d byadditionofthevariablesubs ratATP.Theinit lra sw rme sur dndLinew v -Burk Hanesplotderived^asscribediM t ri lethod(S ct on2.10n.25).R ac ionmix ure with:6x10MG3PandB-B.
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terms using the models available for this purpose. However some of the
evidence presented suggests a rapid equilibrium random mechanism in
which the binding of one substrate does not affect the binding of the
other (Larsson-Raznikiewicz and Ardivison, 1971; Lee and 0'Sullivan,
1975) .
An attempt to characterise the mechanism of action of the trypanosome
enzyme was made in order to compare the parasite enzyme with that of
the host.
a. Effect of G3P on the binding of ATP
There are different steady-state kinetic methods available for
elucidating the mechanism of addition of substrates and release of the
products (Cornish-Bowden, 1979); one of these methods is the measurement
of the initial velocities in the absence of products at different
concentrations of the cosubstrate. The information gathered in this
fashion gives some preliminary evidence on the type of mechanism involved.
Figure 3.26a shows the initial velocities for PGK as a function of
the concentration of ATP at two fixed concentrations of G3P (1 and
-3
6 x lO M), the assay conditions are as described in Materials and
Methods. By looking at the plot of v against s it can be seen that there
is a considerable reduction in the V at low concentration of the
max
cosubstrate G3P. To obtain more information about the binding of the
substrates, linearisation of the hyperbola is shown in Figure 3.26b.
A very complex pattern is obtained, possibly due to the reported
possibility of two binding sites. Two straight lines are apparently
presentwhich intersect at common points (K 0.26 x 10 ~^M and 1.25-
-3 12
2.50 x lO M).
The data treated in this fashion were difficult to interpret because
of the concentration of the points at the high substrate range of the
scale. However at least for K there is no clear evidence of
ml
dependance on the concentration of G3P; K was more difficult to
m2
interpret as it appeared with a competitive component which produces a
Figure3.27:TheffectofATPnthbindingG3isemipurifiedphosphoglyc ratek as . Alltheexperimentalconditio sweresaasFigu3.26;ncentrationfTPask pns ant andthereactionwasst r edbyddiofvariablesubs ratG3P.Thinitr te emea ur d andthed tawe^enalysed.asifigurme ion dbov .Reactionix urei h:3x10MATP 0.9x10mATP.
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higher apparent K .
m
In order to clarify the situation the data was transformed again
with the help of another primary plot (Figure 3.26c). The complex
pattern was observed at low substrate concentration and the independence
of the K on the concentration of G3P is substantiated. What originally
ml
looked like a competitive component is corroborated but with the
difference that the inhibition is more of the mixed type. Different
possibilities regarding the significance of this pattern of inhibition
can be proposed; these are presented in the Discussion,
b. Effect of ATP on the binding of G3P
The effect of the other substrate (ATP) on the binding of G3P can
be studied only by reversing the conditions of the assay. The results
of the influence of the nucleotide on the initial velocities as a function
of G3P concentration are shown in Figure 3.27a. The same transformations
showed linear plots as seen in Figure 3.27b. The lines did not converge
to the same point on the horizontal axis nor did they show the pattern
for a substituted enzyme mechanism which in this particular plot appears
as a set of parallel lines. The observation is further corroborated
when the other transformation is carried out (Figure 3.27c). Apparently
what is observed is a classical pattern of competitive inhibition when
the concentration of ATP is varied.
3.5.5 The inhibition of phosphoglycerate kinase by melarsen oxide from
parent and resistant lines
It was found that PGK from, the parent and the resistant lines has
the same kinetic parameters. The enzyme from parent and resistant line
was prepared as reported at the beginning of this chapter and the
standard assay constituents were used. The enzyme was incubated for
5 minutes in the presence of melarsen oxide and the reaction was started
by the addition of the substrates (ATP and G3P). Addition of the
substrates to the medium produced protection against inhibition.
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The results in Figure 3.28 represent the residual activities
compared to the control without drug, as a function of the melarsen
oxide concentration. The patterns of inhibition were apparently similar
for the enzymes from parent and resistant lines of T. brucei, the I
-3
values being 0.60 and 0.46 x 10 M respectively.
3.5.6 Mechanism of inhibition by melarsen oxide
It was found in the last section that melarsen oxide produced an
inhibitory effect on the action of PGK. The aim of the next series of
experiment was to characterise the mechanism of inhibition. The enzyme
(parent line) was prepared and assayed using the standard conditions
already described, the only modification being that the enzyme was
incubated with the components of the assay system excepting the variable
substrate to be investigated. The reaction was started after 5 minutes
of incubation by addition of the variable substrate. The cosubstrate
was kept constant at saturating concentration.
a. Effect of melarsen oxide on fiTP binding
When the concentration of ATP was varied in the presence of 0.5 x 10
melarsen oxide and a fixed concentration of G3P (10 x 10 ^M), it was
observed that there was a considerable reduction in the activity of the
enzyme as seen in Figure 3.29a.
A further analysis of the data with the linear transformation
(s/v vs s) suggested that the binding of ATP is independant of the
drug (Figure 3.29b). The maximal activity of the reaction was decreased
from ca. 0.85 jimol nin protein^to 0.35 pmol min ^mg protein.- Thus it
is suggested that the pattern of inhibition observed is apparently one
of non-competitive inhibition as melarsen oxide (at 0.5 x 10 ^M) does
not interfer with the binding of ATP but with the catalytic activity.
b. Effect of melarsen oxide on G3P binding
The effect of melarsen oxide on the binding of G3P was studied in
Figure3.30:
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a similar fashion. This time the concentration of the nucleotide was
kept constant at 3 x 10 V
The pattern of inhibition found was typical of competitive inhibition
at above 7 x 10 \ G3P as seen in Figure 3.30a,b. It may be seen in the
linear transformation of the data that some points departed from
linearity at low concentrations of G3P.
As mentioned above the inhibition produced by melarsen oxide on
the binding of G3P affected mostly the binding of the substrate producing
an increase in the apparent Km.
The overall inhibition presented is rather similar to the one
reported for PK for the same drug (Flynn, 1971); it was found that PK
was inhibited noncorapetitively with respect to the nucleotide (ADP),
and competitively for the cosubstrate (PEP).
3.5.7 The Inhibitory constant for phosphoglycerate kinase
The method of Dixon (1953) was used to estimate the inhibitory
constants for both substrates of phosphoglycerate kinase. The results
were obtained using the standard assay system for the enzyme with the
difference that the system was incubated with different concentrations
of drug for 5 minutes. The reaction was started by the addition of
the variable substrate, the other cosubstrate already being present at
a constant concentration in the assay system. The data were presented
as the mean of duplicates for either substrate as a function of the
concentration of melarsen oxide in Figure 3.31. The results obtained
apparently substantiated the information already discussed, non¬
competitive inhibition is found with ATP and competitive inhibition with
-3
G3P. The values of the inhibitory constants were = 0.25 x 10 M and
-3
0.03 x lO M melarsen oxide for ATP and G3P respectively.
Figure 3.32: The effect of different arsenicals on the activity of
phosphoglycerate kinase.
Aliquots of semipurified phosphoglycerate kinase were incubated for
5 minutes with different concentrations of organic arsenicals and
the components of the as^ay mixture. The reaction was started by
addition of ATP (3 x 10 M) and G3P (10 x 10 M). The results are
presented as percentages of inhibition compared to the uninhibited
enzyme. melarsen oxide; phenyl arsenoxide; 0-0 reduced
atoxyl; arsenite.
101.
3.5.8 The effect of different arsenicals on phosphoglycerate kinase
The effects of the inhibition of PGK by other arsenicals were shown
in Figure 3.32} the experimental conditions were similar to those used
when studying the inhibition of melarsen oxide. Significant differences
are found with regard to the sensitivity to the different structures
tested. The values presented are assumed to represent the overall
effectiveness of the drugs to produce inhibition of PGK.
The order of effectiveness was melarsen oxide>phenylarsenoxide>
p-aminophenylarsenoxide with I values of 0.55; 1.45; and 3.40 x 10 ^M
respectively. Inorganic arsenite did not show inhibition
within the range of concentrations used. Neither melamine nor the
pentavalent arsenical sodium melarsen inhibited the enzyme at a
concentration of 5 x lO "^M.
As described in Material and Methods the standard assay for PGK
uses glyceraldehyde phosphate dehydrogenase as a coupling system with
the subsequent oxidation of NADH. It was found that the coupling
enzyme was not sensitive to most of the arsenicals used when the
reaction was started, after incubation with the drug, by addition of
excess of yeast PGK. An exception should be made for p-aminophenyl¬
arsenoxide which produced 30% inhibition at the highest concentration
of drug used, therefore it is suggested that the I value-for -fchxs~T~7~--
drug is lower than the one presented above.
3.5.9 Summary
As mentioned in the Introduction the possibility of enzymic changes
resulting in the development of resistance to active drugs has been
suggested before. However little attention has been paid to this
particular aspect of the development of resistance to arsenical drugs.
The experiments designed with PK and PGK from parent and resistant
lines were performed with the objective of gaining some insight into:
102.
1) whether or not an increased specific activity of either of these
enzymes was present in order to overcome the action of the drug, and
2) whether modification of the kinetic parameters or sensitivity to
the drug has occurred in the resistant line. Neither possibility is
substantiated as the two enzymes tested were not different in parent
and resistant lines.
The results obtained however corroborate the hypothesis postulated
in the metabolic studies, that a permeability barrier for the drug
exists in the resistant line. As the possibility of modification of
the target enzymes was discarded, the alternative of differential uptake
of the drug in the resistant line remains to be confirmed experimentally.
With regard to the data obtained with PK, the results corroborate
those reported by other authors (Flynn and Bowman, 1980). It was found
that the parent enzyme has a sigmoidal response with respect to PEP
with S_ values = 1.60 - 0.30 x 10 and a Hill coefficient = 2.16 - 0.30.
50
The enzyme also has a typical Michaelis-Menten pattern with respect to
ADP with K value = 3.17 - 0.22 x 10 ^M.
m
PGK received considerable attention. It was found that the enzyme
has a hyperbolic response of velocity as a function of G3P and ATP
concentrations. However upon transformation of the data a linear
-3
biphasic response was obtained for ATP with K value = 0.90 x lO M
-3 1
and K = 0.30 x 10 M. The data is interpreted as the enzyme having
m2
two binding sites for the substrate but with different affinities.
Transformation of the data for G3P produced simple linear responses,
-3
evidence of a single binding site with a K value = 6.0 x lO M
m
(approximately). The experiments on the mechanism of action of the
enzyme showed a very complex picture; some evidence points towards a
sequential mechanism of action.
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Finally PGK was inhibited by melarsen oxide, competitively with
respect to G3P and noncompetitively with respect to ATP. The values
-3 -3
were 0.03 x 10 M and 0.25 x 10 M melarsen oxide respectively.
Other aromatic arsenicals also inhibit the enzyme.
104.
3.6 Drug transport studies
In the last two chapters of this thesis, an attempt has been made
to rationalise the problem of drug resistance in the newly developed
melarsen oxide resistant line. The possibility of a metabolic
alteration resulting in the development of the new character was
considered and although it was found that the resistant line showed some
minor metabolic differences, this could not explain directly the
development of the new character. However, the metabolite inhibition
studies suggested the possibility of a permeability barrier for the drug
in the resistant line.
The hypothesis suggested above does not eliminate the alternative
of modified drug targets to account for the phenomenon of drug resistance.
Therefore a closer look was taken, first at pyruvate kinase, a demonstrated
target for melarsen oxide and secondly at phosphoglycerate kinase,
another enzyme potentially involved in the development of the phenomenon
because of its sensitivity to melarsen oxide. The kinetic parameters
and the inhibition patterns of both enzymes did not show any significant
differences to explain the development of the resistant character.
The alternative of differences in the mechanism of uptake of the
drug can be singled out as the most viable proposition from the
experiments performed up to this point. Indeed this alternative has
been suggested before to explain the phenomenon of resistance to organic
arsenicals (Yorke and Murgatroyd, 1930; Eagle and Magnuson, 1944;
Williamson and Rollo, 1959). However, most of the studies done so far
have only taken into account the abilities of the parent and resistant
parasites to accumulate the drugs over relatively long periods of time.
Therefore the main objective of this section was to characterise the
mechanism of uptake of melarsen oxide, in kinetic terms, in both
parent and resistant lines of T. brucei.
Figure3.33:Estimationofmelarseoxidands diumelarsenusingthsilyerdiethyld thio- carbamatemethod. p.gofdru Aliquotsofstandarddr gol ti nwerepl cein125mlc calflask ,dthganicigestion arsinegenerationa dsubs quenttr ppi giA DDColut owasc riedo tde cribMat i l andMetho s(Section2.19).T ebsorbancewasre t525nmithAgDDCsolutiongain tappr pr ate blankspreparedusingthesamexp ri entalco ditio s.
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3.6.1 Estimation of the arsenical drugs using the silver diethyldithio-
carbamate method
One of the first requirements for this kind of work is to have a
suitable and sensitive assay system for the estimation of the drug being
used. As discussed in the Introduction different methods are available.
The method of choice should be accurate, reproducible and sensitive at
low levels of the drug.
As described in Materials and Methods the system chosen was a
colorimetric one, which uses silver diethyldithiocarbamate (AgDDC) as a
chelating agent for inorganic trivalent arsenic. Upon formation of the
complex with the metal a red colour is developed in the AgDDC solution
in pyridine, which absorbs light at 525 nm.
Calibration curves were produced with melarsen oxide and sodium
melarsen after digestion of the organic matrix, generation of arsine
and trapping by AgDDC in solution. The results are presented in
Figure 3.33 where the colour developed was measured in a triplicate
set of standards for each drug. It was found that the standard curves
were linear up to 6.5 jag of either drug. In general the standard
deviations were higher towards the low drug concentrations but the
linearity of the system was conserved. Standards were prepared with
every set of unknowns because of the small day-to-day variation found
with the calibration curves. It is concluded also that the sensitivity
of the assay system is independant of the original state of oxidation
of the arsenical moiety in the drug as there was a comparable level of
sensitivity in both estimations.
3.6.2 Trypanosome motility test in the presence of melaminyl arsenicals
As described in Materials and Methods, an oxygen electrode chamber
was used to incubate the trypanosomes at the temperature at which exposure
to the drug is to be carried out. After addition of the drug it was
Table 3.9: The action of melarsen oxide on the motility of the
parent line of T. brucei.
Time (seconds)
[Melarsen oxide] 30 60 90 120 180 210
-6
x 10
0 +++ +++ +++ +++ +++ +++
lO +++ +++ +++ +++ +++ ++
25 +++ +++ +++ +++ +++ ++
50 +++ +++ +++ +++ ++ +
60 +++ +++ +++ ++ + +o
70 +++ +++ ++ + +o +o
80 +++ ++ + +o +o +o
lOO +++ ++ +o +o +o +o
Trypanosomes from parent line were isolated from blood elements as
described in Section 2.5, resuspended in PSGA, pH 8.0 and incubate
in an oxygen electrode chamber at 21 C as described for uptake studie:
(Section 2.16) with different concentrations of melarsen oxide.
Every 30 seconds approximately, the motility was monitored under
phase contrast microscopy (400 x) and the population of trypanosomes
evaluated as described under Materials and Methods (Section 2.7).
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necessary to check that under the conditions of incubation the trypanosomes
remained motile for enough time to ensure that uptake studies are a
real feature of the population of living cells.
The concentration of trypanosomes used in these experiments was
approximately equivalent to 5.0 mg of trypanosome protein/ml buffer
3
(c.a. 10 cells/ml). This high concentration of trypanosomes was chosen to
increase the total concentration of drug taken by the parasites and to
produce significant results with the drug assay system described in the
o
last section. The first preliminary experiment was done at 21 C,
the reason being that at higher temperatures the cells may metabolise
the substrate available in a very short period of time.
After incubation of trypanosomes from both lines of parasites at
different concentrations of melarsen oxide, the results shown in
Table 3.9 were found. As observed in earlier motility test for the
parent line the activity decreased more rapidly as the concentration of
drug increased. It should be noticed that no apparent decrease . in
the motility of the resistant line was observed. However the main
feature of this motility test is that up to 60 second incubation with
—6
up to 70 to 80 x 10 M melarsen oxide the organisms retained full
motility. This time was therefore chosen as the standard time of
incubation for the uptake experiments with the concentrations of
melarsen oxide mentioned above.
It is also suggested, that to produce a rapid effect like the one
produced by melarsen oxide on sensitive cells, the mechanism of
transport of the drug should allow the rapid translocation of the drug
from the extracellular medium to the site of lethal effects.
Finally the motility was tested with sodium melarsen under the
same conditions described for melarsen oxide and no effect was
observed on this parameter in either parent or resistant lines even
after an incubation period of 210 seconds.
Figure 3.34: Trypanosome protein clearance from the exposing

























Trypanosomes isolated as described in Section 2.5 were resuspended
in PSGA buffer pH 8.0 to a final concentration of about 5 mg of
trypanosome protein per ml suspension. Aliquots (0.5 ml) of this
suspension were poured on to silicone sandwiches and centrifuged
at 10,000 g for different time intervals. The results are
presented as the percentage of protein in the bottom layer as a
function of time.
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3.6.3 Trypanosome protein clearance using the silicone layer filtration
technique
A relatively rapid exposure technique should be used in order to
have a reliable estimate of the initial rates of absorption of the drug
(Halestrap and McGivan, 1979) . The silicone layer filtration technique
as described by Damper and Patton (1976b)was used for the uptake experiments
in this thesis. The method was slightly modified to allow for the
amount of trypanosomes required in the experiments, by increasing the
volume of the microcentrifuge tube and doubling the volume of the
incubation and the silicone layers. Further details of the technique
are presented in Materials and Methods.
A preliminary experiment was performed to illustrate the clearance
of trypanosome protein from the exposing solution, when submitted to
centrifugation in a bench microcentrifuge at 10,000 g value for different
periods of time. For this experiment the bottom layer of perchloric
acid was substituted with PS buffer. The protein pellets.- formed- after -
centrifugation were washed twice in saline and the protein estimated.
The results of this experiment are shown in Figure 3.34. It was found
that after centrifugation for 45 seconds practically all the protein
had crossed the silicone layer and formed a pellet at the bottom of
the tube. The standard time of 60 seconds for centrifugation was
therefore chosen for experiments on the uptake of arsenical drugs.
3.6.4 Extracellular volume determination
One minor disadvantage of the silicone layer filtration technique
is that when the parasites are centrifuged through the silicone layer,
they drag some extracellular fluid. In the case of the uptake experiments
this fluid will contain some free drug which is not bound to the parasite.
In order to correct for this extracellular drug, a non-permeable marker
was used to estimate the amount of extracellular fluid involved.
Table 3.10: Determination of extracellular volume carried through
using the silicone layer filtration technique.
cpm in perchloric extracellular fluid






X 12.56-0.72 meantst.error of the mean
All the experimental conditions regarding the purification of
trypanosomes and incubation^Jjor uptake studies were the same
as in Table 3.9. 10 |il of C inulin (30,000 cpm approx.)
were added to 2 ml of trypanosome suspension and incubate for
60 seconds or described in text. Aliquots (0.5M) were centrifuged
using the silicone layer filtration technique and the radioactivity
estimated in the perchloric acid soluble layer as described under
Materials and Methods (Section 2.18). (See text.)
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C inulin has been used previously for this purpose with trypanosomes
and found not to penetrate the parasites (Damper and Patton, 1976b) .
To ensure that the polymer was free of low molecular weight
components that may be taken up by the trypanosomes, the original
source of inulin was purified using a small column of Sephadex G25.
Details of purification are found in Materials and Methods.
Table 3.10 shows the results of a representative experiment in
14
which C inulin (3000 cpm in 10 p.1) was added to 1.5 ml of trypanosome
suspension. After centrifugation, samples from the perchloric acid
soluble layer were estimated by scintillation counting in a water soluble
scintillation fluid (see Materials and Methods). The results obtained
after correcting for acid quenching were consistant in the different
samples taken; the mean value being 12.56 - 0.72 p.1 of extracellular
fluid carried through by 0.5 ml of a trypanosomal suspension of
approximately 5.0 mg/ml (parent line).
The value obtained was constant even if the trypanosomes remained
in contact with the inulin for different lengths of time of up to
4 minutes. It should be pointed out that the value obtained for the
extracellular fluid volume is used to correct for the extracellular
drug in all the uptake experiments in this thesis.
3.6.5 Distribution of melarsen oxide after centrifugation using the
silicone layer filtration technique
After incubation of the parasites (parent line) in the oxygen
electrode chamber using the standard conditions described in Materials
o
and Methods, at a temperature of 21 C, an attempt was made to determine
the distribution of the drug in the different layer of the silicone
sandwich after centrifugation.
Upon contact with the perchloric acid layer the trypanosome protein
denatures and two fractions appear; an acid soluble and an acid
Figure 3.35: The distribution of melarsen oxide after centrifugatio
using the silicone layer filtration technique.
5 lO 15 20 25
[Melarsen oxide] 10 ^ M
Trypanosomes from parent line were isolated from blood elements as
described in Section 2.5, resuspended in BSGA pH 8.0, and incubated
in an oxygen electrode chamber at 21 C with different concentrations
of melarsen oxide. Aliquots were centrifuged after 60 seconds incuba
using the silicone layer filtration technique and the drug estimated
in the different layers of the centrifuge tube. The data were
corrected for the extracellular drug component. Details of the
methods are as described under Materials and Methods (Sections 2.15,
2.16, 2.17 and 2.19). upper layer; perchloric acid
soluble layer; perchloric acid insoluble layer.
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insoluble layer. For the purposes of the uptake studies it was necessary
to know the distribution of the drug among the different fractions
obtained. Samples were taken from the exposing solution (upper layer)
and from the acid soluble and insoluble layer, after incubating the
trypanosomes in different concentrations of melarsen oxide. The results
obtained are shown in Figure 3.35. Itwas found that most of the drug
was concentrated in the pellet (acid insoluble layer). It should be
noticed that the figures obtained for the concentration of the drug
appearing in the acid soluble layer approached the expected theoretical
value calculated using the figure obtained, in the last section, for the
extracellular fluid drug carried through with the trypanosomes.
3.6.5 Time course of melarsen oxide uptake at different temperatures
in parent and resistant lines
An evaluation of the mechanism of transport of the arsenicals should
take into consideration the influence of the temperature on the rate of
the transport as it has been found that different transport systems
studied show different responses with respect to this parameter
(Goldman, 1973).
Therefore an experiment to illustrate the effect of temperature
on the rate of transport, in both parent and resistant lines was
performed. As reported in Materials and Methods the incubation of the
trypanosome suspension, from both sources, was carried out in an oxygen
electrode chamber coupled to a variable temperature water bath. The
suspensions of trypanosomes were added to the chamber and allowed to
equilibrate to the required working temperature (0.5 min for 2°C,
3 min for 21°C and 7 min for 33°C). As soon as the required temperature
was reached, melarsen oxide was added to the suspension to a final
concentration of 80 x 10 ^M. Samples were taken from the oxygen electrode
chamber every 15 seconds, loaded onto the top of a silicone sandwich
Figure3.36:Theeffectofthemp raturonthuptakmelarsenoxidinparentanresistantlin . 10. M f?£8S IT\ •' f\J ®a•aob •HX& o 0> aB " m«SIUO4 oa -as. a£ .H*• ®OPf-°??°c Trypanosomesfromparentandresistantlin sw reisolatedfr mb odelementsasdescrib dinS cti n2.25 andresuspendedinPSGAbufferpH8.0.Ths spensionsweincubatedwith80x1Mmelar eno idat differenttemperaturesandvery15secon s;aliqu ts(0.ml)w rcentrifugedusingthsili onlaye filtrationtechnique*T edrugw sestim t dintheperchloricacidlay .Thresultsrpresent da thedrugconcentrationfou dinthelayasfunc i nft meforp renta dresist ntlinresp ctively. Thedatawercorr ctedforthextracellulardrugcompon nt.Detailsofthm th dsarsdescribeun MaterialsndMethods(Sec ions2.15,6,.17and2.19)andinthext.pare tlin ;resist nt line;O-Oparentlincorrect dfoadiffusionc mp n n .
Figure3.37:Theeffectoftemperat renthratesfuptakeomelarsenoxidinpar nanresist ntl n . CP a LO C\] U (L) w 0) T3C •H <u ■U O U C Q) 10 (0a rHO 0)10 aoc a"32p.. —>1 d)wCl4J o .-I wo0.2~ 0.1- B 10~r 2030 Temperature(C) FromtheresultsobtainedinFigur3.6,t era sftra sporfop e tdresi t ntlinw calculatedandtheresultsarp se tedfunctionofthtempe turesed.par ntlin ? resistantline;0-0parentlincor ctedfoadiffusioncom onent.
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and centrifuged. Estimation of the drug was performed as reported in
Materials and Methods. The results of a triplicate experiment are
presented in Figure 3.36 where the concentration of drug found in the
perchloric acid layer (soluble and insoluble) is shown as a function
of time.
From these results it is observed in the first place that different
patterns of drug uptake are present in the parent and the resistant
lines, the latter showing a considerably lower rate of uptake; secondly
that the rate of uptake in the parent line is affected considerably
by the temperature.
To illustrate the effect of temperature on the rates of uptake in
both parent and resistant lines, the slopes obtained from the regression
lines were plotted as a function of temperature in Figure 3.37. It was
found that the rate of transport was affected considerably in the
parent line with a of approximately 2.0. The situation was different
with the resistant line, the for the latter being 1.2.
Some alternatives have been suggested to explain stringent changes
in the rate of uptake of a drug as a function of temperature. The first
is that the drug is transported by a carrier which is energy dependant,
hence the energy yielding process is disrupted by the decrease in
temperature (Neame and Richards, 1972; Oxender, 1972). Another possible
alternative is in terms of a change in the conformation of the membrane
phospholipids, with a subsequent reduction in the fluidity of the membrane
as the temperature is reduced (Kaback, 1968). The alternatives will
be covered in more details in the Discussion.
With regard to the resistant line, it is possible that the temperature
dependant transport may have disappeared and instead a low (i.e. a
simple diffusion) uptake system is responsible for the uptake of the
drug.
Figure 3.38: The Arrhenius plots for the uptake of melarsen oxide
by parent and resistant lines.
From the results obtained in Figure 3.36, the Arrhenius plots were
derived as described under Materials and Methods (Section 2.25).
The results presented are the logarithm of the rate of the reaction
against the reciprocal of the absolute temperature. parent
line; resistant line.
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Another observation from the temperature dependance experiment
(Figure 3.37) is that the rate of transport of the drug in the parent
line approached the rate of transport in the resistant line at low
temperature. Therefore it is assumed that the total transport of the
drug in the parent line is a complex system with a temperature and a
non-temperature dependant component, or simple diffusion system.
In all cases the rate of transport were corrected for the extra¬
cellular drug component in the extracellular fluid (see Figure 3.10).
3.6.7 The thermodynamic characteristics of the transport systems in
parent and resistant lines
To account for the effects of temperature on the rate of transport
of the drug the phenomenon itself may be considered as a chemical
reaction in which the active agent is taken from one side to the other
side of a membrane (Stein, 1967). By using the Arrhenius equation it is
possible to obtain some thermodynamic data inherent to the transport
mechanism. Details of the calculation are presented in Materials and
Methods. As suggested in the last section the rate of transport in the
parent line approached the rate of transport in the resistant line at
low temperature (2°c) (see Figure 3.37). Therefore assuming that the
diffusion component is also present in the parent line, it is possible
to calculate the thermodynamic data inherent to the temperature dependant
transport system by substracting the rate of transport found in the
resistant line from the rate of transport in the parent line at the
different temperatures investigated.
After correction for the diffusion component in the parent line
and transformation of the data (rates of transfer in parent and resistant
lines) using the Arrhenius plot, the results shown in Figure 3.38 were
obtained. Calculation of the slopes of both straight lines allowed
estimation of the energy of activation (Ea), enthalpy of activation
(Alit) , entropy of activation (As+) and Gibbs free energy of activation
(Ag+) for the transition state (see Materials and Methods).
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Parent Resistant Ratio
Ea (kJ mol 59.71 19.33 3.09
AH+ (kJ mol "S 57.20 16.82 3.40
As+ (J mol"1 K_1) 1164.66 515.76 2.26
Ag+ (kJ mol 1) -292.30 -137.98 2.12
The results obtained indicate that changes have definitively occurred
in the transport system of melarsen oxide as a result of the development
of resistance.
Apparently two transport systems are involved, an energy dependant
transport system in the parent line and a non-energy dependant diffusion
mechanism, demonstrated to exist in the resistant line and assumed to be
present in the parent line. It appears that the resistant line has
apparently lost the energy dependant transport system or that it has
been modified, and only a simple diffusion mechanism is operating for
the transport of the drug as suggested by the low energy of activation
obtained. With regard to the other thermodynamic parameters, the
enthalpy, entropy and Gibbs free energy of activation, these are
**>•
evaluated in more detail in the Discussion.
3.6.8 Concentration dependance of melarsen oxide uptake in parent and
resistant lines
As mentioned in the Introduction most of the work done on the uptake
of organic arsenicals has been about the relative drug uptakes of the
different drugs tested, over long periods of time (Yorke et al., 1931;
Hawking, 1937). Although this work has suggested the possibility of a
reduced uptake in the resistant lines tested, the experiments design
did not allow any definitive conclusion on the nature of the mechanism
of transport. Hence no information exists on the nature of the change
in the mechanism of transport during the development of resistance.
Therefore, in order to understand the mechanism of transport in terms
Figure3.39:Thein tialratofupt kemelarsenx dagainsttheexternald ugconcentr tion
♦
inparentandresista tl nes. 20460 _6BO [Melarsenoxide]10
Alltheexperimentalcond tio sw rthsamasinFigu3.35,withthdifferencethdrugis estimatedinthep rchloricacidlayerntresultspre entfunctionofthextrac llular concentrationfmelarsenoxidus dinthexperiments.par nl n ?resistantlin .
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of the kinetics of the uptake of melarsen oxide a series of experiments
were performed, as described below, on parent and resistant lines.
Trypanosome suspensions were incubated in the oxygen electrode chamber
o
at a temperature of 21 C. The highest concentration of drug used was
~6
80 x 10 M melarsen oxide; this concentration was chosen from the
motility experiment (Section 3.6.2) as at this concentration the
trypanosomes remain motile after 60 seconds of incubation. The silicone
layer filtration technique and the standard system for estimation of
the drug were used as described in Materials and Methods.
The results of the influence of the concentration of melarsen oxide
on the initial rates of uptake of the drug from three different experiments,
for both parent and resistant lines are shown in Figure 3.39. In the
first place a completely different pattern of drug uptake was found for
parent and resistant lines. The possibility of a differential drug
uptake as suggested in the metabolic section is corroborated here.
It should be noticed that the short exposure (60 sec) of the trypanosomes
to the drug ensures that the rates obtained are approaching the initial
rates of uptake of melarsen oxide.
In the second place, the initial rates of uptake in the parent line
as a function of the drug concentration approached a maximum value.
Therefore a saturable carrier system is suggested for the transport of
melarsen oxide in the parent line. This sustains the results of the
last section as this pattern is typical of an energy dependant carrier
mediated transport system.
Regarding the transport of the drug in the resistant line, low levels
of drug uptake were associated with the trypanosomes after correction
for the extracellular drug carried through. Although the concentration
of the drugs are found at the low end of the calibration curve,an
apparently linear rate of uptake was found. It is suggested that the
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drug is probably taken by a phenomenon of simple diffusion,/ suggestion
substantiated by the low values of and energy of activation obtained
for the transport of the resistant line (see last section).
3.6.9 Kinetic parameters of the transport of melarsen oxide in parent
and resistant lines
The information obtained from uptake experiments is often analysed
in the same manner as the data from enzyme kinetics, the main objective
being to show whether or not the data conform to the Michaelis-Menten
type of kinetics (Neame and Richards, 1972). It was suggested by these
authors that the graphical methods used to estimate the kinetic parameters
of enzymatic reactions may be used to quantify the kinetic parameters of
drug transport. However due to the scattering of the points, non¬
linear regression of the Michaelis-Menten function (Atkins and Gardner,
1977) and Hill equation (Atkins, 1973) were used to study the results
obtained for the uptake of melarsen oxide in the parent line. It should
be mentioned that these data were corrected by the diffusion component,
supposed to be present in both lines of the parasite. Of the two computer
programmes used the latter produced a better representation of the data
obtained. The parameters estimated for the parent line were:
—6
Kt = 14.42 x 10 M
-1 . -1
V =5.19 nmoles min mg protein
max
Hill coefficient = 2.27
(K is defined as the drug concentration needed to produce 50% of the
maximal velocity for the transport of the drug.)
For the rate of uptake by the resistant line, a linear regression
programme produced the following value:
KD = 3.1 pmoles min ^ mg protein /|uM melarsen oxide
(Kd is defined as the diffusion constant for the transport of melarsen
oxide in the resistant line.)
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3.6.10 Concentration dependance of sodium melarsen uptake in parent
and resistant lines
In general, pentavalent organic arsenicals are less toxic and less
rapid in their action in vivo than the corresponding arsenoxides
(Williamson, 1970). The possible lack of uptake of such pentavalent
forms of organic arsenicals in vitro may be inferred from the work on
cross resistance analysis of Williamson and Rollo (1959).
As for the trivalent arsenical drug little information exists on
the mechanism of uptake of the pentavalent analogue. It is noteworthy
that sodium melarsen is cross resistant in vivo with melarsen oxide
(Williamson and Rollo, 1959) . Therefore reduction before any biological
effect is considered to be the first stage in the mechanism of action
of pentavalent arsenicals (Lourie et al., 1935).
An experiment was designed to illustrate whether there was transport
of the pentavalent drug in either line of trypanosomes. The results
obtained for the uptake of sodium melarsen were different to those
obtained with melarsen oxide, as it was observed that regardless of the
concentration of sodium melarsen used there was no measurable uptake
by either line of the parasites even after a period of incubation of
10 minutes. Hence, these results corroborate the need for extratrypanosomal
reduction of the pentavalent arsenicals before they can be taken into
the parasite.
3.6.11 The effect of different arsenicals on the motility of parent and
resistant lines
Cross resistance studies have shown that trypanosomes made resistant
to melaminyl arsenicals do not remain sensitive to neutral aromatic
arsenicals (Williamson and Rollo, 1959). A study of the sensitivity of
the newly developed resistant line to other arsenicals may help to
understand the mechanism of development of resistance in terms of the
structure of the drug.
Figure3.40:
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Table 3.11: The effect of different arsenicals on motility in paren-
and resistant lines.
Time (minutes)
Parent 2 5 10 15 20 25
control +++ +++ +++ +++ +++ +++
melarsen oxide ++ ++ + + +o +o
reduced atoxyl ++ ++ ++ ++ ++ +
phenyl arsenoxiae ++ + +o +o +o +o


















Trypanosomes from parent and resistant lines were isolated from bloot
elements as described in Sections 2.5, resuspended in PSGA buffer
pH 8.0 (2.5 mg protein/ml apgrox.) and incubated with different
organic arsenicals (10 x 10 ). The motility was evaluated as
described under Materials and Methods (Section 2.7).
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The arsenicals used were: arsenite, phenylarsenoxide, para-amino
phenyl arsenoxide and the already tested melarsen oxide; the organic
arsenicals used may be considered to be structural analogues of the
melaminyl drug (see Table 1.2).
A preliminary motility experiment was carried out, the trypanosomes
being incubated under the standard conditions (see Materials and Methods)
-5
with 1 x 10 M of the various drugs. The motility was monitored under
phase contrast microscopy at different times after the addition of the
drugs, the results are shown in Table 3.11. It is inferred from these
results that the melarsen oxide resistant line of T. brucei is still as
sensitive to para-aminophenyl arsenoxide and phenyl arsenoxide as the
parent line. Inorganic arsenite did not show any effect on either line under
the conditions used. Therefore it is suggested that the resistant character
is apparently developed against the melaminyl ring of the drug.
3.6.12 The uptake of different arsenicals by parent and resistant lines
In order to corroborate the suggestion made of the possible development
of resistance towards the melamine residue in the molecule of melarsen
oxide, an uptake experiment was performed using the different arsenicals
mentioned in the previous section. All the standard conditions for
incubation and exposure of the trypanosomes, and estimation of arsenicals
were used (as reported in Materials and Methods).
The results are shown in Figure 3.40. It was found that both lines
take up phenylarsenoxide very actively. Reduced atoxyl penetrates the
resistant cells less readily than the parent cells.
Regarding the kinetic parameters for the transport of para-amino-
phenyl arsenoxide and phenyl arsenoxide in parent and resistant lines,
the following data were obtained after linear transformation (s/v vs S)
of the initial velocities as a function of the substrate concentration:
Figure 3.41: The effect of melamine on the transport of melarsen oxj
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Trypanosomes from parent line were prepared and resuspended in buffei
as in Figure 3.85. The cglls were incubated with a fixed concentrate
of melarsen oxide (80.10 M) and different concentrations of melamine
for 60 seconds. Aliquots (0.5 ml) were centrifuged using the silicoi
layer filtration technique and the drug estimated in the perchloric e
layer. Details of the methods are described in Materials and Methods
and in the text. The results are presented as percentages of the








- Para-aminophenyl arsenoxide 81.05 9.5 182.6 9.1
- Phenyl arsenoxide Not calculated as the uptake was
apparently linear in the V vs S
plot. However the rate of
transport are apparently the same
in parent and resistant lines.
(it = UM; V = nmoles min
t max
-1
mg protein ) .
3.6.13 The effect of melamine on the transport of melarsen oxide
From the studies on the selective reversal of the action of melaminyl
arsenicals by melamine in_ vivo and in_ vitro, it has been inferred that
melamine interferes with the initial binding of the drug to T. rhodesiense
(Williamson, 1959a). However, little is known on the mechanism by which
the structure inhibits the action of the melaminyl drugs. Furthermore
any inhibition produced by melamine can be used to illustrate the
specificity of the transport mechanism of the melaminyl drugs as the
triazine ring is a structural analogue of the active agents.
Some experiments were designed to investigate this point. The
standard conditions of incubation and exposure of the parasites using
the silicone layer filtration technique were used. Trypanosomes from
the parent line were incubated with different concentrations of melamine
(from a freshly prepared solution in warm buffer) for 30 seconds prior
to the addition of melarsen oxide to a final concentration of 80.10 ^M.
Samples were taken in triplicate and analysed for arsenic; the results
are shown in Figure 3.41. It was found that the inhibition of drug
uptake increased with the concentration of melamine.
3.6.14 The influence of melamine on the uptake of melarsen oxide in
parent line
It was of interest to investigate the type of mechanism involved in
the inhibition of melarsen oxide uptake. The design of the next experiment
Figure3.42:Theffectofmelaminentinitialr tesftransf romelarsenxidethp tli . i —6~~6[MelarsenOxide]%10M[Melars nOxide] Trypanosomesisolatedf oblelementssdescrib diSection2^w rere usp n edimm iatelyb for incubationnPSGAb fferpH8.0withandithoutmelamine(3x1M).A erincub tionfo6s c. 21Cofb thsuspensionstrypanosomeswithdiffere tconcentrationsfm la sex de,aliquo(0.5l) werecentrifugedusingthsilicolayerfiltratitechniquedwase imatedpe chloric acidlaver.Theresultsrpresentedastinit alatoft an portfuncti nmela s novirie
Figure 3.43: The estimation of the inhibitory constant (lO for
transport of melarsen oxide with melamine as the inhib
—
p— 1—————r—— -]—
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[Melarsen oxide] : 10 M
The results shown in Figure 3.42 were analysed using the Hunter and
Downs method and the values for the fractional_gelocities obtained,
in the presence of inhibitor (melamine 30 x 10 M), are presented
as a function of the melarsen oxide concentration (see text for deta
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is similar to the one used to study the concentration dependance of the
uptake of the drug in Section 3.6.8, the only difference being that
melamine is present in the buffer to a final concentration of 30.10 ^M
in one set of experiments.
The results of the influence of inhibitor on the uptake of
melarsen oxide are shown in Figure 3.42a. The data is presented as the
initial rate of uptake with and without melamine as a function of
melarsen oxide concentration. To illustrate the type of inhibition
produced, a linear transformation of the data (s/v vs S) is used?
the results are shown in Figure 3.42b. The pattern found is consistant
with the suggestion of competitive inhibition. Perfect parallel lines
are not found, hence a small mixed inhibition component is present
affecting the vmax of the transport system when melamine is present.
It may therefore be suggested that the transport mechanism for
melarsen oxide is specific for the melaminyl part of the drug. This
data on the effect of melamine on the uptake of melarsen oxide can also
be used to estimate the value (inhibitory constant) of the former
for the drug. The method of Hunter and Downs (1945) is used for this
purpose (see Materials and Methods).
Figure 3.43 shows the results obtained when the fractional
velocity in the presence of the inhibitor is plotted as a function of
the drug concentration. The straight line obtained intersects the y
—6
axis at the 10 value, found to be 7.0 x 10 M melamine under the conditions
used.
3.6.15 The effect of iodoacetate on the uptake of melarsen oxide by
parent line
There are some difficulties in demonstrating the energy
dependance of an active or uphill transport mechanism, as the coupling
to the energy yielding process is not always direct. Furthermore the

































Trypanosomes were isolated from blood elements using the standard tec
(Section 2.5). QThe cells were resuspended in PSGA buffer pH 8.0 and
incubated at 21 C with different congentrations of iodoacetate, prior
addition of melarsen oxide (30 x 10 M). Aliquots (0.5 ml) were cent
and the drug estimated as described under Materials and Methods
(Sections 2.15, 2.16 and 2.19). Cells were checked for viability at
end of the experiment. The results are presented as percentage of
inhibition compared to untreated trypanosomes as a function of iodoac
concen tration.
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metabolic poisons used for this purpose may produce non-specific changes
in the membrane that could generate; %> artifacts in the flux of the
substrate being studied (Goldman, 1973).
In spite of these difficulties an experiment was performed to show
the possible effect of iodoacetic acid, a classical metabolic inhibitor
(Lehninger, 1975) which has been reported as being toxic to the metabolism
of trypanosomes (Williamson, 1959b).
Trypanosomas were incubated under the standard conditions (see
Materials and Methods) at a temperature of 21°C with different concentrations
-3
of iodoacetate (0.3; 1.0 and 3.0 x 10 M) for 30 seconds. After this
period melarsen oxide was added to a final concentration of 30 x 10 ^M
and incubated for a further 50 seconds. The centrifugation and estimation
of the drug was carried out as described in Materials and Methods.
The results of the residual uptake of melarsen oxide when compared
with the uptake in iodoacetate untreated trypanosomes are in Figure 3.44.
It is suggested that the mechanism of transport of melarsen oxide in the
parent line is energy dependant under the conditions described as the
trypanosomes were 100% motile at the end of the incubation with IAA and
melarsen oxide.
3.6.15 Summary
It was suggested from the metabolic experiments that the development
of resistance in the new line of T. brucei was probably associated with
a permeability barrier for the drug. However the suggestion at that
stage did not discard the possibility of modified target enzymes. As a
result of this, PK a focal point of arsenical action and PGK a similar
enzyme, as function is concerned, were examined and apparent differences
were not found. Therefore the permeability properties of melarsen oxide
were investigated in parent and resistant line organisms.
The conditions were set up to ensure a short exposure of the
trypanosomes to the drug, a necessary requirement to have good estimates
of the initial rates of uptake of the drug in both lines. The silicone
layer filtration technique was used for this purpose, a method which
has already been used for studies of drug uptake by trypanosomes, as
mentioned at the beginning of this section. According to the concentration
of trypanosomes used for incubation (c.a. 5.0 mg protein/ml) the
conditions were: 60 seconds incubation at a maximum of 80 x 10
melarsen oxide in the exposing solution, and 60 seconds centrifugation
at approximately 10,000 g for complete separation of the parasites from
the exposing solution. The extracellular fluid value of 12.56 - 0.72 pi
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per 2.5 mg of trypanosomal protein was calculated using C inulin as an
extracellular marker. This value was used to correct for the extracellular
drug associated with the uptake experiments of this section.
A chemical method for the estimation of arsenic in the drug was
used in these studies as an assay system for total drug.
The first evidence of a different mode of uptake of melarsen oxide
by parent and resistant line organisms was obtained from the time
course experiments at different temperatures. It was found that the
parent line has a large value (2.0), i.e. a temperature dependant
transport system for melarsen oxide. However the resistant line has a
low value (1.2), i.e. a non-temperature dependant transport system
for the drug; this low Q transport mechanism seems to be present as
well in the parent line as its rate of transport approached the rate of
the resistant line at low temperature. The thermodynamic data calculated
from these experiments using the Arrhenius equation showed an Ea+value
of 59.71 and 19.33 kJ mol for parent and resistant lines respectively.
These data corroborate that the high rate of transport may be due to
a carrier mediated system in the parent line, and a simple diffusion alone
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for the drug transport in the resistant line. Further evidence in this
respect was obtained from the concentration dependance experiments,
where a carrier mediated system is suggested for the parent line with a
—6
K value of 14.42 x 10 M melarsen oxide and a V value of 5.19 nmoles
t max
min \mg protein \ The transport system appeared to be complicated
as the Hill equation was the mathematical model able to explain the
data obtained.
With regard to the resistant line a low rate of diffusion was
obtained with a value of 3.1 pmoles min ^.mg protein "*"/10 melarsen
oxide.
From the uptake studies of other related arsenicals it was found
that the resistance is mainly developed against the melaminyl residue of
melarsen oxide. Further experiments on the mechanism of inhibition of the
transport of melarsen oxide by free melamine suggested that the latter
inhibits by competing with the drug with a K_^ value of 7.0.10
melamine. This in turn suggests that the melaminyl residue is vital
for the uptake or in other words that the mechanism of transport shows
some specificity for this part of the drug. Iodoacetate inhibition of
the uptake of melarsen oxide suggests the possibility of energy dependance
in the transport of the drug in the parent line.
4. DISCUSSION
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4.1 Discussion of the studies on phosphoglycerate kinase
As mentioned in the Introduction, the kinases are considered to be
the main targets of organoarsenical drugs in trypanosomes. Some of the
enzymes in this group have been studied in certain detail with respect
to their sensitivity to these drugs (Table 1.3). PGK was the least
studied enzyme of the group. Evidence has been presented in this
thesis that the enzyme is in fact inhibited by different arsenicals,
including a member of the melaminyl series. Furthermore, the similar
function of this enzyme to PK in substrate level phosphorylation and
the known nature of the latter as a target for organoarsenical drugs
(Flynn and Bowman, 1974), suggested a potential participation of PK or
PGK in the development of resistance. However, it was found that this
was not the case for either enzyme.
In spite of the lack of participation in the development of resistance,
the fact that the enzyme was inhibited by arsenicals was considered of
sufficient importance to study the enzyme in more detail, as basic
knowledge on the general mechanism of action of organoarsenicals can be
used in a rational approach to the development of new trypanocides.
4.1.1 The general properties of phosphoglycerate kinase from T. brucei
The pH profile observed for the trypanosome enzyme (Figure 3.18),
showed maximal activity between 6.5-8.2. This range is not as great as
the pH range of PGK from other sources. It was found, for example,
that the range of the rabbit muscle and yeast enzymes was approximately
between pH 6.0-9.2 (Kritsch and Bdcher, 1970) and for the pea seed enzyme,
pH 6.7-9.2 (Axelrod and Bandurski, 1953). The biological interpretation
of pH profiles is complex, as assumptions have to made with regard to
the physicochemical characteristics of the enzyme that are not necessarily
valid (Cornish-Bowden, 1979). However, the localisation of the trypanosome
enzyme in the glycosome (Opperdoes and Borst, 1977? Oduro, 1977)
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may suggest that PGK is in a rather specialised environment where changes
in pH could play an important role in the control of enzyme activity.
2+ 2+
It has been reported that PGK is activated by Mg and Mn ions
(Larsson-Raznikiewicz, 1964, 1967; Rao and Osper, 1961). The possible
function of the metal ion has been studied and it is likely that the
divalent cation complexes of ATP and ADP are the true substrates of
the reaction (Larsson-Raznikiewicz, 1964, 1967).
2+ 2+
It was found in this work that Mg and Mn are also activators
2+
for the trypanosome enzyme (Figure 3.19). In the case of Mn , the ion
had an inhibitory effect at concentrations above 5 x lO V A similar
inhibitory effect has been observed in studies of the metal ion
specificity of yeast PGK (Larsson-Raznikiewicz, 1970a). This author
found that at low concentration, this ion is a competitive inhibition
2-
with respect to MnATP . However as the concentration of the free cation
increases the inhibitory effect becomes uncompetitive. It was also
found by the same author that the uncompetitive inhibition is caused by
2+
complexing of Mn to the cosubstrate G3P the complex being suggested
as the true inhibitor. Therefore it is concluded that the inhibition
2+
effect observed for Mn on trypanosomal PGK may be produced by a
similar mechanism.
With regard to the nucleotide specificity of PGK it has been found
that yeast and muscle PGK are not specific as the phosphate donor for
the back reaction. Hence ATP, ITP, and GTP support similar levels of
activity (Krietsch and Bucher, 1970). However this concept is not
accepted by all authors as it has been reported that rabbit muscle PGK
is absolutely specific for ATP, ADP, G3P and 1.3-diphosphoglycerate
(Rao and Osper, 1961). The results obtained on the nucleotide
specificity of the trypanosome enzyme showed it to be rather specific
for ATP with only residual activity with CTP and UTP. Negligible activity
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was found with GTP as the cofactor (Table 3.6). The biological
significance of this finding is difficult to appraise. However this
enzyme is situated inside the glycosome which is self-sufficient in
keeping the ATP/ADP balance. It may be inferred that the specialisation
of the particle may have favoured the development of a variant PGK
which is more specific for its phosphate donor.
4.1.2 The kinetic properties of phosphoglycerate kinase from T. brucei
The kinetic properties of PGK from different sources have been
investigated recently, using the back reaction of the enzyme, coupled
to the oxidation of NADH by glyceraldehyde phosphate dehydrogenase
(Scopes, 1973) . When the interaction of ATP and G3P was similarly
studied with the trypanosome enzyme, it was found that when varying
the concentration of either substrate and keeping the cosubstrate
concentration constant apparent hyperbolic responses were obtained for
the activity of the enzyme as a function of the variable substrate
concentration (Figures 3.21 and 3.23). After transforming the data
using the equation proposed by Hanes (1932) biphasic linear responses
were found for ATP as the variable substrate and a single linear
response for G3P (Figures 3.22 and 3.24). Similar observations have
been reported on the binding of the nucleotide to PGK from different
sources (Yoshida and Watanabe, 1972; Schierbeck and Larsson-Raznikiewicz,
1979; Scopes, 1978a,b). It has been suggested that the enzyme does
not follow the typical Michaelis-Menten pattern and that two binding
sites for ATP exist on the enzyme, with different kinetic constants.
Regarding the Michaelis-Menten constants; the two K values reported
for ATP in trypanosome PGK (Table 3.8) are similar to those suggested
for human erythrocyte PGK (Yoshida and Watanabe, 1972). The K value
for G3P however was higher than the respective K value for the enzyme
m
described by the latter authors.
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On the function of the two binding sites, it was proposed that the
low affinity binding site acts as a regulatory site (Larsson-Raznikiewicz
and Schierbeck, 1977) and that the other binding site acts as the only
catalytic site of the enzyme (Schierbeck and Larsson-Raznikiewicz, 1979).
In view of the evidence gathered on PGK from other sources and
because of the similarities to the binding characteristics of the
nucleotide in the trypanosome enzyme it is suggested that the trypanosome
enzyme is similar to PGK from other sources with respect to the number
of nucleotide binding sites and their functions.
Regarding the binding of G3P at a constant concentration of the
nucleotide a hyperbolic function was obtained and after transformation
of the data, a simple linear response was observed (Figure 3.24). One
binding site is therefore suggested for this substrate in the trypanosome
enzyme. In this respect the parasite PGK is similar to human red cell
PGK as it has been reported that this enzyme has only one site for G3P
(Yoshida and Watanabe, 1972).
When the data obtained from the kinetic studies were transformed
using the Hill equation (Hill, 1910) (Figure 3.25) it was noticed
that the fractional velocity as a function of logw ATP concentration
at constant concentration of G3P was biphasic, with a Hill coefficient
(n values) of less than one at low concentrations of ATP and an n
value of about one at higher substrate concentrations. This phenomenon
can be interpreted in terms of negative cooperativity at low substrate
concentrations with subsequent activation by higher substrate concentrations.
The results obtained with respect to G3P using the Hill equation did not
suggest any cooperative effects. Similar conclusions to those presented
here can be drawn from experiments performed with yeast PGK (Schierbeck
and Larsson-Raznikiewicz, 1979). Substrate activation has also been
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found in erythrocyte PGK when studying the binding of substrates in the
forward reaction (Ali and Brownstone, 1976).
The biological significance of the change in the n value described
for trypanosomal PGK is difficult to appraise, and more data is needed
to clarify the situation, preferably, with a purer preparation of the
enzyme. However, the bilobular model suggested for horse muscle PGK
from data obtained using X-ray crystallography (Blake et al., 1972;
Banks et al., 1979) may be used to visualise the situation. These studies
showed that two domains are found in the monomeric enzyme. Therefore
the possibility, that binding of the nucleotide to one domain may alter
the catalytic properties of the other domain, is apparently feasible.
4.1.3 The mechanism of action of phosphoglycerate kinase from T. brucei
The mechanism of action of PGK has been studied on the yeast and
human erythrocyte enzymes (Larsson-Raznikiewicz and Ardvison, 1971;
Lee and 0"Sullivan, 1975). These authors suggest that the enzyme has a
sequential mechanism from kinetics studies in the absence of the products.
These studies, however, did not discriminate between an obligatory
order of addition and release of reactants, and combination in random
order. Product and substrate analogue inhibition experiments carried
out by the same authors finally defined the system as a rapid equilibrium
random-type mechanism. These results are corroborated by recent
experiments of Schierbeck and Larsson-Raznikiewicz (1979).
When an attempt was made to illustrate the mechanism of action of
trypanosomal PGK using the back reaction of the enzyme, a very complex
picture was obtained because of the biphasic linear nature of the
primary plots. In the first primary plot used (1/v vs 1/s) (Figure 3.26b)
to show the binding of ATP at different concentrations of G3P, it was
observed that the binding of ATP was apparently independant of the
concentration of the cosubstrate as the lines obtained converged at the
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same values of low and high K values. However when using a second
primary plot (s/v vs S) (Figure 3.26c) a small competitive component
was observed with respect to the low affinity binding site of the enzyme.
One possible explanation for these deviations is the presence of free
2+
Mg ions in the assay system which might act as a competitive inhibitor
with respect to ATPMg (Larsson-Ranikiewicz, 1964).
With regard to the effect of the concentration of ATP on the
binding of G3P, it was observed that there is, an apparent effect on
the K for G3P (see primary plots (Figure 3.27)). It is therefore
m
suggested that ATP may produce a change in conformation in the enzyme
to allow for the different affinities found for G3P.
In general the mechanism of trypanosomal PGK was found to be
complex. The possibility of a sequential mechanism, where the binding
of substrates occurs prior to the release of the products may be
allowed. However no definitive conclusion can be reached as it was
2+
found that free divalent cations (Mg ) have a possible inhibitory
effect as reported above. Furthermore the binding of G3P at different
concentrations of ATP produced anomalous results.
4.1.4 The effect of melarsen oxide on phosphoglycerate kinase from
T. brucei
As reported in the Introduction, arsenical drugs are general
inhibitors of different enzymatic reactions, the main common factor
being that these drugs are regarded as thiol inhibitors. Although the
reaction of the metal moiety accounts for the lethal action, the organic
residue explains the structural specificity of the drug for the
parasite (Williamson, 1970).
It can be seen from Table 1.3 that the kinases are the most sensitive
group of enzymes in trypanosomes, due apparently to their thiol
character. With respect to the focal point of action of arsenicals in
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the parasites, different alternatives have been prepared. It was originally
suggested that the action of these drugs was due to the specific action
on hexokinase (Chen, 1948; Marshall, 1948). The evidence was not
however accepted by other authors (Cantrell, 1953) . The situation was
finally clarified by Flynn and Bowman (1974), who suggested pyruvate
kinase as the primary focal point of action in the parasite.
Although evidence has been presented in this work that PGK is also
sensitiv^e to inhibition by arsenicals (Figure 3.32), the metabolic
evidence (Section 3.3) indicates that PK is still a major focal point
of action in the resistant line of T. brucei.
When the effect of melarsen oxide on PGK was studied, it was found
that the inhibition produced by the drug was directly related to the
binding of the different substrates. Variation of ATP concentration
with and without the drug showed a typical non-competitive inhibition
with a considerable reduction in the V value. The K values are
max m
apparently independant of the presence of the drug (Figures 3.29).
It must be pointed out that the primary plot showed a typical linear
biphasic response in the presence of the drug. It is concluded that
melarsen oxide acts in a similar way at both binding sites producing
the non-competitive inhibition mentioned above. When the effect of
the drug was studied on the binding of G3P (Figure 3.30) a different
pattern of inhibition emerged, producing an increase in the apparent
K value for G3P. It appears, therefore, that melarsen oxide is
m
competing for the G3P binding site.
With respect to the general mechanism of action of mela^minyl
arsenicals, a great similarity is found when comparing the patterns
of inhibition of PGK and PK (Flynn, 1971). It appears that melarsen
oxide acts by a general non-competitive mechanism regarding the
nucleotide and by a competitive effect with the cosubstrate. This
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similarity is probably widespread as it has been found that most of the
kinases studied by X-ray crystallography have active sites with a similar
spatial structure (Anderson et al., 1979).
Reversible inhibition in general is characterised by an equilibrium
between enzyme and inhibitor. The equilibrium constant (K ) defines
the effectiveness of the inhibitor (Dixon and Webb, 1964). These authors
proposed that the reversible character also applies to inhibitors which
do not dissociate spontaneously but which can be removed by a suitable
chemical reaction. The nature of the thioarsenite interaction is not
definitively settled but it has been suggested that the relatively
stable interaction between trivalent arsenicals and -SH groups is
readily reversed (Webb, 1966) . values reported for other enzymes
which are inhibited competitively with respect to their substrate tend
to have a wide range of variation; liver aldehyde oxidase is inhibited
by arsenite with a value of 3 x lO indicating a rather low
affinity of the enzyme for the inhibitor (Palmer, 1962), when compared
with the same enzyme in rabbit liver which is inhibited competitively
but with a value of 0.0063 x 10 "^M (Rajagopalan and Handler, 1964) .
The values for melarsen oxide were calculated on the assumption
that the interaction of the drug and the enzyme is reversible under
the condition described above; the values were calculated with the
method of Dixon (Figure 3.31). The low K values found in particular
with respect to G3P imply that melarsen oxide appears as a good inhibitor
of the trypanosomal enzyme„
Trypanosome PGK was not only sensitive to melarsen oxide but also
to other organic arsenicals. The efficiency of each of the arsenicals
tested is described in terms of the amount of drug required to produce
50% inhibition vafues)* was found (Figure 3.32) that the order
of efficiency was melarsen oxide>phenyl arsenoxide>para-aminophenyl arsenoxide.









C.R-As=0+E>R—As+•H^O HSXV E- R-Enzyme Residue
130.
The pentavalent sodium melarsen does not produce inhibition under the
conditions used and neither arsenite nor melamine are inhibitors of
the enzyme.
In general the results obtained for the inhibition of PGK were
similar to those presented for the inhibition of PK (Flynn, 1971) which
was not inhibited by inorganic arsenite either but very effectively by
monosubstituted arsenicals similar to those used in this thesis.
At this stage it is interesting to consider the nature of the
interaction between monosubstituted arsenoxides and -SH groups in enzymes .
as it will help to rationalise the results obtained. Of the alternatives
proposed (Figure 3.45) reaction A appears to be unlikely because of
the steric and electrostatic impediment of bringing two enzyme molecules
together by the arsenic moiety of the drug. The other two reactions B
and C can be considered as viable alternatives to explain the interaction
with monosubstituted arsenicals (Webb, 1966). Reaction B can occur but
if it does, it may not produce a very efficient binding in terms of the
rather more stable cyclic thioarsenite formed in reaction C.
Although no evidence is available about the number of -SH groups
at the active site of PGK some suggestions are made according to the
results presented by other authors. By analogy to the similar inhibition
found with respect to PK (Flynn, 1971) there are some main observations
that can help to determine the interaction of PGK with organic arsenicals:
1) the competitive nature of the inhibition with respect to G3P
produced by melarsen oxide, 2) the lack of inhibition by inorganic
arsenite and 3) the lack of inhibition by either melamine or pentavalent
sodium melarsen which suggests the involvement of -SH groups for the
inhibition of trypanosome PGK.
Alternative C (in Figure 4.1) suggests that the cyclic thioarsenite
formed in this reaction may be stable enough to resist any competition
131.
by G3P, hence a primary stage of interaction with the enzyme must take
into account the possibility of a reversible interaction with PGK to
allow for the competition effect with G3P. Therefore alternative B,
forming a less stable, readily hydrolisable compound may be inferred
to explain the results obtained.
As observed in this thesis (Figure 3.35) the interaction of melarsen
oxide with trypanosome protein is relatively stable as most of the drug
was found bound to the denatured protein even under strong acid conditions;
thus the possibility of a more stable interaction may be formed after
the initial stage (B) mentioned above. This suggestion implies the
possibility of time dependant changes in the inhibition produced by
the drug. This specific area was not investigated in this work however
results presented by Peters and Sanadi (1961) showed the xanthine
oxidase is protected against arsenite by the substrate but that the
final inhibition is non-competitive with respect to xanthine. A similar
possibility was also proposed to explain the final inhibition of
trypanosome PK (Flynn, 1971).
The results presented by other authors with respect to the differential
inhibitory power of arsenite and monosubstituted organic arsenicals
observed in other enzymes may help to settle the final mechanisms of
interaction of the drug with -SH groups in enzymes. Succinate oxidase
was inhibited differentially by inorganic arsenite and monosubstituted
organic arsenicals (Barron and Singer, 1945; Peter et al., 1946).
At the same time it is considered that inorganic arsenite has a greater
affinity for dithiol groupings as the drug readily reacts with
dimercaprol (2,3-dimercaptopropanol) but not with the monothiol
glutathione (Aldridge and Gemer, 1955), furthermore no mercapeptide
-3
formation was observed even at 100 x lO M arsenite (Drummond and
Stern, 1960). Strong inhibition by inorganic arsenite as the one
132.
reported for pyruvate oxidase from pigeon brain (Peter et al., 1946)
suggests the possibility of a vicinal dithiol in the enzyme. Neither
trypanosome PGK as observed in this work nor PK (Flynn, 1971) were
inhibited by inorganic arsenite therefore by comparing these observations
it is possible to suggest that the initial interaction with the
trypanosome enzyme occurs via a monothiol and upon binding with the
drug a change in conformation of the enzyme may allow the formation of
a more stable thioarsenite.
Finally the inhibition of trypanosome PGK with monosubstituted
arsenicals confirms the thiol character of the enzyme when compared
with rabbit muscle PGK which is neither inhibited by oxophenarsine or
phenylarsenoxide (Rao and Osper, 1961).
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4.2 Discussion of the studies on drug resistance
4.2.1 The development of the resistant character
Different methods were used in this thesis for the production of the
resistant line of T. brucei. The basic requirements considered necessary
for the method to be used were a fast production of the resistant line,
reproducibility and a minimum requirement of experimental animals.
The first routine tried involved exposure of trypanosomes in vitro to
different concentrations of melarsen oxide; the second routine used was
the continuous exposure of the trypanosomes in vivo. After exposure
by either method the cells were used to infect new hosts. These two
routines were abandoned because even at minimum concentrations of the
drug there was a clear trypanocidal effect; another disadvantage of
these routines was the uncertainty of the critical dose at which
trypanosomes could not be recovered after exposure in vivo or in vitro.
Other methods have been proposed for the development of resistant
trypanosomes in vivo (Schnitzer and Grunberg, 1957); the short passage
method was chosen instead of the relapse method as it has been suggested
that the former does not produce serum resistant organisms (Bishop, 1959).
The resistant line of T, brucei (from stabilate [BEU melarsen oxide
0.52] ) was produced after ten weeks with sixteen passages. The fast
line developed against sodium melarsen (Rollo and Williamson, 1951)
using the relapse method was produced after eighteen weeks and thirty
passages.
By comparing the doses of melarsen oxide used at the beginning and
at the end of the experiment a gross resistance factor of 13 fold is
obtained for the melarsen oxide resistant line; an eleven fold
resistance factor was observed by Rollo and Williamson (1955) for the
line resistant to sodium melarsen. Therefore a comparable level of
resistance has been obtained in the line of T. brucei developed in the
present work.
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The original parent line of T. brucei used in this work is a
relatively old laboratory adapted population of trypanosomes. Similar
results to the ones presented above, with respect to the time for
production of the fast trypanosomes, were reported by Hawking and
Walker (1966) and Walker (1964), when working with another laboratory
adapted line of T. brucei. They reported that the time required for
the production of the resistant line depends on the random appearance
of resistant mutations in the population. This is apparently valid
as the same authors reported that resistance develops very readily in
freshly isolated populations of trypanosomes without previous treatment
with arsenicals. Therefore it is suggested that a similar mechanism
may be responsible for the development of resistance to melarsen oxide
in the line of T. brucei used in this work. Further discussion on
this aspect is covered in Section 4.2.4 of this Discussion.
With regard to the reference collection developed throughout the
production of the resistant line it is suggested that a line produced
from the stabilate [BEU melarsen oxide 0.52] could be called a strain
as soon as the population of trypanosomes is characterised in relation
to the resistant character. There is a clear evidence of ancestry
between the new line developed and the original parent line. These
suggestions are made according to the proposals for the nomenclature of
salivarian trypanosomes and for the maintenance of reference collections,
recommended by the World Health Organisation (1978). Although most of
the work described in this thesis was done with the original parent line
and the line developed from stabilate [BEU melarsen oxide 0.52] a
similar approach can be taken with the intermediate stabilates produced.
New strains could be developed and it could be established whether or
not there is a correlation between the appearance of the resistant
character or characters and the stage of exposure according to the
pedigree produced (Figure 3.1).
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4.2.2 The drug sensitivity test; validity of the parameter used
Trivalent arsenical compounds have been found to inhibit the oxygen
consumption of T. rhodesiense and T, evansi (Fulton and Christophers,
1938? Marshall, 1948). Indeed it was later found that this is not
surprising since arsenicals inhibit aerobic glycolysis, a metabolic
pathway linked to the reduction of molecular oxygen in trypanosomes
(Ryley, 1956).
The production of the resistant line was only possible, under the
conditions described, because of the continuous monitoring of the
different relapses obtained after treatment with increasing concentrations
of melarsen oxide (Figure 3.2). The drug sensitivity test used for the
routine analysis of the treated population of trypanosomes, was based
on the sensitivity of these organisms to inhibition of the oxygen
consumption when treated with different concentrations of the trivalent
drug. The glycolytic sequence is the unique source of energy of these
organisms (Bowman and Flynn, 1976)? also the LS forms of these
parasites lack cytochromes capable of oxygen reduction (Fulton and
Spooner, 1959? Ryley, 1962). Therefore, the mitochondrial glycero¬
phosphate oxidase being the only oxygen consuming system in the LS
forms of these parasites (Opperdoes et al., 1976), it was assumed
that whatever the mechanism of resistance it was possible to detect
it as a change in sensitivity to inhibition of the oxygen consumption.
The drug sensitivity test developed, produced the results expected
since it was possible to differentiate between the lines of trypanosomes
with clear differences in sensitivity to the drug. However the method
had one slight disadvantage in that the system, did not produce linear
traces of oxygen consumption at above 40% inhibition (approximately)
a feature explained in terms of the trypanocidal effect of the drug
in the parent line. This disadvantage of the system does not, however,
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preclude the detection of the resistant character as lower inhibition of
the oxygen consumption was expected with the possible resistant lines.
4.2.3 The oxygen consumption and the probit analysis
It was observed with the drug sensitivity test, that a reduction
in oxygen consumption is accompanied by a reduction in the number of
motile organisms present after treatment with the chemotherapeutic
agent in vitro; thus it is assumed that the oxygen consumption of a
determined population of trypanosomes is a reflection of the number
of active organisms. Furthermore, the motility and the oxygen consumption
decrease more quickly as the drug concentration is increased. Therefore
it was decided to correlate the oxygen consumption observed with the
drug concentration used. For the purposes of this analysis, the linear
portions of the rates of oxygen consumption are compared in the different
populations of trypanosomes. The results obtained for the residual
uptake were transformed using the probit analysis, which is a linearisation
of the drug response analysis (Mather, 1964). According to this author,
this type of analysis is frequently used in toxicology and bioassay
experiments involving similar situations to the one described above.
The analysis was also used by Hawking and Walker (1966), to study the
development of resistance to trivalent tryparsamide in T. rhodesiense
and T. brucei.
The assumption made with respect to oxygen consumption, as a general
characteristic of the population, was apparently valid as a linear
response was observed when the results for the parent line are presented
using the probit transformation (Figure 3.3) . The probit transformation
being a linearisation of the standard distribution of sensitivities to
the drug in the population, it is suggested that there is an apparently
homogeneous population of trypanosomes in the parent line with respect
to drug sensitivity.
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When the results obtained with the resistant line are treated
similarly, a linear biphasic relationship is found (Figure 3.3).
This type of relationship has been interpreted as evidence of a heterogenous
population of trypanosomes with different degrees of sensitivity to the
drug (Hawking and Walker, 1966). The plateau found at probit value
3.75 implies that only about 90% of the population is resistant to the
drug; this conclusion was difficult to reach in practice with the
resistant line, as the inhibition of motility was only evident at a
higher concentration of the drug (250 x 10 M). Therefore it is
suggested that although a mixed population may exist in the new resistant
line of T. brucei a low sensitivity to inhibition of the oxygen uptake
may be responsible for the biphasic results obtained. This situation
can be finally clarified in the future if the population is subjected
to cloning and similar studies are performed on populations derived
from a single organism.
4.2.4 Further studies on the development of the resistant character
using Warburg manometry
The routine drug sensitivity test performed with the oxygen electrode
allowed the analysis of populations of trypanosomes at low concentrations
of organisms with good rates of oxygen uptake; this probe detects very
small changes in the oxygen tension in solution. However in the metabolic
section of this thesis, the experiments were performed using constant
volume Warburg manometry; this technique allows the handling of higher
concentrations of organisms for longer periods of time. Therefore in
order to have a comparable body of evidence, some data was obtained on
the development of the resistant character using the latter technique.
A comment should be made on the meaning of the I values obtained
(I^q = drug concentration to produce 50% inhibition). With the oxygen
electrode the inhibition is considered on the initial (linear) rates of
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uptake; with the Warburg manometric system the inhibition considered is
the one produced over a period of 30 minutes incubation with the drug.
The reason for this long period of incubation is to maximise the
production/consumption of metabolites under the conditions used
(see Figure 3.8). It was found that the values obtained were higher
with the manometric system; this difference is apparently due to the
presence of serum albumin in the buffer. It is suggested that the
protein may decrease the concentration of free drug by unspecific
binding. Organisms from the first relapse, after infection of rodent
hosts with stabilates, were used to study the development of the resistant
character (see Figure 3.4). This precaution was taken as the stability
of the resistant character was only studied in the resistant line from
stabilate [BEU melarsen oxide 0.52] and no information is available on
the other intermediate lines (see Section 4.2.5). The pattern of
inhibition found corroborated the results obtained with the drug
sensitivity test showing great differences between the parent line and
the resistant line (from stabilate [BEU melarsen oxide 0.52]). By looking
at the results obtained (Figure 3.4) it may be suggested that the
patterns of inhibition are similar in the populations exposed to 0.06
to 0.12 mg/kg and the parent line. Comparing the levels of inhibition
in the 0^ consumption at 10 melarsen oxide:
-5
Stabilates % Inhibition at 10 M
melarsen oxide
Parent 90
[beu melarsen oxide 0.06-0.0.12] 90
[beu melarsen oxide 0.18] 78
[beu melarsen oxide 0.32] 62
[beu melarsen oxide 0.52] 15
It appears that there are intermediate levels of sensitivity in the
different lines studied. The results obtained are simiilar to those
reported by Hawking and Walker (1966) for the development of a
tryparsamide resistant line from a laboratory adapted parent line of
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T. brucei. Because of the similar patterns of sensitivity found with
populations exposed to a low concentration of the drug and the parent
line it is concluded that the resistant character does not preexist
in the parent line; furthermore the final resistant character is
apparently developed in stages after the selection of less sensitive
organisms, thus different degrees of heterogeneity with respect to the
sensitivity to the drug may exist in the different stabilates used.
It is also suggested that the melarsen oxide resistant line produced
in this thesis may have been developed after the appearance of one or
more spontaneous mutations which are selected under the pressure of the
drug.
4.2.5 The stability of the resistant character
It has been previously found that resistance, when fully developed,
is a relatively stable character even in the absence of the drug to
which the resistance was developed (Murgatroyd and Yorke, 1937;
Bishop, 1959). Stability may be assessed either by serial passage in
rats or by passage through the insect vector (Gray and Roberts, 1968);
the latter method of testing the stability of resistance was discarded
as the parent line used in the experiments is a laboratory adapted line.
After testing the melarsen oxide sensitivity of the resistant line
in the absence of drug pressure and after serial passage in rats, it was
found that the character was stable up to the 13th passage (Figure 3.5).
The apparent stepwise manner in which the resistant line was obtained
(as discussed in the last section), and the stability of the character
under the conditions used may suggest that the new feature is well
established in the genetic pool of the population of trypanosomes.
The position may not be the same for the other lines produced at lower
resistance factor levels. Similar experiments (Hawking and Walker, 1966)
suggest that a stable character is only found at high resistance factor
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levels. It should be mentioned that although it was found that the
resistant character was stable in terms of sensitivity to the drug,
all the experiments were performed with organisms from the first
relapse after infection from stabilates; the reason was that no
information was available on the stability of any other possible
character in the newly developed line of T. brucei e.g. metabolic
differences or enzymic differences.
The next question to answer was about the stability of the new
line in vivo under pressure of the drug. The results obtained
(Figure 3.6) showed that the resistant line was able to kill the rodent
host despite drug treatment, whereas the parent line was completely
cleared from the circulation after treatment with the drug. However
under treatment with the drug in vivo, there was a delay in the
development of the parasitaemia in the resistant line with a subsequent
delay in the death of the animal. Two alternatives are put forward to
explain this observation. First that there is a mixed population of
trypanosomes as suggested in Section 4.2.3. In spite of the high
level of organisms supposed to be resistant in the population (about 90%)
there was a considerable delay in the development of the parasitaemia.
Therefore the second suggestion is that the resistant line itself
remains partially sensitive to the drug and therefore a delay in the
development of the parasitaemia is observed. This proposition is
difficult to substantiate as the work has been done with a possible
heterogeneous population of resistant parasites without previous cloning.
The two alternatives proposed above have not taken into consideration
the possibility of direct participation of the host in the control of
the infection. The immune system of different hosts infected with
trypanosomes has been studied and noticeable increases in the activities
of certain mechanisms have been observed (Herbert and Parrat, 1979).
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Therefore the combined effect of partial sensitivity to the drug and to
the immune system of the host may explain the delay in the development
of the parasitaemia in the resistant line after treatment with the drug.
4.2.6 Testing different hypotheses for the development of resistance
The main general mechanisms which might be responsible for the
development of resistance in trypanosomes were discussed in the Introduction,
and most of the evidence gathered on the development of resistance to the
arsenicals, including those of the melaminyl series, has pointed towards
two main alternatives; first the development of a metabolic bypass,
and second a reduced uptake of the drug. A new melarsen oxide resistant
line of T. brucei was used in this work therefore it was necessary not
only to cover the two alternatives mentioned above but also the possibility
of modification of enzyme targets for the drug as a cause of the
development of resistance.
The general strategy was as follows: the metabolism of carbohydrate
by parent and resistant lines was first compared, as much information
was available on this particular topic for the parent line. Any
information obtained from this primary analysis could be used as a
general starting point from which further suggestions may be formulated.
Second a comparison was made in terms of the kinetic parameters
and drug sensitivities of two enzymes, PK and PGK. One of these (PK)
has already been pin-pointed as a focal point for the action of melaminyl
arsenicals. Third a closer look was taken at the uptake of the drug by
parent and resistant lines in order to characterise the mechanism of
transport in both populations of trypanosomes.
4.2.7 General carbohydrate metabolism in parent and resistant lines
From the preliminary metabolic experiments performed (Table 3.2)
it is suggested that the parent line of T. brucei (LS form) used in
this work has the same metabolic characteristics as other trypanosomes
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of the subgenus Trypanozoom (Ryley, 1956; Grant and Fulton, 1957;
Brohn and Clarkson, 1978). It was found that the aerobic consumption of
one mole of glucose produced approximately two moles of pyruvate
(Table 3.3); and that the consumption/production of these metabolites
proceeds at an extremely high rate. The results of these preliminary
experiments were not the same when the resistant line was investigated,
as a lower rate of pyruvate production was observed and therefore a lower
yield of pyruvate per glucose was found. Although traces of glycerol
are found in both parent and resistant lines, the amounts produced did
not increase as a function of time. Thus it is concluded that the
appearance of this metabolite is of minor importance as the traces of
glycerol may be due to a transient anaerobic state during the experimental
handling of the trypanosomes.
When the general carbon balance of both organisms was studied
using constant volume Warburg manometry (Table 3.3), the same metabolic
features were found with parent and resistant lines as described in the
preliminary carbon balance experiment. The most important aspect is that
the lower pyruvate production, when compared to the glucose and oxygen
consumption, is corroborated in the resistant line (see Table 3.3).
Another difference found with respect to the parent line was the
production of CC>2 with a RQ of about 0.1 in the resistant line.
Different alternatives can be put forward to explain the results obtained:
a. Production of CO^ metabolism of glucose via the hexose
monophosphate shunt.
b. Production of CO^ by decarboxylation of pyruvate with the
subsequent production of another metabolite.
c. Production of CC^ in the tricarboxylic acid cycle (TCA).
As for the alternative "a", experiments using specifically labelled
14
C glucose have suggested that the pathway is operational in different
lines of T. cruzi (Mancilla and Naquira, 1964). Similar studies in
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some members of the trypanozoon subgenus have shown that the hexose
monophosphate pathway does not operate to a significant extent, as less
than one per cent of the carbon from glucose is found as CO^ (Bowman,
1974). Furthermore the apparent absence of 6-phosphogluconate dehydrogenase,
(Flynn, 1971) shows this pathway very unlikely as the source of carbon
dioxide. On the other hand if the pathway were operational in the
resistant line this would not explain alone the lower pyruvate/glucose
ratio found.
The metabolic characteristics of the resistant line of T. brucei are
in fact not different from those of LS forms of other members of the
Brucei group, in which some CO2 is produced as a metabolic end product
of glucose metabolism (Ryley, 1956; Flvnn and Bowman, 1973). It is
therefore suggested that in the resistant line, decarboxylation of
pyruvate may occur. However no definitive conclusion can be reached
at this stage with respect to the further production of CO^ or about
the nature of the other metabolites involved, as succinate and acetate
may be present as the other final products of glucose metabolism in the
blood stream forms of these parasites. Therefore alternative "b" can
not be discarded at this stage. With regard to alternative "c", it has
been suggested that the TCA cycle is not fully operative in the LS
forms of the parasite (Bowman and Flynn, 1976); instead the possibility
of succinate formation, involving CO^ fixation with reversal of some of
the enzymes of the TCA cycle, has been suggested (Klein et al., 1975).
It is clear that in the hypothetical case of alternative "c" this will
immediately include "b".
The possibility of a metabolic modification as a result of the
development of resistance to arsenicals has been studied in the past;
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earlier evidence of Reiner et al. (1932) when comparing the respiration
rate of normal and neoarspenamine resistant T. equiperdum did not
suggest any major modification in the resistant line. The same
conclusion was reached by Harvey (1949) when studying the metabolism
of carbohydrates in an oxophenarsine resistant line of T. hippicum.
The results presented in this thesis suggest the possibility of a
minor modification on the metabolism of the melarsen oxide resistant
line when studied without the influence of the drug. Modifications,
in this context, were also found in a tryparsamide resistant line of
T. gambiense (von Brand et al., 1953); this line showed lower rates
of glucose consumption and pyruvate production. It was in general
suggested that the characteristic observed were not directly related
to the development of resistance; nonetheless it was inferred that an
alternative pathway was playing a more important role in the resistant
line. A similar type of situation is observed in this work, as the
metabolism of the resistant line in the presence of the drug suggested
the possibility of an alternative pathway for the fate of pyruvate
(see Section 4.2.8).
A distinct change in the metabolism was found in a sodium melarsen
resistant line of T. rhodesiense (Williamson, 1953a). Unlike the parent
line, the resistant line was unable to utilise glycerol pyruvate,
glutamate or succinate but showed increased ability to use citrate and
lactate. Although the changes were quite pronounced it is difficult
to rationalise the differences in terms of the development of resistance.
Further studies on the effect of a variety of metabolic inhibitors on
resistant T. rhodesiense in vitro suggested that although metabolic
modifications may have occurred these were not directly related to the
development of resistance (Williamson, 1959a).
145.
Metabolic changes have therefore been observed in the past with
other organic arsenicals. Indeed it is reported in this thesis that
the melarsen oxide resistant line showed apparent changes in the
metabolite production/consumption when compared with the parent line.
Although this minor modification could suggest a less resistant
secondary pathway to the drug, there is not a clear relationship
in terms of the high levels of resistance observed in the trypanosome.
A further analysis is made however in the Section 4.2.8 on the general
metabolism of the parent and the resistant lines under the influence of
melarsen oxide.
4.2.8 The effect of melarsen oxide on the metabolism of parent and
resistant lines
As reported in Section 4.2.2 the inhibition of oxygen uptake was
used to differentiate parent and resistant lines of T. brucei. However
when the same parameter was compared in water lysates from both lines
of trypanosome (Figure 3.10) it was found that there was no difference;
therefore it is suggested that common sites of inhibition exist in
both lines of the parasite which become available in the resistant line
on disruption of the cell membrane. Alternatives for the sites of
inhibition are discussed below. With respect to the different patterns
of inhibition found in whole cells and the similar pattern found in water
lysates, it is suggested that a permeability barrier for the drug may
be involved in the resistant line. The nature of this permeability
barrier is dealt with in more detail in the drug transport section
(4.2.13) of this Discussion.
As mentioned above common intracellular sites of inhibition are
proposed for both lines of the parasite. Comparison of the inhibition
of metabolite production/consumption in parent and resistant line
organisms by melarsen oxide (Section 3.3.4) suggested that pyruvate
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production could be a site of action; howefer the I values were
considered for the resistant line and I values for the parent line.
The observation that a higher extracellular concentration i%s needed
to produce inhibition in the resistant line substantiates the possibility
of an acquired permeability barrier for the drug. In relation to the
metabolite inhibition, it was found that the CO^ production in the
resistant line is extremely sensitive to inhibition by melarsen oxide
as no CO2 was detected at concentration above 90 x 10 drug.
Oxygen and glucose consumption, and pyruvate production are only
inhibited between 25-30%, at the same concentration of drug. Therefore
it seems that the further metabolism of pyruvate (assuming that this
is the source of CO^) is apparently more sensitive to melarsen oxide
inhibition.
It has been proposed since the work of Krebs (1933a,b) that arsenite
causes the accumulation of a-ketoacids in kidney preparations. These
experiments and those of Peters (1955) and Peters et al. (1946)
confirmed that pyruvate oxidase, from mammalian tissues and from pigeon
brain, was the focal point of action of arsenicals; furthermore it has
been shown from studies on a pleomorphic line of T. rhodesiense that
pyruvate oxidase (from SS forms) is also sensitive to trivalent organic
arsenicals (Flynn and Bowman, 1974). It was also reported by the latter
authors that although pyruvate decarboxylation is sensitive to the
arsenical drugs, the main site of lethal action is PK.
The pyruvate/glucose and pyruvate/oxygen ratios were apparently
constant, even at high concentration of the drug, in the resistant line
when compared with the parent line (Table 3.4) which showed a reduction
in the pyruvate/glucose ratio with increasing drug concentrations.
Also if the inhibition of C0„, production is assumed to come from the
decarboxylation of pyruvate it can be inferred, that although there is
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inhibition in the metabolism of the resistant line another metabolic
route for pyruvate should exist; furthermore this hypothetical metabolic
route plays a more important role in the resistant line when the drug is
present. As discussed in the last section, Williamson (1953a) described
a sodium melarsen resistant line of T. rhodesiense which developed
lactate dehydrogenase activity which was not present in the original
parent line. However, no information was obtained with regard to this
characteristic in the resistant line used in this work.
Negative RQ values were observed when studying CO^ production in
the resistant line at high extracellular concentrations of melarsen
oxide (Figure 3.13). This observation and that of Klein et al. (1975)
who reported the presence of CC^ fixing enzymes in T. brucei could be
used to infer the posssibility of CO^ fixation in the resistant line
when exposed to the action of the drug.
In order to clarify this minor metabolic difference found in the
resistant line, the suggestions proposed by Bowman and Flynn (1976);
about the utilisation of radioactive precursors to estimate the specific
activity of individual carbon atoms in metabolic intermediates and end
products and the identification of the enzymes involved in the pathways
proposed, should be followed.
With regard to the CO^ production in the resistant line, there is
no apparent evidence of pleomorphism in the population of trypanosomes
as shown in Figure 2.2; therefore a viable alternative is the possibility
of an intermediate form of the parasite capable of oxidative decarboxylation
which appears to be sensitive to melarsen oxide inhibition in the
resistant line. This possibility is the most likely alternative,
nevertheless this can only be inferred.
Finally the metabolic differences observed in the parent line,
with and without melarsen oxide in the incubation medium, have only
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been studied and analysed to a limited extent because as already
mentioned, it was found that the main suggestion to explain the
development of the resistant character was in terms of a permeability
barrier for the drug.
4.2.9 The glycosome sensitivity to melarsen oxide and the thiol content
of parent and resistant lines
It has been suggested that several members of the Order kinetoplastida
have the particulate organelle called the glycosome (Taylor et al., 1979),
and that this particle is surrounded by a limiting membrane which allows
a certain level of compartmentation (Visser and Opperdoes, 1980).
The glycosome is therefore potentially important in the development of
resistance. However when the activity of the whole organelle from
parent or resistant lines was studied under the influence of melarsen
oxide, no differences were found in the inhibition patterns (Figure 3.14).
Although the multienzyme activity of the glycosome is inhibited to the
same extent in both parent and resistant lines, this does not rule out
the possibility of different enzymes in the glycosome having different
kinetic properties or being susceptible to different levels of inhibition
by the drug.
Another feature which has been suggested as an explanation of the
development of resistance is the production of an excess of thiol groups
in the resistant line which will detoxify the drug. Although this
hypothesis has been tested before (Hawking, 1938; Harvey, 1948) and
apparent differences were not fcund, it was necessary to check this
feature in the new resistant line of T. brucei. The precaution was
taken this time to estimate both available and total thiol after folding
of the protein (Figure 3.15). Again no differences were found for either
thiol type between parent and resistant lines. Therefore this hypothesis
can be discarded as a possible mechanism for the development of resistance.
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4.2.10 The enzymological studies on parent on resistant lines
From the metabolic section of this Discussion it has been suggested
that although a minor modification exists in the resistant line, the
development of resistance is probably associated with a difference in
drug permeability between the lines of parasite. However it must be
remembered that the mechanism of action of organic arsenicals involves
a preliminary binding of the drug to the parasite, followed by reaction
with specific enzymes in the cell (Williamson, 1970). Therefore
modification at the level of target enzymes is not completely ruled
out from the metabolic results obtained. Indeed the possibility has
already been described for a pyrimethamine resistant line of Plasmodium
berghei which has a modified dihydrofolate reductase activity, ten fold
greater than in the parent line (Ferone, 1970). Modification of the
kinetic parameters of the enzyme in the resistant line were also
reported (Pinder, 1971).
A more detailed study of the general characteristics of some
possible target enzymes was therefore carried out. In the first place
PK was investigated as this enzyme has been reported to be the main
target of organic arsenicals in the parent line (Flynn and Bowman, 1974) .
Other potential targets are difficult to pinpoint as a modification
may arise in any of the enzymes sensitive to melarsen oxide. The other
enzyme chosen for investigation was PGK as it functions similarly to
PK i.e. it is involved in phosphorylation at the substrate level.
The ATP produced by these enzymes is considered to be the only source
of energy available to the parasites (Bowman and Flynn, 1976).
Three alternative enzymological explanations for the development of
resistance are: 1) modification of the kinetic parameters of the
enzymes for their substrates, 2) increased specific activity to overcome
inhibition by the drug and 3) a lowered sensitivity to the drug in the
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resistant line enzymes. These features were investigated in semicrude
preparations (see Figure 3.16) of the two enzymes in order to avoid any
modifications due to a more stringent purification procedure.
a) Pyruvate kinase
Study of the kinetic parameters of PK corroborated previously
published data (Flynn and Bowman, 1980) (Table 3.7). The enzyme is
homotropically allosteric with respect to the substrate PEP. After
addition of the heterotropic activator, FDP, there was no modification
of the V
x of the enzyme allowing classification as a "k" enzyme
(Monod et al., 1965). The same kinetic parameters are found for parent
and resistant line enzymes with regard to the S,. and V values for50 max
PEP in the presence and absence of FDP. The only minor difference
observed was the Hill coefficient value obtained for PEP binding in the
absence of FDP in the resistant line. However the age of the enzyme
preparation and the use of different batches of lyophilised material
can produce some variation in this parameter. Furthermore it has been
suggested (Flynn and Bowman, 1980) that the enzyme is fully activated
by FDP in vivo under conditions of high glycolytic activity. For these
reasons no significance can be attributed to this apparent variation
between parent and resistant line PK. The response of PK with respect
to ADP was found to be of the simple Michaelis-Menten type and again
K and V values were similar in both lines. Thus, it was concluded
m max
that the main target of organic arsenicals is apparently similar in
parent and resistant lines as far as kinetic properties are concerned.
Finally it should be mentioned that the activity of the enzymes
was considered in terms of rate/mg protein for all enzymological
studies Dresented. The analogous V values are therefore evidence
max




This enzyme was also investigated because of its involvement in
energy transduction and because PGK has been poorly studied in trypanosomes.
Discussion at this point will be limited to the possible involvement of
this enzyme in the development of resistance. The general enzymic
properties are dealt with in more detail in Section 4.1
Estimation of the kinetic parameters of the enzyme from both sources
with the technique already described (Table 3.8) showed that the
respective Michaelis-Menten constants and maximal velocities for both
substrates, G3P and ATP, were the same for parent and resistant line
enzymes.
Again the maximal velocities are an indication of the specific
activities of the enzymes from the different sources. Therefore, as
found with PK, the enzyme in the two lines is apparently the same.
4.2.11 The effect of melarsen oxide on pyruvate kinase and phosphoglycerate
kinase from parent and resistant lines
Exclusion of modification of the kinetic parameters and the possible
development of increased concentration of the enzymes in the resistant
line does not rule out the third alternative of differential inhibition
by melarsen oxide between the enzymes from parent and resistant lines.
As suggested by Sevag (1955) and Schueler (1947) conformational changes
of the structures involved in the binding of drugs may alter the
affinities of the latter for their targets. However when the patterns
of inhibition of the two enzymes are studied (PK; Figure 3.20; PGK;
Figure 3.28) no significant changes are apparent under the experimental
conditions used. As mentioned previously, semicrude fractions were used
as the source of the enzymes without major purification (2-3 fold).
Therefore the concentrations of drug presented as the I values are
50
probably overestimates as there are other proteins present with available
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thiol groups that may react with melarsen oxide and hence produce an
artificial reduction in the concentration of the free drug able to
react with the enzymes under study.
To summarise, investigation of some drug targets in parent and
resistant lines was carried out to substantiate the suggestion made from
metabolic studies; no metabolic differences were found to be responsible
for the development of resistance and from the results obtained the
possibility of permeability differences for the drug was inferred.
The alternative of modified targets was thought worthy of clarification
prior to drug uptake studies and the lack of enzymological differences
found between the lines of the parasite reinforces the alternative of
differential uptake as the major feature of the phenomenon of resistance.
This topic is the subject of the next section.
4.2.12 The drug transport studies and the setting Of the experimental
conditions
For the study of melarsen oxide transport in T. brucei several
parameters were controlled in order to ensure that, under the conditions
used, the uptake mechanism was a real characteristic of the cell
population. These precautions had to be taken with this drug due to
its properties as a strong metabolic inhibitor.
The incubation of large numbers of trypanosomes ensured that
measurable amounts of the drug were taken up by the cells. The temperature
(21°C) (Figure 3.36) and the time of incubation (60 seconds) (Table 3.9)
with, different concentrations of the drug were selected in such a way
that there was 100% motility in the cell population at the end of the
incubation.
Another requirement for this type of study is the availability of
a specific assay system for the transported substance. This requirement
was fulfilled by using an assay system specific for the estimation of
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arsenic in the drug (US Pharmacopeia 1975)-The sensitivity of the system
used (Section 3.6.1) allowed accurate measurement of the drug down to
the microgram level.
Due to the fast reaction of trivalent arsenicals it was concluded
that the mechanism of translocation should be rapid to allow for the
fast action of the drug at the intracellular site of action. Therefore
a rapid exposure system was used in order to ensure good estimates of
the initial rates of transport (Figure 3.34). The silicone sandwich
technique, as described by Damper and Patton (1976b) was used for this
purpose. One minor disadvantage of this technique is the extracellular
fluid pulled by the cells through the silicone layer when centrifugation
is performed (see Materials and Methods). This problem was solved by
calculating the fluid volume involved using an impermeable extracellular
14
marker ( C inulin) and correcting for the amount of drug associated
with this volume (Table 3.10).
In a preliminary experiment on the distribution of melarsen oxide
it was found that most of the drug was associated with the acid insoluble
pellet of protein (Figure 3.35). It is therefore suggested that a
relatively stable interaction exists between the drug and the denatured
protein. The nature of the stability of the drug-protein interaction,
in terms of the arsenic-thiol interaction, is covered in more detail
in Section 4.1.4.
4.2.13 The kinetics of the transport of melarsen oxide in parent and
resistant lines
As mentioned in the Introduction, some information available on the
transport of arsenicals into trypanosomes indicates a reduced uptake
in the resistant lines investigated. The evidence obtained by Yorke
et al. (1931) and Hawking (1938) was gathered using a biological assay
for the drug, although in the latter case a chemical estimation was also
used. The experiments performed by these authors were mostly on
laboratory produced resistant trypanosomes. Eagle and Magnuson (1944)
found similar results with a spontaneously developed arsenical-resistant
line of T. equiperdum. Since then these results and others have been
used to explain the development of resistance in trypanosomes. Most of
the data have been obtained from relatively long periods of exposure
of the organisms to the active agents. In other words there is no
definitive evidence available on the mechanism by which the uptake of
the drug is modified or suppressed. Therefore the approach followed
in this work was to study the kinetics of drug transport in parent and
resistant lines in the first place.
The experiments performed showed (Figure 3.39) that the initial rate
of transport, as a function of the drug concentration, approached a
maximum velocity in the parent line which suggests the presence of a
saturable component for the transport of the drug. Similar results to
those presented here were observed for the trasnport of diamidines in
T. brucei (Damper and Patton, 1976a) in which the saturation kinetics
for transport mechanisms were interpreted as evidence of a carrier
mediated mechanism.
With regard to the kinetic parameters of the transport system in
the parent line it should be mentioned that the scatter found in the
experimental values precludes the use of linear transformations of the
data to estimate the kinetic constants. Instead non-linear regressions
were applied in order to calculate the parameter. Two computer programs
were used, one for the Michaelis-Menten equation (Atkins and Gardner,
1977) and the other for the estimation of the parameters of the Hill
equation (Atkins, 1973). The second program was found to give a better
fit to the data obtained. Therefore the flux of melarsen oxide into the
parasite did not show a typical Michaelis-Menten pattern, suggesting a
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more complicated mechanism for the transport of melarsen oxide in the
parent line. The kinetic parameters obtained are interpreted as the
maximal velocity of the transport of the drug (V ) and the S = K
max 50 t
or substrate concentration at which the rate of transport of the drug
is half maximum. The meaning of the Hill coefficient is discussed below.
The possibility of complex carrier mediated mechanisms has already
been reported by Goldman ("1973) . It was shown by the same author that
typical Michaelis-Menten patterns for undirectional fluxes are sometimes
difficult to demonstrate experimentally. The observation that the Hill
equation (Hill, 1910) was the closer mathematical model for the data
obtained for the transport of melarsen oxide in the parent line, may
suggest cooperative binding of the drug. If this is so then the Hill
coefficient (n value) observed in the carrier mediated system will
represent the cooperative index for the drug when binding to its receptors.
By analogy with an enzymic reaction, it may be suggested that the
transport system for melarsen oxide is activated by the drug in a
homotropic fashion.
Allosteric effects and conformational changes, as in enzymic
reactions, have been suggested as unsatisfactory models to explain the
movement of some substrates across membranes (Selwyn et al., 1977).
The view of less satisfactory models is based on the distances involved
in membrane transport. However as suggested by the same author,
a combination of allosteric protein conformation changes with possible
pores in the membrane are postulated to overcome the problem. The
possibility of allosteric transport mechanisms has also been discussed
by Lieb and Stein C1972). They concluded that shuttles or pores could
not account for the kinetics of glucose transport in red cells.
Therefore it was proposed, not only for this carrier but also for the
(Na+/K+) dependant adenosine triphosphatase (Stein et al., 1973),
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a model of transport based on the allosteric transformations of haemoglobin.
In conclusion the transport mechanism for melarsen oxide was found
to be complex in the nature of the interaction between the drug and its
receptors. Further experiments should be performed on this particular
topic, if possible with a more accurate system for estimation of the drug,
in order to rationalise the characteristics observed for this transport
mechanism.
With regard to the transport of melarsen oxide in the resistant line
only a residual and apparently linear rate of transport is observed,
as a function of the drug concentration (Figure 3.39). The first order
kinetics observed for the transport of the drug is suggested as evidence
of a simple diffusion system (Neame and Richards, 1972). Therefore it is
concluded that the resistant line of T. brucei developed in this work
has lost the carrier mediated transport, responsible for most of the
transport of the drug, as a result of the development of the resistant
character. Instead a simple diffusion is alone responsible for the
uptake of the drug in the resistant line. Some evidence to support this
is found in Section 3.3. It was shown that the metabolism of carbohydrates
is only inhibited at considerably higher extracellular concentrations of
the active agent in the resistant line. It is suggested that at high
levels of extracellular drug some diffusion into the parasite occurs
dimply because of the gradient of concentration between the extracellular
and intracellular compartments. Considering that the mechanism of action
of arsenicals involves two stages, binding to the cell and then
lethal action (Williamson, 1970), it is logical to assume that the
reduced effect found on metabolism is the result of lower absorption
of the drug.
The results obtained in this work are in agreement with the cross
resistance pattern of different lines of trypanosomes fast to different
drugs (Williamson and Rollo, 1959). It was then suggested that
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stereospecific changes at the level of the binding of the drug are
associated with the development of resistance. Similarly the results
presented in this thesis suggest that this modification has occurred
to the extent that the carrier mediated system is no longer able to
recognise the drug. The possibility of complete physical deletion of
the carrier is regarded as untenable, as it is difficult to imagine
from the evolutionary point of view, how an organism with a high degree
of specialisation has developed a transport mechanism specific for the
uptake of the drug. Instead it is suggested that the drug normally
shares the transport mechanism of some other metabolite which presumably
is still required in the resistant line. No experiments were performed
in this work to establish the nature of this metabolite; however it is
inferred that the latter must have some structural relationship with
melarsen oxide.
An example of the kind of approach that could be followed is to
compare the transport mechanism of a structurally related metabolite
and also to study the mechanism of inhibition by the drug and in this way
it could be determined whether or not the same transport system is
being shared. A possible candidate for this could be the transport of
purines in T. brucei, metabolites which are not synthesised by the
parasite but salvaged from the host bloodstream (Gutteridge and Rogerson,
1979). The purines are nitroheterocyclic compounds which may have some
resemblance with the triazine ring of melarsen oxide.
Regarding the developments of resistance; the other uptake
mechanism so far investigated is that of pentamidine in T. brucei
(Damper and Patton, 1976b). These authors found that the resistant
lines studied developed a transport mechanism for the drug, which was
less efficient in terms of lower V and higher K values. They
max m
interpreted these kinetic parameters as indicators of a reduced number
of binding sites with also lower affinity for the drug in the resistant
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lines. Similar results to those presented here with a reduced uptake
as a result of the development of resistance have also been reported
for a chloroquine fast line of Plasmodium berghei (Macomber et al., 1966).
Finally, an estimate can be obtained for the actual intracellular
concentration of melarsen oxide at initial velocities approaching
saturation of the drug carrier in the parent line (Figure 3.39).
» -Trypanosoma! suspension used in
uptake experiments
-Volume of suspension used in
uptake experiments
-Approximate amount of melarsen gxide
found in the pellet at 80 x 10 M
extracellular concentration
45 jal Total cell volume/ml
suspension . (1/22 v/v packed
cell volume in buffer)
0.5 ml






(45 jul x 0.5)
= 0.59 10 M
The figure obtained for the intracellular drug concentration is
only an approximation to the real value. It is in fact an underestimation,
as the packed cell volume was used for the calculations. In spite of
this observation the transport of melarsen oxide is considered to be
concentrative as the extracellular concentrations used during the uptake
experiments were all in the micromolar range. The same conclusion is
obtained from the studies of Hawking (1938) on the transport of other
different aresenicals.
Concentrative transfer has been observed in different tissues
specially with amino acids (Johnstone and Scholefield, 1965; Neame,
1968; Wilbrant and Rosenberg, 1961). Indeed it is suggested as a
some
general characteristic of^carrier mediated processes (Goldman, 1973;
Stein, 1967) .
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4.2.14 The influence of temperature on the transport of melarsen oxide
in parent and resistant lines
The influence of temperature on a transport mechanism provides
valuable information on the nature of the mechanism itself (Goldman,
1973). The influence of this parameter on the rate of uptake of melarsen
oxide by parent and resistant line organisms is used to substantiate
the results already obtained in the concentration dependance experiments
of the last section.
A transport mechanism with a high was observed in the parent
line, compared to a low transport mechanism at very low rates of
transport of the drug, in the resistant line (Figures 3.36 and 3.37)
The temperature dependance of the uptake of melarsen oxide in the
parent line suggests a carrier mediated process of transport (Kaback,
1968; Koch, 1964; Goldman,1973). The molecular implication of
temperature dependant transport is not completely clear; however it
is suggested that this temperature dependance is connected with the
structure of the phospholipid matrix of the membrane (Kaback, 1968),
which in turn defines the fluidity characteristics (Harrison and Lunt,
1975). It has also been reported that membrane fluidity is directly
correlated to the permeability properties of the membrane (Chapman and
Dodd, 1971).
The low Q transport observed in the resistant line may be
interpreted in terms of simple diffusion. It has been suggested that
in general the temperature sensitivity of a simple diffusion system is
not as great as that of a carrier mediated process (Goldman,1973).
4.2.15 The thermodynamic characteristics of the transport system in
parent and resistant lines
Assuming that the transition state of a drug entering a membrane
is describable from data on the temperature sensitivity of the rate of
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transport the Arrhenius equation may be used to define the thermodynamic
parameters of the mechanism of transport of the drug. This type of
analysis has been performed in studies on the transport phenomenon of
different permeants in various cell systems (Stein, 1967) . Indeed the
same approach was also used to calculate some thermodynamic parameters
for the transport of pentamidine in T, brucei (Damper and Patton, 1976b).
From the data obtained on the temperature dependance of the transport
of melarsen oxide (Figure 3.38), values were calculated for Ea; AS+;
A H+ and AG+ for the transition state of the drug uptake in parent and
resistant lines. A comment however should be made before going into
further interpretation: as the rate of transport at low temperatures
in the parent line approached the rate of transport in the resistant line
(Figure 3.37), it is assumed that the low transport is also present
in the parent line. Therefore for the thermodynamic calculations the
rate of transport in the parent line has been corrected for the low
values found in the resistant line at the different temperatures studied.
With regard to the thermodynamic parameters obtained, the high Ea
value found in the parent line is suggested as further evidence for the
presence of a carrier mediated system. The low Ea value found in the
resistant line is characteristic of a simple diffusion system.
Similarly the temperature dependency of amino acid transport in bacteria
has been used to substantiate the possibility of a carrier mediated
system in these organisms (Oxender, 1972). As found in this work for
melarsen oxide, the amino acid transport in bacteria was minimal at low
temperatures.
The other two parameters Ah+ and As+ are difficult to interpret in
biological terms. However by analogy with an enzymic reaction (Cornish-
Bowden, 1979), AH+ and AS+ of the transport mechanism of melarsen oxide
may provide some information about the nature of the transition state
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and hence about the reaction mechanism. A large AH+ indicates that a
large amount of "stretching and squeezing" of chemical bonds is
necessary for the formation of the transition state. As+ gives a
measure of the inherent probability of the transition state.
With regard to the negative values of AG+ it is suggested that the
formation of the transition state is favoured in both transport
processes. However further thermodynamic considerations are of limited
value as other characteristics with respect to the structure of the drug
carrier, the drug itself and the kinetics of the transport system play
an important role in the description of the transport mechanisms.
4.2.16 The uptake of sodium melarsen in parent and resistant lines
It was found experimentally that pentavalent sodium melarsen was
non-trypanocidal in vitro. The results of experiments described in this
thesis, on the uptake of the pentavalent analogue of melarsen oxide,
also show that the drug is not absorbed by the trypanosomes under the
experimental conditions used (Section 3.6.10). A similar conclusion
was reached by Hawking (1937) when working with the trivalent and
pentavalent forms of tryparsamide. Therefore the suggestion that
reduction of the pentavalent drug is required prior to penetration into
the parasite is corroborated in this work as there was no apparent
uptake of pentavalent sodium melarsen. Possibly reduction of the drug
may occur on contact with host erythrocytes (Lourie et al., 1935).
Supporting evidence for extra trypanosomal reduction can also be found
in the work of Rollo et al. (1949), where it was found that immediately
after injection with melarsen oxide the trypanocidal titres of rabbit
serum reached maximal values, but that about 6 hours were needed to
reach the same levels when sodium melarsen was used.
With regard to the mechanism of transport of melarsen oxide, it is
inferred from the lack of transport of the pentavalent analogue that the
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uptake of the trivalent arsenical may involve the binding of thiol groups
at the site of the carrier for the drug in the parasites. Indeed thiol
involvement is a characteristic of some carrier mediated systems
(Goldman et al., 1968; van Stevenick et al., 1955). This feature is
concluded from the inhibition produced by sulphydryl reagents on
different carrier mediated mechanisms, including the inhibition of
glucose transport in T. brucei by para-hydroxymercuribenzoate (Gruenberg
et al., 1978).
Further experimental data on the effects of these antagonists,
on the uptake of the trivalent analogue in vitro, should be obtained
to substantiate the hypothesis of thiol involvement at the site of the
carrier.
4.2.17 The effect of a metabolic Inhibitor on the transport of melarsen
oxide
As reported in the Introduction LS forms of T. brucei have an
absolute dependance on the ATP generated from glycolysis for metabolic
needs. Furthermore, iodoacetate (IAA), a classical metabolic inhibitor
(Lehninger, 1975) has been reported to inhibit the metabolism of
members of the Brucei group (Williamson, 1959b). When the effect of
IAA was studied on the transport of melarsen oxide in the parent line
(Figure 3.44), it was found that the inhibition of the transport depends
on the concentration of the inhibitor. Therefore it may be suggested
that the transport of melarsen oxide is apparently energy dependant under
the experimental conditions used as the trypanosomes were 100% mobile
after incubation with IAA for 30 seconds.
This suggestion does not rule out the possibility of thiol interaction
with IAA at the membrane level. As has been discussed in Section 4.2.16
the binding of melaminyl arsenicals may involve interaction with available
-SH groups. Therefore the effect of IAA may have some inhibitory component
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on the transport of the drug by the possible reaction with the -SH
groups at the site of uptake.
4.2.18 The effect of melamine on the transport of melarsen oxide
It has already been reported that melamine interferes with the
action of melaminyl arsenical in vivo and that it occurs at the level
of binding of the drug to the parasite (Williamson, 1959c).
The results presented in this thesis show that the inhibition
produced by melamine on the transport of melarsen oxide is directly
related to the concentration of the inhibitor (Figure 3.41). Further
investigation on the binding of melarsen oxide by the parasite, in the
presence of malamine, suggests that the inhibition of the transport was
mainly due to competition with the drug at the site of uptake (Figure
3.42) . It is also inferred from the nature of the competition that the
transport of melarsen oxide is specific for the melaminyl residue of
the drug, as the inhibition is sharing part of the binding site with a
major competitive component. It is also inferred from these experiments
that the maljminyl ring in melarsen oxide is required for the recognition
of the drug at the binding site. As reported in Section 4.2.16,
the arsenical moiety in the drug may also participate in the recognition
of the binding site as the state of oxidation is important for the
uptake of melarsen oxide. When the K value for melamine was calculated
(Figure 3.43), the figure obtained (7.0 x 10 ^M) was lower than the K
-6
value (14.5 x 10 M melarsen oxide); this is possibly due to the
minor uncompetitive component found when studying the mechanism of
inhibition of uptake of melarsen oxide by melamine.
4.2.19 The effect of different arsenicals on parent and resistant lines
The sensitivity to other arsenicals was tested in both parent and
resistant lines. The structural analogues of melarsen oxide used were
para-aminophenyl arsenoxide, phenyl arsenoxide and sodium arsenite.
The motility tests performed on both lines of the parasites (Table 3.11)
showed that para-aminophenyl arsenoxide and phenyl arsenoxide are still
active against the resistant line. Inorganic arsenite did not have any
effect on parent and resistant lines. Furthermore when uptake studies
were performed on the different structures mentioned above (Figure 3.40)
it was found that phenyl arsenoxide was transported equally effectively
by both lines; however para-aminophenyl arsenoxide is taken up to a
lesser extent by resistant line organisms.
The sensitivity of the melarsen oxide resistant line to neutral
aromatic arsenicals is of relative importance as it has been reported
that a sodium melarsen resistant line developed by Rollo and Williamson
(1951) was resistant to arsenicals of the neutral aromatic type
(Table 1.4). Two alternatives are put forward to explain the differences
observed. The first one related to the oxidation state of the arsenic
moiety is untenable, as it has been reported that this moiety needs to
be in the reduced form before any uptake can take place. Furthermore
it was observed in this thesis that the pentavalent sodium melarsen is
not taken up by the parasite (Section 3.6.10); both observations are not
consistant with the proposition. The second alternative takes into
account the method for the production of the resistant line used by
RolL and Williamson (1951) as the trypanosomes were exposed to the drug
with the relapse method; with this routine the parasites are under
the continuous influence of the drug after inoculation of the infected
hosts until a new trypanosome relapse develops and the parasites are
transferred to a new host. The possibility is that the continuous
influence to the drug may have operated in such a way that the selective
pressure allowed only the development of organisms with resistance to
the entire active agent and hence the cross resistance with neutral
aromatic arsenicals.
165.
With the method used in this thesis, the short passage, the
trypanosomes are taken from the exposed animal to drug untreated
hosts before a considerable reduction in the parasitaemia has occurred,
therefore the selective drug pressure may be lower than the drug
pressure exerted using the relapse method. Thus the organisms did
not develop resistance to the entire drug but to the melaminyl part
of melarsen oxide. This alternative is only an inference as more
experimental data is needed to substantiate it.
Regarding the transport of the different arsenicals studied it is
observed that phenyl arsenoxide was taken with a high rate of uptake
when compared with the other structures, although the high trypanocidal
effect of the drug immobilised the trypanosomes very quickly even at
very low extracellular drug concentration (Table 3.11). As for melarsen
oxide a concentrative effect is observed for the drug; it is suggested
that the drug is apparently taken up by a carrier mediated mechanism
but due to the high trypanocidal effect associated with the drug,
the saturation of the carrier cannot be observed under the conditions
used. Further discussion on this carrier mechanism is presented below.
The second structure studied para-aminophenyl arsenoxide shows a
clear saturation effect in both parent and resistant line; furthermore
a differential uptake is apparently operating in the resistant line as
a higher K for the drug is observed (Section 3.40). The feature is
m
interpreted as a carrier mechanism with less affinity for the drug.
Damper and Patton (1976b) found that among the characteristics developed
for the transport of pentamidine in a resistant line of T. brucei to
this drug y/as a lower affinity for the drug. This characteristic
modification of active transport mechanisms with loss of affinity for
the drug is also observed in different cell lines derived from
cancer tumours (Goldman, 1973).
The observation that the transport system of para-aminophenyl
arsenoxide has been affected by the development of resistance, as shown
by partial resistance to the drug, suggests that this structure is
sharing the same binding site for melarsen oxide in the parasite.
It is more difficult to decide whether or not phenyl arsenoxide is
showing the same transport mechanism with the other drug studied.
Similar results to those presented here were obtained by Hawking
(1937) and Eagle and Magnuson (1944) when working with T. rhodesiense
and T. equiperdum respectively; they reported that aromatic arsenic
resistant lines of these parasites did not absorb organic arsenicals
containing an amide group, but still absorbed and were inhibited by
arsenicals having either unsubstituted phenyl arsenoxide or carrying
the substituents CI or CH^. It appears that the unsubstituted
phenyl arsenoxide may have a separate site of uptake; this proposition
is untenable as it means that more than one normal site of uptake is
being shared by different organic arsenicals (see Section 4.2.13).
Instead it has been suggested (King and Strangeways, 1942) and still
quoted by Adrient(1973) that compounds like phenyl arsenoxide%without
any other hydrophilic group,enter, the cells due to its lipid solubility.
This latter observation is difficult to substantiate as it has been
observed in this thesis that; 1) there is a possible involvement of
the trivalent arsenic moiety in the binding of the drug, 2) the
concentrative effect observed for this drug, an observation inferred
from the results of Hawking (1937) on the transport of this drug,
3) the high rates of uptake at which the drug is taken from the
extracellular compartment and 4) the structural similarities with the
other drugs studied. Therefore it is concluded that the uptake of
phenyl arsenoxide is carrier mediated, and furthermore that the transport
mechanism is the same as for melarsen oxide and para-aminophenyl
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arsenoxide with the difference that the development of resistance to
melarsen oxide is not able to modify the transport of this structure.
A similar conclusion to that presented here is reached when studying
the uptake of different diamididines in T. brucei (Damper and Patton,
1976b) .
Inorganic arsenite was not taken up by any of the parasites
(Figure 3.40) so it is assumed that the organic part of the molecule
is needed for the uptake. Further studies on the mechanisms of
inhibition of the transport systems of the drugs studied are needed to
substantiate the inferences postulated with respect to the transport
of arsenicals in T. brucei, as these studies may confirm whether or not
the same active site is used for the different drugs. Some technical
difficulties have to be overcome in order to complete these studies:
1) very rapid techniques for exposure of the cells to the drug and
the respective transport inhibitors are needed, as both would be active
trypanocidal agents; 2) specific assay systems must be developed to
estimate the levels of the particular drug studied. The technique used
in this work for the estimation of arsenicals could not differentiate
between the inhibitor and the permeant and misleading results would be
obtained.
4.2.20 A model for the binding site for the transport of some organic
arsenicals
In spite of the lack of evidence on the modes of competition of
the different drugs used, a hypothetical model for the site of transport
of some organic arsenicals may be suggested to resume the results
obtained with the transport studies.
As observed in Figure 4.2 the model has three main sites.
Site one is suggested to participate in the binding of the melaminyl
part of the drug and has been shown from the competition studies to
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be specific for the binding of this structure. This site is mainly
affected by the development of resistance to melarsen oxide (Figure
3.46(1)). Support for this proposition is obtained from the cross
resistance studies of Williamson and Rollo (1959), which implied that
the resistant character to melaminyl arsenicals was developed towards
the amidine linkages (=N-C=N) in the triazine ring of the drug and that
I
this modification was at the level of drug binding by the parasite.
Site two of the model intervenes in the binding of the aromatic
residue of the drug; it is suggested that this site is affected only
to a limited extent with the development of resistance. As shown in
this work, the substituent in the para-position of the phenyl arsenoxide
may serve as evidence to illustrate this point. It was also found
that the melarsen oxide resistance line was partially resistant to
para-aminophenyl arsenoxide (Figure 3.40). Again some preliminary
evidence is found in the work of Williamson (1959a) when studying the
effect of antagonists on the action of different arsenicals in vivo and
in vitro. It was found that although melamine was a good antagonist
of melaminyl arsenicals (see above) para-aminobenzoic acid also showed
similar properties as melamine but to a lower extent; due to the
structural similarities of this antagonist and the aromatic part of
melarsen oxide it is suggested that the effect of the former is
probably produced by competition for site two of the binding site.
Mud (1945) commented on the importance of the para-aminophenyl residue
that there were structural similarities of a series of compound with
this particular structure i.e. sulphonamides, local anaesthetic esters
of para-aminobenzoic acid and organometallic antiprotozoal agents.
The argument was further discussed by Williamson (1959a) as he suggested
the existence of a common and widely distributed cellular reaction
site for such structures.
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At this stage it is important to stress the need for a binding
site shared not only by melaminyl arsenicals but also by aromatic
arsenicals and which also explains the partial resistance mentioned
above with respect to para-aminophenyl arsenoxide. A single binding
site will explain as well the findings of Williamson and Rollo (1959)
regarding the complete cross resistance between sodium melarsen and
other aromatic arsenicals; and also the lack of cross resistance
to melaminyl arsenicals showed by an atoxyl resistant line of
T. rhodesiense. A modification of site two in the model will not
necessarily impair the uptake of melaminyl arsenicals, which as shown
in this work needs the melaminyl residue for an effective binding.
Also this residue increases the affinity of the binding site for the
drug when compared with the amino substituted phenyl arsenoxide.
Using the same reasoning, the activity of melaminyl arsenicals against
tryparsamide resistant trypanosomes reported by van Hoof (1947) can
be explained.
On the other hand melaminyl resistant trypanosomes may or may not
show cross resistance with aromatic arsenicals, as this will depend on
the extent to which the trypanosomes are exposed to the drug during
the development of the resistant character. This suggestion is
made on the basis of the comparison reported in Section 4.2.19 on the
development of melaminyl arsenical resistant lines using different
methods.
Site three of the model seems to involve the presence of available
-SH groups. This observation is inferred from the lack of uptake of
the pentavalent melarsen oxide when compared with the trivalent
analogue; this characteristic of the model will also explain the
lack of uptake of pentavalent tryparsamide in T. rhodesiense (Hawking,
1937). Inorganic arsenite was not apparently taken up under the conditions
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of rapid exposure to drug used in this work. However long term exposure
to the drug showed that the drug is taken up and is lethal to the
parasites (Hawking, 1937). It has been found that this arsenical
reacts with simple dithiols such as dimercaprol but not to monothiols
such as glutathione (Aldrigde and Cremer, 1955) hence it is proposed
that site three may have at least two -SH groups for the binding of
trivalent arsenicals.
It is clearly understood that the model proposed is relatively
complex in its structure. However further investigation in relation to
its validity may be useful from the rational chemotherapy point of view,
as any information derived from it may help to increase the understanding
of the mechanism of action of organic arsenicals at the level of binding
to the parasite.
4.2.21 Summary
For the purposes of studying the biochemical rationale behind the
development of resistance to arsenical drugs, a melarsen oxide fast
strain of T. brucei was developed using the short passage method. The
strategy followed in the study, was to compare the basic metabolism of
the new strain with the parent line as a primary examination from which
further alternative explanations for resistance could be proposed.
Although it was found that the fast strain of T. brucei developed a
minor modification in the basic metabolism of carbohydrate, this difference
could not explain directly the levels of resistance observed with the
fast organisms. Detoxication of arsenicals by antagonism with -SH
groups was studied and no differences were found between parent line
and the resistant strain.
One alternative explanation for the development of resistance is by
modification of the enzyme targets to the drug in the resistant strain.
Pyruvate kinase and phosphoglycerate kinase were studied in relation to
171.
their kinetic parameters, specific activities and sensitivity to the
arsenical drugs and no differences were found that can be suggested
as causes of the development of resistance to the drug.
The transport of the arsenicals in the parent line and the resistant
strain of T. brucei was also studied. It was found in the first place
that the uptake of melarsen oxide by the parent line showed saturation
kinetics with a concentrative effect, high temperature dependance,
inhibition by iodoacetate, competitive inhibition by a structural
analogue and finally that -SH groups may be involved at the drug binding
site. As a result of this evidence it was concluded that the drug was
transported by a carrier mediated active process. Furthermore, the
i
kinetic results show a complex mechanism of transport in terms of the
interaction with the membrane.
Regarding the development of resistance, it was observed that the
fast strain lost the capacity for active transport of the drug and
instead a simple diffusion system is responsible for the uptake of
low levels of melarsen oxide. As no direct evidence of modification was
found when testing the other alternatives,the differential drug uptake
is concluded as being responsible for the development of resistance.
It is inferred that the carrier mechanism is modified in the resistant
is
strain and/,-either absent, or can no longer bind the drug.
Further studies on the uptake of other organic arsenicals suggest
the possibility of a single binding site at the membrane level for the
drugs tested. A modification of part of the binding site is apparently
responsible for the development of resistance to melarsen oxide;
this modification does not necessarily alter the uptake of other drugs
using the same carrier. Further studies are suggested on the structure
of the transport mechanism, if possible with a more sensitive method
of estimation for the drug.
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